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Abstract
Blood pressure varies over 24 hours with levels during sleep about 20% less than those
during the day. Variations in this pattern are now recognised, and preliminary work
suggests that those whose pressure does not fall at night - "non-dippers" - may have a
greater prevalence of cardiovascular disease. This thesis, based on clinical studies
utilising non-invasive ambulatory BP monitors (ABPM), explores the nature and potential
clinical significance of diurnal blood pressure variation in detail.
ABPM is of proven accuracy in sinus rhythm, but its reliability has not been
demonstrated in patients with cardiac arrhythmia. Validation of two commonly used
ABPMs in patients with atrial fibrillation has demonstrated significant device inaccuracy,
and such patients have therefore been excluded from further clinical and research study.
The optimal method for characterising the diurnal BP profile remains unknown but a
change in the definition of night-time has been shown to have a major impact upon the
nocturnal dip. A more physiological description, using sleep time, can be achieved using
electronic activity meters to quantify sleep. The potential to improve reproducibility by
correcting for day-time activity levels has also been explored.
Analysis of ABPM recordings from a large, heterogeneous population has
demonstrated approximately Normal distribution of the nocturnal dip, with no evidence of
bimodality. This study has also shown age, but not severity of hypertension, to be an
important determinant of diurnal variability, while anti-hypertensive drug treatment, as
used in normal clinical practice, appears to have no significant independent effect.
Blunting of diurnal variability in some forms of secondary hypertension has been
confirmed. Study of such patients provides an insight into potential mechanisms
underlying the nocturnal dip. Catecholamine excess appears to have a profound effect,
confirming the importance of the autonomic nervous system in its regulation. Attenuation
of the dip in those with volume mediated hypertension and those with impaired renal
function suggests that hypervolaemia resulting in posture related changes in BP may also
impact upon this rhythm. Glucocorticoid excess has been shown to blunt diurnal
variability, but a modest increase in glucocorticoid exposure in hypopituitary patients has
no effect, suggesting that pathological but not physiological quantities of corticosteroid are
required to modify the diurnal rhythm.
Study of patients with accelerated phase hypertension has demonstrated loss of the
diurnal rhythm which returns towards normal with successful treatment. However, such
patients are commonly hospitalised and study of other groups requiring emergency
hospital admission suggests that this process may in part explain this effect.
Mean wake blood pressure has been shown to be the most important predictor of target
organ damage, assessed by echocardiography and microalbuminuria, but some further
independent predictive information is provided by knowledge of diurnal variability.
The hypothesis that occult sleep apnoea or nocturnal hypoxia may account for loss of
diurnal variability is tested. Patients with essential hypertension, sleep apnoea syndrome
and chronic obstructive pulmonary disease were studied, with no direct link between
nocturnal hypoxaemia and the night-time BP dip apparent.
A potential active role for the heart in the control of the diurnal rhythm is examined in
a study of patients with mild cardiac failure starting treatment with an ACE inhibitor. The
nocturnal dip was preserved but blunted, and was reduced still further by treatment, due
to a greater fall in day than night BP.
Diurnal BP variability is a complex phenomenon which, although intrinsically related
to sleep, is influenced by many other variables. Factors affecting the rise in BP during the
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Introduction : The Measurement Of Arterial Blood Pressure
Historical Background
The development of methods for the measurement of blood pressure (BP) had, of
necessity, to await the description of the circulation by William Harvey (1628). A further
century then had to pass before the pressure exerted by the heart on the circulation was
first measured by the Reverend Stephen Hales who, in 1733, cannulated the femoral artery
of a horse and measured the vertical height to which blood rose in a glass tube some 9 feet
in length (Hales, 1733). In 1828 this procedure was simplified by Poiseuille, who used a
much shorter U-tube filled with mercury and measured arterial pressure in millimetres of
mercury for the first time (Poiseuille, 1828). Poiseuille was also the first to recognise that
the same pressure is maintained throughout the arterial tree. In 1847 Ludwig connected
Poiseuille's manometer to a writing pen attached to a revolving smoked drum, thus
enabling the recording of changes in the arterial pressure (Ludwig, 1847). This
instrument was used by Faivre during a limb amputation to record the systolic blood
pressure for the first time in man (Faivre, 1856).
However, routine blood pressure measurement in man required a non-invasive technique.
Vierordt (1855) was the first to attempt this, in 1854, using a scale pan attached to a lever
pressed on the radial pulse, to determine the weight in grams required to obliterate the
radial pulse - the sphygmograph. Mahomed, working in Guy's Hospital in London,
modified this device (Mahomed, 1872) and began to apply these techniques to human
disease for the first time. Thus, in 1874 he described the association between high blood
pressure and acute nephritis (Mahomed, 1874). The potential importance of an accurate
technique for the measurement of blood pressure was beginning to be appreciated.
The sphygmograph, while capable of giving a pulse wave tracing, was not an accurate
device for measuring blood pressure, largely because it took no account of the size of the
arterial surface being compressed (Lawrence, 1979). Further refinement of the indirect
measurement of blood pressure was described by von Basch (1880). In experiments on
cadaver arteries he was able to demonstrate that the pressure required to occlude the
lumen of an artery equals the pressure within the vessel plus that required to overcome
wall rigidity. As the rigidity of arteries was small, the occlusion pressure was a
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reasonable estimate of the intra-arterial pressure. He then developed a device - which he
called the 'sphygmomanometer' - utilising a fluid-filled rubber bulb which was used to
compress the radial pulse, with the pressure required to achieve this forcing water from
the bulb into a manometer; the point of disappearance of the pulse being taken as the
systolic pressure. Importantly, this instrument provided an estimate of pressure per unit
of surface, overcoming the major limitation of the sphygmograph. Zadek (1880) used this
sphygmomanometer extensively and was probably the first to observe the variability of
blood pressure under different measuring conditions.
The von Basch sphygmomanometer, although the first reasonably accurate device for
clinical measurement of blood pressure, was flawed in that it assumed that the artery could
be uniformly compressed against underlying bone. The prototype of the modern mercury
sphygmomanometer was devised by Riva-Rocci who, in 1896, placed a band around the
upper arm and inflated it with air until the pressure was sufficient to obliterate the pulse
(Riva-Rocci, 1896). By releasing the air gradually while observing the pressure on a
manometer and palpating the pulse, he was able to record the systolic pressure,
overcoming the deficiencies of von Basch's device. It was not long, however, before a
serious source of error was noted with this instrument. First von Recklinghausen (1901)
and then Janeway (1904) showed that the 5 cm wide cuff used by Riva-Rocci resulted in
erroneously high systolic pressures, which could be corrected by using a 12 cm cuff.
Contemporaneously Hill and Barnard were developing their own sphygmomanometer,
utilising an aneroid gauge connected to an arm cuff, which was the first device capable of
recording both systolic and diastolic pressure (Hill & Barnard, 1897). Although Hill
referred to diastolic blood pressure (Hill & Barnard, 1897), it was Janeway (1904) who
described the correct use of their device, demonstrating that the point of maximum
oscillation of the needle corresponded to diastolic and not, as previously thought, to mean
arterial pressure.
The major disadvantage of this device was that the gauge became inaccurate with use and
frequent recalibration was necessary. This led to methods of determining diastolic blood
pressure by observing the oscillations in a mercury manometer, rather than on an aneroid
gauge, and indirectly to the auscultatory measurement of systolic and diastolic pressure.
Janeway (1901) described the occurrence of sounds during deflation of the cuff but it was
Korotkoff (1905) who related these sounds to the systolic and diastolic pressure :
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'The cujf of the Riva-Rocci is placed on the middle third of the upper arm; the
pressure within the cuff is quickly raised up to complete cessation of circulation below the
cuff. Then, letting the mercury of the manometer fall one listens to the artery just below
the cujf with a children's stethoscope. At first no sounds are heard. With the falling of
the mercury in the manometer down to a certain height, the first short tones appear; their
appearance indicates the passage ofpart of the pulse wave under the cuff. It follows that
the manometric figure at which the first tone appears corresponds to the maximal
pressure. With the further fall of the mercury in the manometer one hears the systolic
compression murmurs, which pass again into tones (second). Finally, all sounds
disappear. The time of cessation of sounds indicates the free passage of the pulsewave; in
other words, at the moment of the disappearance of the sounds the minimal blood pressure
within the artery predominates over the pressure in the cuff. It follows that the
manometric figures at this time correspond to the minimal pressure.' (Laher & O'Brien,
1992)
The equipment used has since been modified to improve accuracy, but the technique is
essentially unchanged.
Blood Pressure Measurement and the Mercury Sphygmomanometer
In 1939, in an attempt to standardise the technique for the measurement of blood pressure,
the American Heart Association and the Cardiac Society of Great Britain and Ireland
issued joint recommendations on methods of blood pressure determination (American
Heart Association, 1939). These have subsequently been updated at intervals as
appropriate by the American Heart Association (AHA) in the US (Frohlich et al, 1988)
and the British Hypertension Society (BHS) in the UK (Petrie et al, 1986) and, despite
some vacillation over the issue of the diastolic end-point (Frohlich et al, 1988), are now in
broad agreement. With careful attention to detail, the mercury sphygmomanometer
provides accurate, reliable and reproducible blood pressure measurement.
In clinical practice, however, errors in blood pressure determination are common.
Despite the AHA, BHS and World Health Organisation all recommending the routine use
of Korotkoff sound phase V, many physicians continue to record phase IV (Manek et al,
1984, Padfield et al, 1990). As the vast majority of epidemiological data (Kannel, 1974)
and the major therapeutic intervention trials (Management Committee, 1980; Medical
Research Council Working Party, 1985) have used phase V readings, and as there are
greater errors in the identification of phase IV (Freis & Sappington, 1968), the arguments
in favour of the universal use of phase V (with the possible exception of readings in
children, when sounds may persist to zero) are overwhelming.
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Controversy over the appropriate euff size continues. The AHA recommend the use of a
cuff with a ratio of bladder width to upper arm circumference of 0.4 (Frohlich et al,
1988). The bladder length should be at least twice the width, thus ensuring that the
bladder will encircle 80% of the arm, and the centre of the bladder should be over the
brachial artery. A bladder which encircles the arm completely correlates better with intra¬
arterial recordings (Russell et al, 1989; Croft & Cruickshank, 1990), yet the standard
adult cuff (12 by 23 cm) will encircle only 33% of adult arms. The British Hypertension
Society therefore recommends the use of a standard cuff measuring 12 by 35 cm, which
would encircle 99% of adult arms (Petrie et al, 1986). Under-estimation of pressure with
larger cuffs is not a problem in practice (Croft & Cruickshank, 1990). As many as 14%
of hypertensive patients may have spurious elevation of BP related to use of a standard
cuff (Linfors et al, 1984). Pseudo-hypertension in the elderly (Messerli et al, 1985) is
probably an artefact related to inappropriate cuff size and is not seen when larger cuffs are
used (O'Callaghan et al, 1983; Linfors et al, 1984).
Observer bias, particularly when there is an arbitrary division between normal and high
blood pressure, is a common cause of error in blood pressure measurement, the magnitude
of which is sufficient to have important implications for both research and management
(Bruce et al, 1988; Padfield et al, 1990), and the reduction in bias seen with re-training of
observers is short-lived (Bruce et al, 1988). Terminal digit preference is also widespread,
with as many as 84% of systolic and 73% of diastolic values being recorded to the nearest
'0' (Hessel, 1986; Padfield et al, 1990). As this tendency tends to be more common
around diagnostic levels for hypertension (Padfield et al, 1990), this could well affect the
level of treatment in a population. The Hawksley random- zero sphygmomanometer,
designed to reduce the effect of observer bias, introduces computational error and may
also be subject to additional, systematic machine error (O'Brien et al, 1990b).
Problems with the equipment in common usage are also widespread, with as many as a
half of hospital sphygmomanometers being defective (Burke et al, 1982), and regular
maintenance being the exception rather than the norm. Aneroid sphygmomanometers,
which are commonly used by general practitioners, are even more susceptible to failing
accuracy if not regularly serviced (Burke et al, 1982).
Blood Pressure Variability and "White Coat" Hypertension
Ayman and Goldshine (1940) first reported that the blood pressure of hypertensive
patients measured in their own home was substantially lower than that recorded in the
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clinic and they suggested that home measured pressure may he a better indicator of
prognosis. At around the same time Smirk and co-workers (Smirk, 1944; Smirk et al,
1959; Smirk, 1964) were studying casual (clinic), basal and supplemental blood pressures
in essential hypertension. Basal blood pressure was that measured after subjects had spent
a night in a single room under mild sedation using a barbiturate, and had been habituated
to the blood pressure measuring procedure. Supplemental pressure was defined as the
difference between casual and basal blood pressure and is the more variable part of the
casual pressure, representing the response of the individual to the current environment
(Smirk, 1944). Basal blood pressure was shown to be a strong predictor of morbidity and
mortality, while supplemental pressure had little predictive value (Smirk et al, 1959;
Smirk, 1964).
However it is only with the development of techniques for monitoring blood pressure
throughout 24 hours that the extent of the variability of arterial pressure has been
appreciated (Richardson et al, 1964; Raftery, 1983). Ambulatory intra-arterial recording
of blood pressure demonstrates that it is a continuous variable with considerable beat-to-
beat and minute-to-minute variation (Raftery, 1983). Consequently any non-invasive
measure of BP can only be a rough estimate of a subject's true pressure, with repeated
measurements over a period of time improving the precision of the estimate (Armitage &
Rose, 1966; Armitage et al, 1966). Conventional clinic blood pressure measurement
should be performed twice per visit for at least three visits (Rosner & Polk, 1981), and
preferably more often (Littler & Komsuoglu, 1989), to achieve a reasonable estimate of
hypertensive status, and this process should be repeated each time a change in anti¬
hypertensive therapy is considered.
In addition to spontaneous variability in pressure, a large proportion of subjects who come
to a doctor's clinic show a transient rise in blood pressure, seen almost immediately after
the arrival of the doctor, peaking within 1 to 4 minutes and averaging 27/15 mmHg in one
study (Mancia et al, 1983a). This response is highly variable, with the rise in systolic
pressure ranging from 4 to 75 mmHg, and is unrelated to age, sex, baseline blood
pressure or blood pressure variability (Mancia et al, 1983a). It persists with repeated
visits over a short time span (Mancia et al, 1987) and as the rise is also seen when a
subject measures his own pressure in the presence of a doctor (Mengden et al, 1990), it is
clearly due to subject-doctor interaction, rather than the measuring procedure itself. A
similar but smaller rise is seen when BP is measured by a nurse (Mancia et al, 1987).
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As a result of this "white coat" hypertension, between 20 and 50% of subjects with
borderline hypertension may be misclassified as hypertensive (Laughlin et al, 1980;
Pickering et al, 1988; Hall et al, 1990) and started on treatment, perhaps unnecessarily
(O'Brien & O'Malley, 1988). In both the Medical Research Council (Medical Research
Council Working Party, 1985) and Australian National Blood Pressure studies
(Management Committee, 1980) a fall in blood pressure to normotensive levels was seen
in up to 50% of placebo treated patients and these subjects had a similar prognosis to
hypertensive subjects with the same blood pressure on anti-hypertensive therapy. This fall
largely occurred in the first 3 to 4 months and, as no clinically significant placebo effect is
seen when 24-hour mean ambulatory pressure is measured (Gould et al, 1981; Mutti et al,
1991) it seems likely that this fall in pressure with time is due to both diminution of the
"white coat" effect and regression to the mean.
"White coat" hypertension may not be an entirely benign condition. Epidemiological
studies show that a single clinic blood pressure reading is predictive of cardiovascular
morbidity and mortality (Kannel, 1974). Furthermore, in the Tecumseh study subjects
with "white coat" hypertension have a cardiovascular risk profile and haemodynamic
parameters (vascular resistance and minimal forearm resistance) similar to those with
sustained hypertension and significantly different from a normotensive group (Julius et al,
1990). In contrast to patients with borderline or mild hypertension, the clinic blood
pressure of normotensive subjects tends to be slightly lower than the day-time average
ambulatory blood pressure (O'Brien et al, 1991c). The "white coat" effect may, then, be
one of the earliest clinical indications of the transition from a "normotensive" to a
"hypertensive" state (Cox et al, 1991a). Thus, while such patients are probably at lower
risk of hypertensive complications and may not require anti-hypertensive therapy, they
should be monitored and counselled on non-pharmacological methods of blood pressure
control and the modification of other cardiovascular risk factors.
Home (Self) Monitoring of Blood Pressure
In addition to the diagnosis of "white coat" hypertension, home monitoring of blood
pressure by a patient or a member of the family allows more frequent readings of blood
pressure over a short time period, improving diagnostic accuracy. The average home
pressure over a period of three days predicts the ultimate clinic pressure of newly
diagnosed hypertensives after 4 weeks with an accuracy of 79% (Padfield et al, 1987).
Home pressure is highly reproducible (James et al, 1988) and remains stable over a four
week period (Jyothinagaram et al, 1990a). It has also been shown to correlate better than
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clinic BP with left ventricular hypertrophy (Kleinert et al, 1984) and its regression
(Ibrahim et al, 1977).
Home measured BP is devoid of a placebo effect (Cottier et al, 1982) and should provide
a better guide to changes in drug therapy (James et al, 1988). It may also be of benefit
when assessing the effect of new anti-hypertensive agents in clinical trials (Gould et al,
1986). Blood pressure measurement with an electronic sphygmomanometer will abolish
observer bias, which may be an advantage in clinical and epidemiological studies, and
machines of proven accuracy are available (Jamieson et al, 1990).
Self-monitoring techniques can also improve patients' understanding of their disease and
many patients appreciate the opportunity to participate in the management of their disease
(Hunt et al, 1985), which may improve patient compliance (Edmonds et al, 1985).
Conversely, other patients may become overtly conscious of minor fluctuations in
pressure, which could result in anxiety and possibly inappropriate self-adjustment of
therapy (Hunt et al, 1985). Inadequate instruction may lead to inaccurate readings,
misleading both the patient and the physician. Detailed education on correct methodology
is therefore of considerable importance (World Hypertension League, 1988).
At present, there is no agreed standard for the frequency or duration of self-measurement
regimes, with published work ranging from blood pressure readings taken twice daily for
one week to six times daily for fourteen days or longer (Julius et al, 1974; Laughlin et al,
1980; Kleinert et al, 1984; Padfield et al, 1987). A series of 5 readings a day for 3 days
has been shown to be a valid (Padfield et al, 1987) and reproducible (Jyothinagaram et al,
1990a) regimen, which is well tolerated by patients.
Home or self-measured blood pressure recording remains under utilised in the UK. This
may reflect concerns over the ability of patients to learn self-measurement techniques. In
early studies, in which patients were taught to use a stethoscope and mercury
sphygmomanometer, many patients were unable to master the technique (Julius et al,
1974; Burns-Cox et al, 1975; Laughlin et al, 1980). However techniques for self-
monitoring have become simpler with the development of micro-electronics (Hunt et al,
1985) and a wide variety of semi-automated machines are now available. Virtually all use
a sphygmomanometer cuff and utilise either a microphone for Korotkoff sound detection,
oscillometry or ultrasound. No one technique appears to be consistently more accurate,
though oscillometric machines have the advantage of not requiring accurate cuff
placement. Fully automatic machines, which do not require self-inflation of a
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sphygmomanometer cuff, are preferable as the isometric exercise involved in self-inflation
can raise BP significantly (Veerman et al, 1990). Unfortunately the accuracy of these
machines is variable, with many inaccurate and unreliable machines marketed (Hunyor et
al, 1978; Pickering et al, 1986; O'Brien et al, 1990a) and it is important that any machine
used is validated prior to use and at regular intervals thereafter, ideally after each set of
home recordings is complete (Hall et al, 1990).
Despite the apparent advantages, prospective data on clinical outcome based on home
monitored pressures are still lacking, and this technique therefore compliments rather than
replaces clinic BP measurement.
Ambulatory Blood Pressure Monitoring
The development of devices for monitoring blood pressure over periods of 24 hours or
more while subjects continue their normal daily activities has added a new dimension to
the evaluation of the hypertensive patient. Early work with invasive, intra-arterial
monitoring systems clearly demonstrated the extent of the variability of blood pressure
throughout the day (Littler et al, 1978) and the extent of the diurnal variation of blood
pressure (Littler et al, 1975). Although this technique has proved to be a valuable
research tool (Raftery, 1983), it is clearly not suited to general clinical use.
Consequently, a variety of non-invasive, fully automatic ambulatory blood pressure
recorders have been developed, generally using oscillometric or Korotkoff sound
techniques (The National High Blood Pressure Education Program Co-ordinating
Committee, 1990; Meyer-Sabellek et al, 1990). These devices can be programmed to
inflate an arm cuff automatically at pre-set intervals, typically ranging from 6 to 120
minutes, throughout a 24 to 48 hour period. Data are stored on microcomputer hardware
within the monitor and down-loaded directly onto a personal computer at the end of the
monitoring period. Data can then be edited and analysed according to pre-set criteria.
As with home monitors, the accuracy and reliability of ambulatory blood pressure
monitors is variable (O'Brien & O'Malley, 1990) but standards for the evaluation of these
devices have been agreed (Association for the Advancement of Medical Instrumentation,
1987; O'Brien et al, 1990c; O'Brien et al, 1993). When starting this work, only the
SpaceLabs 90202 (O'Brien et al, 1989b), SpaceLabs 90207 (O'Brien et al, 1991b) and
Medilog (Hope et al, 1988) systems had fulfilled the criteria of the Association for the
Advancement of Medical Instrumentation for both systolic and diastolic pressure and were
therefore recommended for routine use (O'Brien & O'Malley, 1990). The Accutracker
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device had been validated using less stringent standards (Appel et al, 1990; Jyothinagaram
et al, 1990b) and was used initially in small numbers of patients, but, in light of the
results of more detailed validations, the majority of this research utilised the SpaceLabs
90207 ambulatory monitor.
Although reasonably accurate at rest, no currently available device is accurate during
exercise (White et al, 1990) and subjects must therefore be instructed to keep their arm
motionless during each BP reading. Similarly, accuracy may be significantly reduced in
the presence of cardiac arrhythmias such as atrial fibrillation (Caramella & Desmonts,
1986) and at present this represents a serious deficiency in these devices.
Nonetheless, 24-hour ambulatory blood pressure records, with blood pressure readings
every 30 minutes or less, correspond closely to simultaneous intra-arterial recordings (Di
Rienzo et al, 1983) and are highly reproducible (James et al, 1988). No alerting reaction
or pressor response is seen with intermittent cuff inflation (Parati et al, 1985b; Brigden et
al, 1990), monitoring does not affect the normal haemodynamics of sleep (Parati et al,
1985a), and no placebo response is seen in clinical trials (Conway et al, 1988). Thus non¬
invasive ambulatory blood pressure recorders appear to accurately reflect an individual's
BP over 24 hours and will provide similar information to home blood pressure
monitoring, including the recognition of "white coat" hypertension (Pickering et al,
1988).
These machines are generally well tolerated, with less than 10% of patients being unable
to tolerate the equipment or refusing to wear it in public (Meyer-Sabellek et al, 1990), and
disturbance of sleep is less of a problem with newer, quieter devices (Meyer-Sabellek et
al, 1989). Complications are exceptionally rare. Petechiae and oedema distal to the cuff
(White, 1985), and ecchymoses (Burris et al, 1988) and thrombophlebitis (Creevy et al,
1985) at the cuff site may appear. Localised exfoliative dermatitis (Burris et al, 1988) and
allergic reactions (Meyer-Sabellek et al, 1990) have also been reported. These
complications appear to be more common with very frequent measuring intervals or when
the equipment is malfunctioning, with delayed relaxation of the cuff.
A major disadvantage of these devices is their cost, with current machines costing over
£3000 each. Computer hardware and software for analysis are also necessary, adding to
the costs. As it takes around 30 minutes to fit a device and educate a subject, personnel
costs also need to be considered. However, in patients with mild hypertension,
ambulatory monitoring has shown that as many as 40% of patients have pressures low
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enough to withhold antihypertensive treatment (Krakoff et al, 1988) and it has been
suggested that the resultant cost savings would offset the cost of the investigation (Krakoff
et al, 1988). By enabling the direction of treatment at those with the highest pressures, a
more effective reduction in cardiovascular morbidity could be achieved, while actually
lowering the cost of the drug bill.
Data Analysis
There are many different approaches to the analysis of a 24-hour ambulatory blood
pressure trace, designed to provide information on blood pressure profdes over 24-hours,
during day-time and night-time. The simplest and most widely used method is to calculate
the 24 hour, day and night mean blood pressure values. Some workers have excluded
readings in the early morning and late evening from this calculation (O'Brien et al,
1991c), when rapid changes in blood pressure may be taking place. However as there is
an excess of cardiovascular events at these times (Mitler et al, 1987), important prognostic
or diagnostic information may be omitted. Any arbitrary definition of day and night times
may also affect the mean values calculated, and analysing wake and sleep periods may
therefore be more appropriate.
Smoothing procedures, including the use of spline functions and Fourier analysis, have
been developed (Streitberg et al, 1989; Streitberg & Meyer-Sabellek, 1990). While such
methods overcome problems in analysis resulting from irregular spacing in time of blood
pressure measurements and smooth the spikes inherent in blood pressure over time, they
are complex to compute and assume, wrongly (Pickering, 1989), that blood pressure has a
natural circadian rhythm.
An alternative method of presenting and analysing data is to calculate the blood pressure
load, defined arbitrarily as the percentage of blood pressure measurements exceeding
140/90 mmHg during waking hours and 120/80 mmHg during sleep (White, 1991).
While of some prognostic relevance (White et al, 1989), this method fails at extremes in
that all normotensives will have a load of 0% and all severe hypertensives a load of
100%.
In routine clinical use, the arithmetic mean blood pressure values for wake, sleep and 24
hours remains the simplest and most appropriate way to present data.
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Prognostic Value ofAmbulatory Monitoring
Evidence that these readings are of prognostic importance and a better predictor than
clinic BP of cardiovascular risk is growing (Pickering & Devereux, 1987). Several
workers have demonstrated that mean ambulatory blood pressure is a better predictor of
echocardiographically determined left ventricular mass (Rowlands et al, 1982; Drayer et
al, 1983; Devereux et al, 1983; Gosse et al, 1988a; White et al, 1989; Verdecchia et al,
1990), a marker of hypertensive target organ damage. Patients whose ambulatory BP is
similar to clinic pressure have a higher prevalence of target organ damage (assessed by
ECG and fundal change) than those who have lower ambulatory pressure (Floras et al,
1981) and latent cerebrovascular disease, assessed by nuclear magnetic resonance imaging
of the brain, is related to mean ambulatory BP but not clinic BP (Shimada et al, 1990).
There are also two prospective studies relating clinical events to ambulatory blood
pressure. Perloff et al (1983) have followed 1076 patients for 5 years and shown that
subjects whose day-time mean ambulatory blood pressure is low relative to their clinic
pressure at presentation have a better prognosis, with lower mortality and lower incidence
of cardiovascular events, than those whose ambulatory pressure is higher. Thus, as clinic
pressures were comparable in the two groups studied, ambulatory pressure recording
appeared to provide prognostic information over and above the clinic pressure. This was
true particularly in younger patients and those with borderline or mild hypertension, in
whom the decision to treat can be the most difficult, but also applied to patients who had
already developed a cardiovascular complication (Perloff et al, 1989). However this study
depended entirely on the initial ambulatory pressure, with no information on the change in
ambulatory pressure with time, and recorded day-time pressures only.
Mann et al (1985) have followed 137 patients for a mean of 2 years with 14 subjects
experiencing a first cardiovascular event in this time. Ambulatory pressures were better
than clinic pressure at predicting these events.
Ambulatory monitoring also provides an accurate estimate of BP variability, usually taken
as the 24-hour blood pressure standard deviation (Littler et al, 1978; Floras et al, 1988),
provided readings are every 15 minutes or more frequently (Di Rienzo et al, 1983). The
importance of this measurement is not clear. Early studies (Rowlands et al, 1982; Mann
et al, 1985) did not find any correlation between BP variability and target organ damage
or cardiovascular damage. However Parati et al (1987) and Palatini et al (1985) both
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found that variability provided additional prognostic information and suggested that it may
be an independent risk factor for cardiovascular disease.
Diurnal Variation in Blood Pressure
Since the introduction of techniques for ambulatory blood pressure monitoring it has been
clear that blood pressure has a diurnal rhythm, with levels during sleep about 20% less
than during the day (Littler et al, 1975). This rhythm is generally preserved in
hypertensive patients, with an upward shift of the entire curve (Raftery, 1983), but in
about 20% of essential hypertensives (O'Brien et al, 1988) this "dip" in blood pressure
during sleep is reduced or absent. This observation has resulted in the suggestion that the
hypertensive population can be subdivided into two broad groups, "dippers" and "non-
dippers" (O'Brien et al, 1988; Pickering, 1990b). As preliminary work suggests that an
absent or reduced nocturnal dip may impart increased cardiovascular risk, this may be of
more than academic interest. O'Brien et al (1988) have reported the frequency of stroke
in a population of non-dippers to be 23.8%, compared to a frequency of only 2.9% in
age, sex and weight matched dippers with similar day-time blood pressure. Kobrin et al
(1984) studied 21 elderly (>65 years) hypertensives and found a normal diurnal blood
pressure rhythm in 14, but a reduced or absent nocturnal dip in 7. All of the non-dippers,
but only 43% of the dippers, had clinical evidence of hypertensive or atherosclerotic
complications.
Gosse et al (1988a) have found night-time BP to be the best correlate of left ventricular
mass in 24 treated hypertensives and Verdecchia et al (1990) have published the results of
a large study comparing 24 hour ambulatory blood pressure profile and echocardiographic
left ventricular hypertrophy in 137 untreated hypertensives and 98 healthy normotensives.
In the hypertensive group left ventricular mass correlated more closely with night-time
than with day-time blood pressure. Of the hypertensive patients, 40% had a reduced
nocturnal dip (< 10% of systolic and diastolic BP) and this group had a greater LV mass
index. There was an inverse correlation between LV mass index and the nocturnal dip.
Thus these data suggest that the nocturnal dip in BP prevents or delays the development of
left ventricular hypertrophy.
Shimada et al (1990) have also found that hypertensive cerebrovascular disease, assessed
by brain magnetic resonance imaging in 73 elderly, asymptomatic subjects, correlates
more closely with night-time BP than with day-time or 24-hour BP.
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Perhaps more importantly, using a retrospective case-control study, Verdecchia et al
(1993) have recently demonstrated an association between a reduced diurnal rhythm and
future cardiovascular morbid events, with the groups matched for both clinic and day time
ambulatory blood pressure. Although apparent only in women, this work is the first to
relate changes in diurnal variation to mortality.
Secondary Hypertension and the Diurnal Variation in Blood Pressure
Many, but not all, causes of secondary hypertension disturb the diurnal blood pressure
rhythm (Baumgart et al, 1989a; Imai et al, 1990; Middeke & Schrader, 1994). An absent
diurnal rhythm is seen in patients with phaeochromocytoma (Littler & Honour, 1974;
Padfield et al, 1991), end-stage renal failure (Abel et al, 1990), pre-eclampsia (Oney &
Meyer-Sabellek, 1990), Cushing's syndrome (Imai et al, 1988b) and treatment with high
dose corticosteroids (Imai et al, 1989). Sleep apnoea syndrome, which several studies
suggest is present in around 30% of treated hypertensives (Kales et al, 1984; Lavie et al,
1984; Fletcher et al, 1985), could also result in a non-dipping BP profile (Tilkian et al,
1976).
The renin-angiotensin system seems to have less influence on the blood pressure rhythm.
Early reports which suggested that patients with primary aldosteronism and renovascular
hypertension lost their diurnal variation studied older patients with more severe
hypertension (Tanaka et al, 1983). Later studies have failed to confirm these observations
(Munakata et al, 1988; Baumgart et al, 1989a). Younger patients with fibromuscular
dysplasia have a normal diurnal rhythm; and treatment with angioplasty for renovascular
hypertension or excision of an adrenal adenoma in primary aldosteronism does not affect
the rhythm (Imai et al, 1990).
Complete reversal of the diurnal rhythm is also seen in patients with autonomic failure
(Mann et al, 1983), and the nocturnal dip is attenuated or absent in patients with diabetic
autonomic neuropathy (Reeves et al, 1986; Hornung et al, 1989) and quadriplegic spinal
cord injury patients (Krum et al, 1991). Patients with cardiac failure (Caruana et al,
1988) and cardiac transplant patients (whose ventricles are denervated) (Reeves et al,
1986; Sehested et al, 1990b) also have a disturbed rhythm.
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Pathophysiology of the Diurnal Variation in Blood Pressure
The normal dip in blood pressure is intrinsically related to sleep. Junior hospital doctors
lose their nocturnal dip when on-call (Mehler & Anderson, 1987) and shift workers
reverse their diurnal rhythm when moving from night to day shift (Baumgart, 1990). This
reversal occurs immediately, without a period of adjustment, in contrast to true circadian
rhythms, suggesting that there is no "internal clock" determining the diurnal variation
(Baumgart, 1990). Patients on strict bed rest also exhibit a diurnal rhythm (Athanassiadis
et al, 1969) suggesting that activity is not solely responsible. This concept is supported
by the observation that many patients with secondary hypertension lose their nocturnal
dip.
A reduction in sympathetic nervous system activity during sleep may be an important
factor controlling the nocturnal fall (Pickering, 1990b) and would explain the absent dip in
autonomic neuropathy, phaeochromocytoma and following cardiac transplantation.
However urinary catecholamines do not correlate with diurnal blood pressure changes in
patients with essential hypertension (Messerli et al, 1982), suggesting that other
mechanisms are involved.
While the observation that patients with Cushing's syndrome (Imai et al, 1988b) or on
high dose corticosteroids (Imai et al, 1989) have no nocturnal dip in blood pressure is
intriguing, physiological doses of Cortisol do not appear to influence the diurnal rhythm in
patients with hypopituitarism (Jyothinagaram et al, 1989), and a major role for the
pituitary-adrenal axis in essential hypertension seems unlikely. Similarly, conditions
affecting the renin-angiotensin system do not appear to consistently alter the nocturnal
blood pressure (Baumgart et al, 1989a), and the diurnal variation in blood pressure of
essential hypertensives is not affected by treatment with an angiotensin converting enzyme
inhibitor (Mejer et al, 1986). Thus the cause for differences in the blood pressure pattern
of patients with essential hypertension remains obscure.
Clinical Relevance of the Diurnal Rhythm
Knowledge of the diurnal rhythm of blood pressure, which can only come from
ambulatory monitoring, appears to provide additional prognostic and diagnostic
information. Although the effect of treatment of night-time pressures on prognosis is
unknown, it seems likely that, where it is high, treatment which reduces BP throughout 24
hours will be beneficial. Patients with pre-eclampsia are more susceptible to crises during
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the night (Oney & Meyer-Sabellek, 1990) and treatment should be given and monitored
accordingly (Oney & Meyer-Sabellek, 1990). Following heart transplantation, patients
may initially have hypertension during the night only (Sehested et al, 1990b), and again
the need for treatment needs to be assessed and given accordingly.
Conversely, dippers may drop their blood pressure to normal levels during sleep and,
particularly in the presence of left ventricular hypertrophy and ischaemic heart disease,
may be at further risk if drug therapy induces a further significant reduction in blood
pressure (Cruickshank et al, 1987; Cruickshank, 1988). It has even been suggested that
unrecognised nocturnal hypotension may be one reason why the reduction in the incidence
of myocardial infarction with anti-hypertensive treatment has been so disappointing
(Floras, 1988). Although as yet unknown, it is possible that drug therapy in such patients
should be tailored to reduce BP during the day only.
Ambulatory Monitoring - Normal Reference Data
Despite the wealth of information on ambulatory blood pressure monitoring in disease, the
need to determine adequate normal reference values for 24-hour ambulatory blood
pressure has only recently been addressed. Initial values for ambulatory blood pressure
normality were based on relatively small numbers, and groups studied were often
preselected by normal clinic blood pressure (Kennedy et al, 1983; Weber et al, 1984;
Drayer & Weber, 1985; de Gaudemaris et al, 1987). A meta-analysis of studies on non¬
invasive ambulatory monitoring in normal subjects determined the day-time mean to be
122/77 mmHg, night-time pressure to be 106/64 mmHg and 24-hour mean ambulatory
pressure to be 117/72 mmHg (Staessen et al, 1990). In a large epidemiological study
O'Brien et al (1991c) have recorded ambulatory blood pressure in 815 employees of the
Allied Irish Bank, aged 17-79. This population was not pre-selected, although subjects on
antihypertensive drugs were excluded, and should therefore be reasonably representative
of the population. The results were similar to those of this large meta-analysis: mean day¬
time pressure was 124/78, night-time 106/61 and 24-hour 118/72 mmHg. Significant
differences in relation to age and sex were observed and means for different age groups
and sex are provided.
Baumgart et al (1990), performing linear regression analysis on ambulatory blood
pressure records of 1039 subjects to relate ambulatory pressure to their clinic pressure,
calculated that mean day-time values of 135/85 were equivalent to clinic pressures of
140/90 mmHg. Data such as these provide reference values for non-invasive ambulatory
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blood pressure monitoring, but the relevance of such data to morbidity and mortality is
still not proven. However at the current time a day-time mean blood pressure of > 135/85
mmHg has been suggested as representing a hypertensive condition (The Scientific
Committee, 1990).
Ambulatory Monitoring in Clinical Studies
Ambulatory blood pressure monitoring, by identifying and excluding "white coat"
hypertensives (Pickering et al, 1988) and by improving the reproducibility of the blood
pressure measurement (Trazzi et al, 1991) can assist in clinical trials and reduce the
sample size necessary to show a significant blood pressure lowering effect (Conway et al,
1988). A sample size of only 16 should be sufficient to detect a reduction in 8/5 mmHg
in a cross-over study (Conway et al, 1988). In addition, as ambulatory blood pressure
monitoring appears to be devoid of a clinically significant placebo effect (Conway et al,
1988; Mutti et al, 1991), studies without a placebo limb may be possible, which could
simplify the design and conduct of clinical studies of anti-hypertensive drugs (O'Brien et
al, 1989a). However, recently published data from the Syst-Eur study (Staessen et al,
1994) has demonstrated a small reduction in 24 hour mean systolic blood pressure in
patients treated with placebo over one year, suggesting that placebo-control is necessary in
long-term studies.
A further advantage of ambulatory monitoring is the ability to indicate the duration of
drug effect and the influence of drugs on nocturnal blood pressure (O'Brien et al, 1991 d).
In a clinical trial comparing once daily lisinopril (a long-acting ACE inhibitor) to twice
daily captopril (a short acting ACE inhibitor) blood pressure control was maintained for 9
to 10 hours after each dose of captopril hut then began to return towards baseline
(Whelton et al, 1990). As a result blood pressure reduction over 24 hours was greater
with lisinopril. Similarly in a comparison of the anti-hypertensive effect of beta-blockers
(Floras et al, 1982), atenolol was shown to reduce blood pressure throughout 24 hours,
while the anti-hypertensive effect of pindolol lasted only 15 hours and metoprolol 12
hours.
Information such as this is only available from clinical trials involving ambulatory
monitoring and its routine use in the evaluation of drug efficacy has been advocated
(O'Brien et al, 199Id).
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Clinical Applications ofAmbulatory Monitoring
Whilst ambulatory blood pressure monitoring may not be necessary in individuals with
moderate to severe hypertension or with evidence of target organ damage, in whom the
benefits of treatment are clear, it is a valuable technique in the assessment of borderline
hypertension (Pickering & James, 1989), to help exclude "white coat" hypertensives and
target those who will benefit most from treatment (Pickering et al, 1988). It should also
be regarded as an initial investigation in the evaluation of apparently resistant hypertension
when there is no evidence of target organ damage (Pickering, 1988; Metia et al, 1990),
both to document the size of the "white coat" response and to demonstrate the degree and
duration of antihypertensive drug action.
Symptoms suggestive of hypotension due to antihypertensive medication can also be
investigated, when symptomatic marked reductions in blood pressure in response to taking
medication may be identified (White, 1986).
Episodic hypertension may cause concern, as it can indicate adrenergic excess. If
phaeochromocytoma is suspected, ambulatory monitoring may document episodic
hypertension, which could otherwise be missed by clinical evaluation (Imai et al, 1988a).
Episodic hypertension may also be associated with anxiety syndromes, and such patients
can present with a variety of cardiovascular symptoms. Ambulatory monitoring may help
in the identification of such patients (White & Baker, 1986).
Ambulatory monitoring may help in the evaluation of patients with type 1 (Wiegmann et
al, 1990) and type 2 (Hansen et al, 1991) diabetes mellitus, when early intervention with
blood pressure lowering drugs may be of benefit. It has also been recommended for the
diagnosis of hypertensive disease in pregnancy (Margulies et al, 1989) and particularly in
pre-eclampsia (Oney & Meyer-Sabellek, 1990). However, the lack of normative data in
these populations must hamper the interpretation of ambulatory blood pressure results.
More widespread use of ambulatory monitoring techniques as part of the routine
evaluation of hypertensive patients cannot be recommended until more information about
the relationship of data derived from ambulatory blood pressure monitoring to morbidity
and mortality is available. On-going prospective studies should provide this information
in the next few years (Clement, 1989).
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New Methods of Blood Pressure Measurement
Application of the plethysmographic method first described by Penaz has provided a non¬
invasive means of measuring blood pressure continuously (the Finapres system) (Boehmer,
1987). Arterial pulsation in a finger is detected by a photoplethysmograph under a
pressure cuff. The size of the artery is measured when its internal pressure (i.e. arterial
pressure) equals external cuff pressure. This point, when transmural pressure equals zero,
is maintained by continuous, automatic adjustments of external cuff pressure. These
adjustments parallel intra-arterial pressure variations and algorithms determine the
systolic, diastolic and mean arterial pressures (Boehmer, 1987). The pressures so
determined appear to reflect intra-arterial pressure (Imholz et al, 1988), though under¬
estimating indirect brachial artery pressure (Takahashi et al, 1990).
This device appears to accurately follow pressure changes over time and as such has been
of particular interest to anaesthetists (van Egmond et al, 1985; Gibbs et al, 1991) and
obstetricians (Kinsella et al, 1989; Epstein et al, 1989). It is also of use in clinical
research studies monitoring blood pressure changes over short time intervals (Christen et
al, 1990). However, its accuracy in routine clinical use remains unproven and there is
evidence that digital blood pressure is influenced by the severity of hypertension and anti¬
hypertensive drugs (Takahashi et al, 1990), when peripheral circulation may be impaired,
and by diseases affecting the peripheral circulation (Kurki et al, 1990).
A prototype ambulatory version of this device has recently been developed which,
although still prone to the problems detailed above, has the potential to allow continuous
non-invasive blood pressure monitoring over 24 hours (Schmidt et al, 1992; Imholz et al,
1993) with less disruption of sleep and more accurate information on blood pressure
variability. However, this instrument is bulky, expensive and still to be formally
validated. Nonetheless if early promise is confirmed it could prove to be a valuable
additional tool in the study of cardiovascular disease.
A technique for indirect blood pressure measurement based on wave form analysis of the
Korotkoff signal has also been described - the K2 technique (Blank et al, 1988). The
potential advantage of this system is its dependence on pattern recognition, rather than the
absolute level of sound, which varies widely from one individual to another (Pickering,
1989). This technique is, however, still in the developmental stage.
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Conclusions
Although careful measurement of blood pressure with stethoscope and mercury
sphygmomanometer is a valid and accurate technique, there are many potential sources of
error, due to both equipment and methodology. More importantly, the inherent variability
of blood pressure itself, and its tendency to increase in the presence of medical and
nursing staff, means that clinic measurement cannot reliably reflect the blood pressure
load affecting the individual patient. With the development of reliable electronic
sphygmomanometers which have a reasonable standard of accuracy, patients can be taught
how to measure their own blood pressure in their normal environment over several days.
In addition to providing information on an individual's blood pressure profile, home
measurement is a valuable opportunity to educate patients and can improve compliance.
By reducing observer bias electronic sphygmomanometers are also of use in clinical and
epidemiological studies. Unfortunately many of the electronic devices marketed to date
are unreliable and no machine should be purchased unless supported by data on its
accuracy from a reliable and independent source.
Newer techniques for the non-invasive measurement of ambulatory blood pressure now
allow us to obtain a large number of measurements over 24 hours, including during sleep.
This technique is safe, can be repeated and is reproducible. Information on the
variability, and particularly the diurnal variation, of blood pressure is also obtained. The
evidence that these measurements provide prognostic information over and above the
clinic pressure is growing and on-going prospective clinical trials should help delineate the
place of ambulatory monitoring in the diagnosis and management of essential
hypertension. Again, it is imperative that these devices are validated prior to use and the
publication of guidelines on methodology for their evaluation is a great advance in this
regard.
"White coat" hypertension appears to be a common phenomenon and, while not
synonymous with normotension, may indicate a substantially lower cardiovascular risk. It
may, therefore, be possible to target antihypertensive therapy at those who will benefit
most. Although this equipment is expensive, this may well be offset by the financial,
therapeutic and social advantages of not treating thousands of individuals unnecessarily.
Ambulatory or home monitoring of blood pressure should also be an integral part of the
evaluation of apparently resistant hypertension, and can be valuable in the differential
diagnosis of episodic hypertension.
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Ambulatory monitoring has proved to be a valuable research tool. Preliminary clinical
trials of new anti-hypertensive agents should be possible with smaller numbers and
without a placebo limb. Information on the action of such agents over the whole 24 hours
is available, and may become of increasing importance if preliminary data on the
prognostic importance of an absent nocturnal dip in blood pressure is borne out in
prospective studies. New methods of blood pressure measurement being developed may
improve the diagnostic accuracy of such devices further, and allow continuous non¬
invasive ambulatory monitoring.
We have come a long way since Reverend Hales first measured blood pressure in animals,
but our understanding of the significance of blood pressure measurements in man remains
far from complete. In particular, the importance of blood pressure changes during sleep
remains uncertain. The recent description of the non-dipping blood pressure profile, its
apparent association with target organ damage, and its increased prevalence in secondary
hypertension, implies that important diagnostic and prognostic information may be
imparted by knowledge of the diurnal blood pressure profile. This hypothesis forms the
basis of this thesis.
Outline of Thesis
The technique of ambulatory blood pressure monitoring has progressed from being
predominantly a research tool to an accepted and often essential investigation in the
assessment of the hypertensive patient. The development of methods of confirming the
accuracy of these devices in routine clinical practice has been an essential pre-requisite of
this, and protocols for validating these devices have now been agreed. Several monitors
have been rigorously assessed and deemed suitable for clinical use, including the
SpaceLabs 90207 used for the majority of the work described here. However, the need to
validate such equipment for use in particular patient groups has recently been emphasised,
yet at the outset of this study no device had been validated in the presence of cardiac
arrhythmia, and, in particular, in patients with atrial fibrillation, who are known to
present particular diagnostic difficulty. In Chapter 2, I compare the performance of two
ambulatory blood pressure monitors and two electronic sphygmomanometers to
measurements made by a trained observer with a mercury sphygmomanometer in patients
with controlled atrial fibrillation, and demonstrate major errors associated with the use of
electronic measuring devices.
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Activity is a major determinant of blood pressure, and differences in the pattern of activity
on different monitoring days can have a major impact on the reproducibility of the diurnal
blood pressure profile. Moreover, the onset of sleep is probably the major factor
influencing the nocturnal fall in blood pressure. A method to quantify activity, relate this
to changes in blood pressure, and allow the measurement of sleep time, could therefore
improve the precision with which changes in blood pressure over 24 hours are assessed.
In Chapter 3, I explore the potential of wrist worn activity meters to achieve these goals.
The impact of a change in the arbitrary definition of day and night periods on the
determination of diurnal blood pressure variation is assessed and compared to that
calculated on the basis of activity-derived sleep time. The reproducibility of ambulatory
blood pressure monitoring and the ability of activity monitoring to influence this is also
examined.
Blood pressure has a Gaussian distribution in the population, and the diagnosis of
hypertension is dependant on an arbitrary definition of "high" blood pressure. This fact,
although now accepted dogma, was the centre of a major debate amongst those at the
forefront of hypertension research for many years, yet much published work on diurnal
blood pressure variability relies on the division of the population into two groups,
"dippers" and "non-dippers". In Chapter 4, by examining the frequency distribution of
the nocturnal dip in blood pressure of all patients referred for ambulatory blood pressure
monitoring over a 4 year period, I attempt to determine whether this distinction is as
fallacious as that dividing the general population into "normotensive" and "hypertensive".
This data is also used to study the impact of diagnosis, age, severity of hypertension and
antihypertensive treatment on diurnal blood pressure variation.
One consistent observation from earlier work has been loss of the nocturnal fall in blood
pressure in patients with pathological Cortisol excess, but the mechanisms underlying this
and the potential importance of the pituitary-adrenal axis in the control of diurnal blood
pressure variability in subjects without hypercortisolaemia are not understood. The study
of patients with hypopituitarism, who require lifelong Cortisol replacement therapy,
enables assessment of the effect of manipulation of exposure to Cortisol within the
physiological range. In Chapter 5, I examine the impact of modest changes in exposure to
Cortisol on the diurnal blood pressure profile of such patients.
Accelerated hypertension is frequently quoted as resulting in loss of the diurnal blood
pressure rhythm, yet only one study, performed over 30 years ago, has studied the diurnal
rhythm of such patients in any detail. Moreover, this condition normally results in
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emergency or early admission to hospital, but little is known of the effect of
hospitalisation per se. In Chapter 6, I study the ambulatory blood pressure profile of
patients with accelerated phase hypertension before and after treatment, and compare this
to patients with benign essential hypertension and to other patient groups requiring acute
hospitalisation. The factors potentially governing changes in diurnal blood pressure
variation in accelerated phase hypertension are discussed.
Both cardiac and renal target organ damage are correlated with blood pressure and the
severity of hypertension, but the importance of nocturnal blood pressure elevation and
blunting of diurnal blood pressure variation remains uncertain. Previous studies have
either been limited in scope, or studied selected patient groups. In Chapter 7, I describe
the results of a blood pressure screening exercise performed in a healthy, working
population, from which a cohort of randomly selected subjects, weighted to include all
those with elevated clinic pressures, were studied in detail. All underwent ambulatory
blood pressure monitoring and measurement of their blood pressure response to isometric
exercise. The relative importance of different measures of blood pressure and blood
pressure variability is assessed by comparing each to measures of cardiac structure and
function, assessed echocardiographically, and to urinary albumin excretion.
Hypertension and sleep apnoea commonly co-exist, and sleep apnoea syndrome is now
known to be a common but still under-diagnosed condition in the general population.
Sleep apnoea syndrome in its severe form has been shown to cause nocturnal hypertension
and abolition of the diurnal blood pressure profile. In Chapter 8, the possibility that
occult sleep apnoea in patients with essential hypertension accounts for attenuation of the
nocturnal blood pressure dip is investigated. To determine whether nocturnal hypoxia
itself influences the nocturnal dip, patients with chronic obstructive pulmonary disease
were also studied.
Blunting of the diurnal blood pressure rhythm in patients left ventricular hypertrophy and
in orthotopic cardiac transplant recipients has led to the suggestion that the heart has an
active role in the control of blood pressure. Studies of patients with severe congestive
cardiac failure, demonstrating reduction in diurnal blood pressure variability, have tended
to confirm this view. In Chapter 9, I compare the blood pressure profile of patients with
systolic heart failure to that of a randomly selected control group and study the impact of
treatment with angiotensin converting enzyme inhibitors on the diurnal rhythm and on
renal function of the heart failure patients.
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In Chapter 10, these studies are considered together and the nature and potential clinical
importance of diurnal blood pressure variability is discussed.
Methods and Materials
Detailed methodology is described in each chapter. Ethical approval was obtained for the
individual studies from the Lothian Health Board Ethics of Medical Research Committee
and informed consent was obtained from all patients prior to study. Patients described in
Chapter 4 all underwent ambulatory blood pressure monitoring as part of their clinical
assessment and therefore no specific consent was deemed necessary for this work.
Ambulatory blood pressure monitors were all fitted by myself or by a Research Nurse
under my direction. Initial studies used the Accutracker monitor (Figure 1.1) which relies
upon the detection of Korotkoff sounds via a microphone taped over the brachial artery.
The auscultatory technique is prone to error resulting from extraneous noise, including
muscle contraction and the transmission of noises from the motorised pump required to
inflate the arm cuff. To minimise this potential source of error the Accutracker device
requires the application of 3 ECG electrodes to the chest, enabling ECG gating, ensuring
that only Korotkoff sounds occurring within the R-wave window are registered. This
does, however, reduce the tolerability of this device.
From October 1990 the SpaceLabs 90207 monitor (Figure 1.2) was used for the majority
of studies. This device uses an oscillometric technique for the recording of blood
pressure, requiring application of an arm cuff only. The oscillometric technique relies
upon internal algorithms to register waves generated by the brachial artery during cuff
deflation. The initial wave form is taken as systolic pressure and the point of maximum
oscillation mean arterial pressure. Diastolic pressure is calculated via pre- and post-
maximal oscillations. Such monitors are smaller, lighter, easier to use and better tolerated
than those requiring application of a microphone.
Monitors are capable of being programmed to measure blood pressure for a time interval
between 6 minutes and 2 hours. In the studies described here, blood pressure readings
were obtained every 30 minutes throughout the 24 hour period, or, where short-term
blood pressure variability was of particular interest, every 15 minutes.
23
Figure 1.1 Subject with the Accutracker 2 Ambulatory Monitor
A microphone has been positioned under the arm cuff. ECG electrodes are required to
enable R wave gating of the Korotkoff sounds, improving accuracy but reducing tolerance
of the procedure.
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Figure 1.2 Subject with the SpaceLabs 90207 Ambulatory Monitor
Blood pressure is monitored using the oscillometry technique, obviating the need for a
microphone. As a result, cuff placement is less critical and accurate measurement when
worn over a thin shirt, as shown here, is possible, improving tolerability. However, the
equipment is normally positioned under clothing to make the procedure as unobtrusive as
possible.
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Blood pressure values with systolic BP of less than 70 mmHg or diastolic BP of less than
30 mmHg, or which were physiologically impossible, e.g. mean arterial pressure greater
than systolic BP, were automatically rejected by monitor software. Where this occurred,
or when movement artefact prevented accurate recording, a second reading was attempted
after 3 minutes, minimising the number of failed readings.
Both devices are equipped with liquid-crystal displays, capable of displaying the blood
pressure reading or an error signal if an erroneous reading is obtained. At the time of
fitting, simultaneous measurement with a mercury sphygmomanometer, using a Y-
connector attached to the monitor cuff, was performed to ensure satisfactory accuracy.
Readings had to concur to within 5 mmHg to be deemed satisfactory. The device was
then programmed not to display the blood pressure value, to remove the possibility of the
subject observing blood pressure readings during the recording period and modifying
behaviour as a result. Monitors were also programmed to emit a warning bleep
immediately prior to each recording and subjects were instructed to keep their arm as still
as possible during cuff deflation, minimising movement artefact. This facility was
switched off from midnight until 7 am to minimise sleep disruption. An instruction leaflet
detailing these points was supplied at the time of fitting. This incorporated a diary section
where any problems encountered or unusual activity with the potential to significantly
influence blood pressure were noted. Details of sleep time and quality were also
requested.
At the end of the monitoring period data were downloaded onto personal computer using
proprietary device interface and software. Data were then transferred to a DBase IV file,
with further automatic data editing designed to eliminate physiologically implausible
readings. Any value with a pulse pressure less than half the mean pulse pressure over the
24-hour period was rejected (Conway et al, 1988). Automatic calculation of hourly mean
pressures, 24-hour mean, day-time (defined as 7 am to midnight), night-time (midnight to
7 am), wake and sleep blood pressures and diurnal blood pressure variability (percentage
change from day to night or wake to sleep) was performed at the same time.
Further clinical data, including patient demographic details and other clinical information




The Accuracy of Automated Blood Pressure Measuring Devices in Patients with
Controlled Atrial Fibrillation
Background
Hypertensive patients with co-existent atrial fibrillation (AF) present particular diagnostic
difficulty as there is beat to beat variation in the intensity of the Korotkoff sounds and the
level at which they can be heard, increasing both intra- and inter-observer variability (Sykes
et al, 1990). At present these patients cannot be monitored using electronic BP measuring
equipment as these have not been validated in the presence of cardiac arrhythmia. In theory,
by reducing observer variability and by increasing the number of available readings, these
machines should be of particular value in this group of patients. However, clinical
experience with these devices has suggested that they may be significantly less accurate in the
presence of arrhythmia, and a single case report, in which a patient developed atrial
fibrillation during the comparison of an oscillometric device to intra-arterial recording,
supports this view (Caramella & Desmonts, 1986).
Introduction
The importance of properly evaluating blood pressure monitoring equipment before use is
now accepted (O'Brien et al, 1990c) and the need to validate such equipment for use in
particular patient groups recently emphasised (O'Brien et al, 1993). I have compared the
accuracy of two electronic, semi-automatic sphygmomanometers and two ambulatory blood
pressure monitors to the measurements of a trained observer using a Hawksley random zero
sphygmomanometer in patients with controlled atrial fibrillation.
Patients and Methods
Thirty patients with electrocardiographically confirmed atrial fibrillation, identified as
hospital in-patients, were studied. Two patients did not tolerate the repeated BP
measurements required and were withdrawn, leaving 28 patients, 18 male and 10 female,
mean age 72±9 years, for analysis. All had a controlled ventricular rate, defined as a resting
heart rate of less than 100 per minute with a pulse-apex difference of less than 10. All had
normal arm circumference (less than 42 cm).
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Both normotensive and hypertensive subjects were included, with blood pressures in the
range 90-158/40-96 mmHg, mean 124 + 20/67 + 13 mmHg.
Two ambulatory blood pressure monitors (ABPM) were tested: the Accutracker 1 ABPM
which utilises a microphone to detect Korotkoff sounds, and the SpaceLabs 90207 ABPM
which is dependant upon the oscillometric method. Two semi-automatic electronic
sphygmomanometers were also tested (Table 2.1).
Table 2.1 Devices Used in the Study
1. Hawksley Random Zero Sphygmomanometer
2. Takeda UA-751 Digital Blood Pressure Meter (Oscillometric)
3. Copal UA-251 Auto-inflation Digital Sphygmomanometer (Korotkoff)
4. SpaceLabs 90207 Ambulatory Blood Pressure Monitor (Oscillometric)
5. Accutracker 1 Ambulatory BP Monitor (Korotkoff)
The performance of these instruments was assessed during a single sitting in all patients.
Each patient had their BP measured twice with each test device and twice with the Hawksley
random zero sphygmomanometer (HRZ) before and after each test device measurement. As
the time taken to set up and calibrate the Accutracker ABPM is much longer than that
required with the other devices, the initial measurement was made with this machine in all
patients. Each patient also had three sequential measurements with the HRZ, enabling
comparison of the HRZ as a "test" device to the electronic sphygmomanometers.
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Statistical Analysis
The first reading obtained with each device was compared to the immediately preceding and
following mercury measurements using the sequential same arm technique (Atkins et al,
1990). In this test, there is a basic assumption that the difference between these sequential
readings may not be linear and the difference is calculated as follows: where the test device
measurement lies between the first and third HRZ measurement, the difference is taken to be
zero; otherwise the nearer of the HRZ readings is subtracted from the test value to give the
difference. The proportion of machine readings > 5 mmHg different from the HRZ was
then compared to that obtained by 3 sequential HRZ measurements, using Chi-squared test.
Finally the variability of each measuring method was assessed by determining the standard
deviation of the difference (s.d.d.) for the paired readings from each device, and the
difference between the variability of each device was compared to that of the HRZ using
Wilcoxan signed rank procedure.
Results
Although BP readings could be obtained in all patients and on every occasion using the HRZ,
readings could not be obtained with the Takeda and Copal electronic sphygmomanometers on
3 occasions each (5%), with the Accutracker on 8 occasions (14%) and with the SpaceLabs
on 14 occasions (21%).
The results of sequential testing against the HRZ are given in Figure 2.1. Only the Copal
electronic sphygmomanometer, which uses the Korotkoff technique, obtained a level of
accuracy approaching that of three sequential HRZ measurements. The two ABPMs were
markedly less accurate than the cheaper electronic sphygmomanometers.
Intra-patient variability with each device was assessed by determining the standard deviation
of the difference from paired readings obtained with each device. The results are given in
Figure 2.2. Although the differences observed did not achieve statistical significance, both
ABPMs and the Takeda electronic sphygmomanometer demonstrated greater variability than
HRZ while the Copal had a level of consistency comparable to paired HRZ readings.
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Each device, including the Hawksley random zero sphygmomanometer, has been tested using
the sequential same arm technique (Atkins et al, 1990). The proportion of readings falling
within 5 mmHg of immediately preceding and following measurements obtained with the
HRZ is expressed as a percentage for both systolic (SBP) and diastolic (DBP) blood pressure.
The accuracy of each electronic device has been compared to the HRZ and statistical
significance at the 5% level is given along the x-axis.
HRZ = Hawksley random zero sphygmomanometer
TAK = Takeda UA-751 Digital Blood Pressure Meter
COP = Copal UA - 251 Auto-inflation Digital Sphygmomanometer
ACC = Accutracker 1 Ambulatory BP Monitor
SL = SpaceLabs 90207 Ambulatory Blood Pressure Monitor
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p<0.01 SBP p<0.01 SBP
p<0.01 DBP P<0.001 DBP
Figure 2.2 Intra-patient Variability of BP Monitors in Patients with Atrial
Fibrillation
S.d.d. (mmHg)
Each patient had their blood pressure measured twice with each device, both measurements
being obtained within 120 seconds, leaving at least 30 seconds between readings. The
standard deviation of the difference (s.d.d.) was calculated for each pair of readings for both
systolic and diastolic BP. The variability of each electronic device was compared to paired
readings obtained with the HRZ but did not achieve statistical significance.
Abbreviations as for Figure 2.1
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Discussion
The use of semi-automatic and ambulatory BP measuring equipment is of proven benefit in
the management of patients with hypertension and its use is increasing. Patients with atrial
fibrillation form a group whose blood pressure is particularly difficult to assess, as beat to
beat variation is much greater than normal. As such, automated BP measurement could be
particularly valuable, as repeated measurements over a short time period would provide a
better estimate of cardiovascular risk. However their use in such patients has not previously
been validated.
I have tested 4 devices in patients with atrial fibrillation and found marked differences in
their performance. One device, the Copal UA-251, appears to provide a level of accuracy
equivalent to that of a trained observer using the Hawksley random zero sphygmomanometer.
While the use of the HRZ in validation studies has recently been criticised (Conroy et al,
1993), many workers feel that it does provide a satisfactory level of accuracy when used
carefully and correctly (Various, 1993). Moreover, it does have the important advantage of
reducing observer bias which, as I was also comparing intra-patient variability, was
particularly important in this study.
Clearly, despite such concerns, the performance of three of these devices, all previously
validated (albeit not all to current protocol standards) and shown to be accurate in patients
with normal sinus rhythm (Jamieson et al, 1990; Appel et al, 1990; O'Brien et al, 1991b), is
poor in patients with atrial fibrillation. The routine use of these devices in patients with AF
cannot therefore be recommended. However, it is encouraging to note that one device, the
Copal UA-251, does provide a satisfactory level of accuracy, and the use of such devices in
the assessment of fibrillating patients with hypertension warrants further assessment.
Unfortunately this particular device is no longer marketed.
Conclusions
Accurate measurement of BP with an electronic device is possible but the marked difference
between devices and limited accuracy of the ambulatory blood pressure monitors tested here
demonstrates the need to ensure that such devices are of proven accuracy in this patient
group. As a result of this study, patients with atrial fibrillation have been excluded from
routine clinical study and all subsequent research work.
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CHAPTER 3
Simultaneous Ambulatory Blood Pressure and Activity Monitoring to Improve
the Definition of The Diurnal Blood Pressure Profile
Background
Reproducibility of Ambulatory Blood Pressure Monitoring
The introduction of ambulatory blood pressure monitoring has improved our
understanding of the variability of blood pressure and the nature of hypertension. Day¬
time mean ambulatory blood pressure is clearly more reproducible than clinic BP (Coats,
1990), presumably due to the greater number of available readings (Trazzi et al, 1991),
and preliminary evidence suggests that it is also better able to define those at risk (Perloff
et al, 1983), but this does little to improve the problem of separating "normal" from
"high" blood pressure (Pickering, 1992b), and any cut-off value at which treatment is
advised remains arbitrary. However, such improved reproducibility enables the
comparison of different anti-hypertensive drugs with smaller numbers (Conway et al,
1988), and improves our confidence in the blood pressure lowering effect of a drug in the
individual (Coats, 1990).
Unfortunately, within-subject variability is greater than that of a group mean (Pickering,
1990c; Bottini et al, 1992), and hence the pressure recorded in the individual is less
reliable. Moreover, within-subject variability is greater still when the level of activity on
two separate study days differs significantly (Pickering, 1990c). Indeed, activity (both
physical and mental) is probably the main determinant of long-term blood pressure
variability (Pickering, 1990d).
Diurnal Blood Pressure Variation
When deciding upon the level of cardiovascular risk in the individual, as determined by
ambulatory blood pressure monitoring, physicians have traditionally relied upon the day¬
time mean pressure (The Scientific Committee, 1990). However, there is growing
evidence that additional prognostic information is available if night-time or sleep blood
pressure is also considered. Since the introduction of ambulatory blood pressure
monitoring, it has been clear that blood pressure has a diurnal rhythm, with levels during
sleep about 20% less than those during the day (Littler et al, 1975). This rhythm is
generally preserved in essential hypertension, with an upward shift of the entire curve,
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but has been noted to be absent in a substantial proportion of patients with secondary
hypertension (Hany et al, 1987; Imai et al, 1990; Middeke & Schrader, 1994), and a
minority of those with essential hypertension (O'Brien et al, 1988). This has led to the
concept of two groups within the hypertensive population : "dippers" and "non-dippers"
(O'Brien et al, 1988). As the potential pathological significance of a blunted nocturnal
fall in blood pressure is explored, it has become clear that this distinction is of more than
academic interest.
Kobrin et al (1984) studied 21 elderly (> 65 years) hypertensives and found a normal
diurnal blood pressure in 14, but a reduced or absent fall in 7. All the non-dippers, but
only 43% of the dippers, had clinical evidence of hypertensive or atherosclerotic
complications (Kobrin et al, 1984). O'Brien et al (1988) later reported the frequency of
stroke in a population of non-dippers to be 23.8%, compared to a frequency of only 2.9%
in age, sex and weight matched dippers with a similar day-time blood pressure. Shimada
et al (1992) have found asymptomatic hypertensive cerebrovascular disease, as assessed by
brain magnetic resonance imaging, to be more closely correlated with sleep blood pressure
than with wake or 24 hour blood pressure.
Hypertensive heart disease may also be influenced by the diurnal variation of blood
pressure. Gosse et al (1988a) have found night-time BP to be the best correlate of left
ventricular mass in a group of 24 treated hypertensives, while Verdecchia et al (1990)
found greater left ventricular mass in hypertensive patients with a reduced nocturnal dip,
and an inverse correlation between LV mass index and the nocturnal dip. The LV mass of
hypertensive dippers was similar to that of normotensive controls, suggesting that the
nocturnal dip may prevent or delay the development of left ventricular hypertrophy.
Thus knowledge of the diurnal rhythm of blood pressure may provide additional
prognostic information in patients with essential hypertension.
The Definition of Dippers and Non-dippers
Despite the increasing importance given to differences in the diurnal variation of blood
pressure, there is no clear consensus as to how this should be best defined. Although
several complex statistical methods for describing diurnal variation have been described
(Streitberg et al, 1989; Streitberg & Meyer-Sabellek, 1990), most workers appear to use
the difference between day and night blood pressure as a measure of the nocturnal dip
(The Scientific Committee, 1990), and recent papers have variously defined night for this
purpose as 8 pm - 6 am (Verdecchia et al, 1990), 8 pm - 8 am (Hany et al, 1987), 10 pm
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- 6 am (Middeke & Schrader, 1994), 12 midnight - 8 am (O'Brien et al, 1988), or sleep
(Shimada et al, 1990).
Unfortunately, the measurement of sleep blood pressure and the day-night blood pressure
dip appears to be less reproducible than the day-time mean pressure (Cox et al, 1991b).
In part, this may be the result of this artificial divide of the hypertensive population into
"dippers" and "non- dippers", which relies on an arbitrary cut-off value. As a result,
relatively minor variation in the nocturnal dip of an individual whose day-night fall is
close to this point can result in a change in "dipping" status. As the nocturnal dip appears
to be distributed unimodally in the population (Stewart & Padfield, 1992) (see Chapter 4)
any associated risk is almost certainly graduated, and hence such a division is probably
inappropriate. Moreover, many studies have artificially divided the 24 hour period into
day and night using fixed time periods. Variation in the chosen definition may
dramatically affect the prevalence of "non-dipping" and any change in the sleeping pattern
of the patient will also reduce the reproducibility of the measure. To try and overcome
this problem some workers have excluded the transition periods between day and night,
defining day as 10 am - 11 pm and night as 1 am - 7 am (O'Brien et al, 1991c), but,
while possibly useful in population studies, individual exceptions to this will still exist in
practice, limiting its clinical relevance. Thus, division of the 24 hour period into sleep
and wake may be preferable, but the problem of defining these remains.
Electronic Activity Monitoring
There are now a variety of wrist-worn activity monitors (actigraphs) available, designed
to sense gross body motion and quantify activity, which are ideally suited to the
simultaneous study of activity during ambulatory blood pressure monitoring (Van Egeren,
1991). We have used the Gaehwiler actigraph (Figure 3.1), a solid state device little
bigger than a wrist watch, which is unobtrusive and easily tolerated by the patient. It
determines an activity value at 125 ms intervals and stores the total activity over a pre-set
measuring period (typically 10 seconds) as a one-byte value, in the range 0-255.
The change in mean activity over 24 hours closely parallels that of blood pressure in a
group (Van Egeren, 1990), although there is wide variation in the strength of the
relationship between individuals (Van Egeren, 1991). As activity normally falls
dramatically with the onset of sleep, the actigraph can also be used to objectively measure
sleep time, and such devices have been shown to provide an estimation of sleep time with
accuracy approaching that of EEG scoring (Mullaney et al, 1980).
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Figure 3.1 The Gaehwiler actigraph
This monitor, normally worn on the wrist of the non-dominant arm, is initialised via a
computer interface and is capable of storing up to 4 days of activity data. Data are
downloaded directly onto computer for analysis at the end of the monitoring period.
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Introduction
Criteria used for analysis of the nocturnal dip vary widely in published work and no
diagnostic criteria for "dipping" have been set. However, guidelines from an
International Consensus Meeting on ambulatory blood pressure monitoring have
recommended that the day-time period run for 15+2 hours and night-time for 9+2 hours
(The Scientific Committee, 1990). To determine whether the extremes of these criteria
could have a significant effect on the diurnal rhythm of the population described, a cohort
of patients who had undergone ambulatory monitoring for varied indications was
examined retrospectively and the proportion of non-dippers calculated for each of 3
definitions of night-time : 8 pm - 7 am, 10 pm - 7 am and 12 midnight to 7 am.
A further group of patients referred for assessment of hypertension was then studied
prospectively to determine whether simultaneous ambulatory monitoring of activity and
blood pressure could improve the definition of the diurnal rhythm, with activity-based
sleep-wake blood pressure values compared to those determined using these pre-set cut-off
points for day and night.
The strength of the relationship between activity and blood pressure has also been studied
in a smaller group to determine the optimal actigraphic measurement for activity-blood
pressure regression analysis, with a view to adjusting blood pressure for activity, and the
ability of this technique to reduce within-patient variation in ambulatory blood pressure
has been assessed.
Patients and Methods
1. When is Night-time '?
Two hundred and fifty seven individual ambulatory BP recordings, performed with either
the Accutracker 1 or SpaceLabs 90207 monitors, were analysed retrospectively. Eight
were excluded as technically unsatisfactory, leaving 249 for final analysis. Patients age
ranged from 18 - 82 years, 53 (21%) were normotensive, 114 (46%) had primary
essential hypertension and the remainder a variety of causes of secondary hypertension.
Non-dippers were classified as subjects whose night-time BP was <10% lower than day¬
time BP for both systolic and diastolic BP. Three separate day and night blood pressure
were calculated, with day-time defined as (i) 7 am - 8 pm, (ii) 7 am - 10 pm and (iii) 7 am
- 12 midnight, all of which would be within the guideline limits set by the first Consensus
meeting (The Scientific Committee, 1990). The change in the proportion of subjects
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classified as non-dippers was then analysed using McNemar's test (with Yates'
correction).
2, Analysis of Sleep Blood Pressure Using Activity Monitoring
The data of all patients referred to our department for ambulatory blood pressure
monitoring who had simultaneous activity monitoring using the Gaehwiler actigraph were
then analysed. Three hundred and nineteen patients with technically satisfactory activity
and blood pressure recordings were included in the analysis. All had ambulatory blood
pressure measured using the SpaceLabs 90207 device with blood pressure recordings
every 30 minutes over 24 hours. Activity was measured using the Gaehwiler wrist
actigraph recording over a 10 second time period.
At the end of the recording period, data from both devices were down-loaded onto
personal computer for analysis. The activity data were manually scored to differentiate
wake from sleep. Total cessation of activity (score = 0) for a minimum of 300 seconds
was taken as the onset of sleep, and the first prolonged (greater than 90 second) burst of
activity not immediately followed by a return to "sleep" taken as wake (Figure 3.2).
Using software designed in our department, the blood pressure data were then transferred
to DBase IV data base management system with automatic elimination of rogue readings
according to a pre-set protocol (those which were either physiologically impossible or had
a pulse pressure less than half the mean pulse pressure over the 24 hour period (Conway
et al, 1988)) and automatic calculation of mean wake, sleep, day-time and night-time
blood pressures, as defined above.
To determine which arbitrary day-night limit most closely matched the actigraph-
determined wake-sleep figure, paired t-test comparison of wake and sleep blood pressure
to each day and night blood pressure respectively was performed, using the Minitab
statistical software package. The nocturnal dip, defined as the percentage difference
between mean day-time and night-time BP, and the proportion of non-dippers, were also
compared for each definition.
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Figure 3.2 Wrist Actigraph-Derived Activity Score Over 24 Hours
Wrist actigraph data presented graphically over a 24 hour period. The abrupt fall in
activity co-incident with the onset of sleep is readily appreciated, with estimated sleep
period on this recording 2258 to 0405.
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3. Activity Monitoring to Improve the Reproducibility of the Diurnal Rhythm
To study the relationship of activity to blood pressure in more detail and determine
whether correction for activity could improve the reproducibility of ambulatory blood
pressure recordings, 30 patients, 13 female, mean age 52+2 years, were asked to undergo
repeat monitoring 1-18 days (mean 8) apart. The monitoring procedure was performed as
detailed above on both occasions. As 1 hoped to determine whether the technique had a
potential role in routine clinical practice, no attempt was made to standardise activity on
the two monitoring periods.
Ambulatory blood pressure parameters from the two monitoring days were compared and
the standard deviation of the difference calculated as a measure of the reproducibility for
each of the calculated methods.
Both activity and BP files were then written in ASCII format and analysed using a Fortran
programme developed for the purpose. The following activity parameters were calculated
and correlated to each blood pressure measurement
1. Mean activity in the 5, 10, 20 and 30 minutes prior to each BP measurement.
2. Maximum activity value within each of these time periods.
3. Maximum activity in any 2 minute period within each time period.
4. Maximum activity in any 4 minute period within each time period.
5. Mean weighted activity in each time period, with increasing weight given to activity
values closest to the measurement.
As the resulting activity values were asymmetrically distributed, logarithmic
transformation was performed before correlating each to the corresponding BP values.
The marked fall in both activity and blood pressure during sleep could result in spuriously
positive correlations if the entire 24 hour period was analysed, therefore wake and sleep
periods were analysed separately. Correlations during sleep were very small and further
analyses therefore concentrated on wake data only.
Correlation coefficients varied widely, both between patients and, to a lesser extent,
within patients. Three activity features were selected as being most closely related to
blood pressure in the patients taken as a whole: (i) Maximum activity within preceding 5
minutes, (ii) maximum activity over 2 minutes within the preceding 10, and (iii) mean
weighted activity over the preceding 30 minutes. These features were then used to form
two multiple regression models
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(a) A model was used to adjust each individual blood pressure reading for activity within
each patient record. This fitted separate slopes for each activity feature and made
adjustments such that the resulting values reflected blood pressure at the mean daily
activity for each patient record.
(b) A second model fitting the 3 activity features was used to model the mean wake blood
pressure values. As the first two features did not significantly improve a model using the
weighted mean activity value alone, this simpler model was used to adjust for activity
such that the resulting blood pressure reflected that expected at the average mean daily
activity for all patients.
Results
1. When is Night-time ?
The number of subjects classified as non-dippers fell progressively as the start of night¬
time rose, from 118 (47%) at 8 pm, to 106 (43%) at 10 pm and 91 (36%) at 12 midnight.
The change in defined proportion was statistically significant for each inter-group
comparison (Figure 3.3). The proportion of non-dippers defined was relatively high,
reflecting the heterogeneous nature of this group, with a large number of patients with
severe and/or secondary hypertension.
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Figure 3.3 The Prevalence of Non-Dipping Defined by Different Definitions of
Day and Night
Proportion of Non-dippers (%)
8pm - 7am 10pm - 7am 12mn - 7am
The prevalence of non-dipping falls progressively as the start of night-time increases.
The proportion of non-dippers described by each definition is significantly different from
the other two groups.
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2. Comparison of Sleep BP
The comparison of mean wake and sleep values and the nocturnal dip in the 319 patients
with hypertension are detailed in Table 3.1. Wake blood pressure was most similar to
day-time defined as 7 am - 10 pm, but all day-time values were similar, being within 1
mmHg of the wake value. In contrast, larger differences were seen in sleep BP, range 1-6
mmHg, and all were higher than the activity derived sleep figure, with 12 midnight - 7
am being most closely matched. The nocturnal dip for wake-sleep also matched 12
midnight - 7 am more closely (Table 3.1).
The change in the proportion of non-dippers with the varying definition of night-time was
less pronounced in this population, with 21% of subjects non-dippers when relying on
sleep time. A trend for the proportion to increase as the start of night-time fell was still
apparent (Figure 3.4). In this analysis the proportion of non-dippers defined by 10 pm - 7
am was not statistically different from that defined by sleep.
3. Reproducibility of Diurnal Blood Pressure Variation
Comparative data from the 30 patients monitored on two occasions, demonstrating the
effect of the differing time periods on reproducibility, is given in Tables 3.2 and 3.3.
Reproducibility was similar regardless of the method used. However, absolute
differences in measures of diurnal blood pressure variability were smaller when using the
activity derived data, despite the nocturnal dip being largest with this method.
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145.7 146 -2.3 145.8 -1.4 145 6.6
Wake DBP
(mmHg)
89.2 89.9 -6.3 89.5 -4 88.7 6.7
Sleep SBP
(mmHg)
126.7 133 -20.1 130.4 -14.7 128 -5.7
Sleep DBP
(mmHg)
74.2 78.6 -19.2 76.8 -14 75 -5.6
Nocturnal Dip
SBP (%)
12.9 8.8 16 10.5 12 11.7 6.8
Nocturnal Dip
DBP(%)
16.6 12.3 14 14.1 10.6 15.1 6.7
The r-statistic reflects the result of paired t-test comparisons of each value to sleep/wake
and is used as a measure of parity between the two values (closeness of t values to zero
indicating the extent of agreement). All are highly statistically significant (p<0.01), with
the exception of 7 am - 10 pm and wake SBP.
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Figure 3.4 Prevalence of Non-Dipping Using Sleep/Wake Times and
Arbitrary Definitions of Day and Night
Proportion of Non-dippers (%)
x =21.8,p<0.ooooi
x = 1.63,p =NS
x2 =4.3,p = 0.038
21%
8pm - 7am 10pm - 7am 12mn - 7am Sleep
The proportion of non-dippers was smallest using activity-derived sleep and wake times,
and this proportion was significantly different from that using night-time defined as either
8 pm - 7 am or 12 midnight - 7 am.
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Table 3.2 Reproducibility of Ambulatory Blood Pressure - Variation
Dependant on Time
Absolute Standard deviation
Mean ± S.E.M. Day 1 Day 2 Difference of the difference
(s.d.d.) mmHg.
Wake systolic BP 147 ±2.7 145 + 3 2.7 7.1
(activity derived)
Wake diastolic BP 91 + 1.8 90+2 0.8 3.8
(activity derived)
Sleep systolic BP 125+2.5 123 + 2.6 1.9 6.3
(activity derived)
Sleep diastolic BP 73 + 1.7 73 + 1.9 0.7 3.9
(activity derived)
Day systolic BP 147+2.6 145 + 3 2.7 7.3
(7am - 8pm)
Day diastolic BP 91 + 1.7 90+2 0.8 4.0
(7am - 8pm)
Night systolic BP 131+2.5 129+2.7 1.5 6.4
(8pm - 7am)
Night diastolic BP 78 + 1.7 77 + 1.8 0.3 3.9
(8pm - 7am)
Day systolic BP 147+2.6 144 + 3 2.7 7.0
(7am - 10pm)
Day diastolic BP 90 + 1.8 90+2 0.5 4.0
(7am - 10pm)
Night systolic BP 128+2.5 126+2.7 1.6 6.7
(10pm - 7am)
Night diastolic BP 75 + 1.7 75 + 1.8 0.6 4.0
(10pm - 7am)
Day systolic BP 146 + 2.6 143 + 3 2.6 6.8
(7am - 12mn)
Day diastolic BP 90+1.7 89+2 0.7 4.1
(7am - 12mn)
Night systolic BP 125+2.6 124 + 2.7 1.6 6.7
(12mn - 7am)
Night diastolic BP 74 + 1.8 73 + 1.9 0.7 3.7
(12mn - 7am)
46
Table 3.3 Reproducibility of Diurnal Blood Pressure Variance
Absolute Standard deviation
Mean + S.E.M. Day 1 Day 2 Difference of the difference
(s.d.d.) %.
Nocturnal SBP dip - 15.1 + 1.4 14.8 + 1.2 0.25 4.7
activity
Nocturnal DBP dip - 18.8 + 1.5 18.9 + 1.5 -0.09 5.1
activity
Nocturnal SBP dip - 11.1 + 1.1 10.5+0.9 0.59 4.1
8pm - 7am
Nocturnal DBP dip - 14.6+1.2 14.2 + 1 0.37 4.5
8pm - 7am
Nocturnal SBP dip - 12.9+1.3 12.5 + 1.1 0.44 4.1
10pm - 7am
Nocturnal DBP dip - 16.4+1.5 16.6 + 1.1 -0.28 4.6
10pm - 7am
Nocturnal SBP dip - 14.1 + 1.3 13.7 + 1.2 0.41 4.1
12mn - 7am
Nocturnal DBP dip - 17.4+1.5 17.6+1.3 -0.13 5.1
12mn - 7am
In these 30 patients the average correlation between the three activity measures outlined
above and blood pressure was 0.34 (range -0.4 to +0.79) for diastolic BP and 0.25
(range -0.38 to +0.75) for systolic. The relationship was statistically significant at the
5% level in over half the readings. The strength of the relationship and the optimal
measure of activity varied widely between patients and, to a lesser extent, within patients.
Adjustment of the half hourly blood pressure readings for activity reduced systolic BP
variation by an average of 20% (range -10 to +70%) and diastolic BP variation by an
average of 26% (range -9 to +65%). The relationship between activity and blood
pressure varied significantly between patients (p < 0.0001) and between the 2 readings in
the same patient (p=0.03).
Correlation coefficients between mean wake activity and blood pressure were 0.24
(p=0.07) and 0.39 (p = 0.002) for systolic and diastolic pressure respectively, with
regression equations:
SBP = 102.3 + 5.67xActivity
DBP = 43.3 + 6.2xActivity
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These were used to adjust mean wake BP for each patient to give expected BP had that
patient's activity heen equal to the average daily activity of the patients
Adjusted SBP = SBP - 5.67xActivity +41.8.
Adjusted DBP = DBP - 6.2xActivity +45.7
This adjustment reduced within-patient (i.e. between reading 1 and 2) variation by
6% 19%, which resulted in an average change in BP of 4/4 mmHg (maximum 9/10
mmHg). Thus, while the overall reduction in variation was small, the size of the change
in patients with either markedly low or high activity could be clinically significant.
The standard deviation of the difference between first and second readings before
adjustment was small (7/4 mmHg), indicating that reproducibility of the group mean was
already good and further adjustment would therefore be hard to achieve with adjustment
for activity.
Discussion
This study has shown that statistically significant, though not necessarily clinically
relevant, differences exist between different definitions of day and night when compared
to wake and sleep. The difference in the proportion of subjects classified as non-dippers
was still more striking, particularly in a heterogeneous population with a large number of
non-dippers. The definition of night-time varies widely in the literature (O'Brien et al,
1988; Verdecchia et al, 1990; Shimada et al, 1992) and current recommendations remain
imprecise (The Scientific Committee, 1990).
I have found wake/sleep data, with sleep time objectively measured using a wrist
actigraph, simple to perform and compute. The additional monitoring procedure was well
tolerated by the vast majority of patients, causing minimal additional discomfort. This
technique overcomes some of the disadvantages inherent in relying on patient diaries,
where sleep time may not be accurately recorded. In addition, simultaneous initialisation
of the two instruments ensures that there is no discrepancy in the timing due to watch or
clock inaccuracy.
Three different definitions of day-time all approximate closely to wake, while larger and
potentially clinically significant differences exist when comparing sleep, with 12 midnight
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- 7 am best approximating to the sleep value. I would suggest that more rigid criteria for
the description of 24 hour blood pressure profiles are required, and as no one time period
is clearly "right", would strongly recommend the use of wake and sleep as both
physiologically and scientifically more sound. To be accurate, this should entail a
constant sampling interval throughout the monitoring period. If an arbitrary cut-off value
for day and night must be used, a definition of 7 am - 10 pm may be preferred when day¬
time BP is the main end-point, while if diurnal variation and the nocturnal dip are the
main indications for the study, 7 am - 12 midnight is preferable.
Reproducibility of the ambulatory blood pressure parameters and of diurnal blood
pressure variation was good and was similar regardless of the method used. However,
the absolute difference in the nocturnal dip was smallest when using the activity derived
method, despite a larger recorded dip, suggesting that this may be more accurately
defining the true fall in blood pressure during sleep.
I have also tried to define which actigraph activity measure most closely relates to wake
blood pressure variability, and determine whether adjustment of mean wake blood
pressure for activity could improve within-patient reliability. Several different time
periods and activity measures were considered but it was clear that no one measure was
ideal, with wide variation in the strength of the relationship between individuals and, to a
lesser extent, within individuals. This fact alone must limit the potential for this
technique as a method of improving the definition of blood pressure in routine clinical
practice. However, with a multiple regression technique, using the three activity features
most closely related to blood pressure in the group as a whole, I was able to show that on
average 20% of systolic and 26% of diastolic day-time variability could be accounted for
by wrist actigraph-measured activity, which is similar to the value previously reported by
Van Egeren (1991) for variability over 24 hours.
Regression analysis, using a simpler model, dependent on weighted mean activity over 30
minutes only, was also used to adjust mean wake BP for activity, such that the activity
value of each BP record was equal to the group mean. On average, this resulted in a 4/4
mmHg change in mean BP, with a maximum change of 9/10 mmHg. This did not
significantly improve the reproducibility of the mean group wake blood pressure.
However, this was relatively good before adjustment (standard deviation of the difference
for day mean BP 7/4 mmHg), with the result that any further improvement was always
going to be difficult to achieve. Correcting mean BP for activity may be of more
importance when baseline reproducibility is poorer. Moreover, at either extreme in
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activity, change in blood pressure of as much as 9/10 mmHg was seen, which could
significantly improve within-patient variation in some individuals. Such an alteration
could be clinically relevant and help, for example, in the assessment of the blood pressure
response to anti-hypertensive therapy in the individual. However, the precise effect on
within-patient variation and any possible clinical role for this technique requires further
study.
Conclusions
Any change in the definition of day and night can affect the diurnal blood pressure profile
described, with the potential to effect major differences in the proportion of non-dippers
defined. The use of sleep time to define diurnal variability appears more physiologically
sound and may be more reproducible than any arbitrary definition of night-time. The use
of activity monitors can provide an objective measurement of sleep time. Although such
devices also allow a correction to be made for day-time activity levels the overall effect




The Distribution of Diurnal Blood Pressure Variation in Patients Attending a
Hypertension Clinic : Impact of Age, Treatment and Cause
Background
Unimodalitv versus Bimodalitv - The "Normal" Distribution of Blood Pressure
Hypertension research was enlivened and changed for ever by the historic debate between
Sir George Pickering and Sir Robert Piatt on the fundamental nature of hypertension
which raged throughout the 1950's and 60's (Swales, 1985). The conventional view, as
espoused by Piatt, was that of essential hypertension as a distinct disease entity, inherited
as a Mendelian dominant trait, and hence distributed bimodally in the population (Piatt,
1947; Piatt, 1959). Pickering, however, argued that arterial blood pressure was
distributed continuously, with a skew at the upper end of the curve, and as such any
separation between normotension and hypertension was arbitrary (Oldham et al, 1960;
Pickering, 1961). He was the first to express the view that the sharp distinction between
hypertension and normotension was a medical artefact (Pickering, 1955). He therefore
felt that hypertension should be defined and analysed quantitatively and not qualitatively
(Pickering, 1961) and deplored the continuing tendency of doctors to divide the population
in two - normotensive and hypertensive (Pickering, 1978). Indeed he felt that this attitude
had hindered research in the field for decades (Pickering, 1961).
Pickering eventually won the day and, although recent complex statistical analyses have
suggested that the two populations may indeed be distinct (McManus, 1983; Julius et al,
1991), few would argue today that there is any clear dividing line between them, and the
problem of defining hypertension remains.
Despite the pivotal role of this debate in hypertension research, early work on the
potential importance of diurnal blood pressure variation has concentrated on differences
between the two extremes - "Dippers" and "Non-dippers" (O'Brien et al, 1988; Pickering,
1990b). This distinction is based on an arbitrary division to separate them, commonly a
day-night difference of < 10% (Verdecchia et al, 1991). The distribution of the
nocturnal dip has not been studied in detail, but preliminary observations have failed to
reveal any evidence of bimodality (Stewart & Padfield, 1992), suggesting that such a
definition may be erroneous and potentially misleading.
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Ambulatory Blood Pressure and Blood Pressure Variation
The introduction of ambulatory blood pressure monitoring has improved our
understanding of the variability of blood pressure and the nature of hypertension. Day¬
time mean ambulatory blood pressure is clearly more reproducible than clinic BP (Conway
et al, 1988; Coats, 1990; Bottini et al, 1992), largely due to the greater number of
available readings (Trazzi et al, 1991). Preliminary evidence suggests that this
measurement also better defines those at risk (Perloff et al, 1983), but this does little to
improve the problem of separating "normal" from "high" blood pressure (Pickering,
1992b), and any cut-off value at which treatment is advised remains arbitrary.
The variation in blood pressure in different clinical situations has been appreciated since
the earliest days of blood pressure measurement (Zadek, 1880) and differences in blood
pressure during the day and the night appreciated for the most of this century (Janeway,
1904). However, it is only with widespread use of ambulatory blood pressure monitoring
that the extent of the variation from day to night has been realised (Richardson et al,
1964; Littler et al, 1975). From the early days of this technique it was appreciated that
the diurnal variation present in normotensive subjects persisted in most hypertensive
patients, with an upward shift of the entire curve (Littler et al, 1975; Raftery, 1983;
Mancia et al, 1983b). Thus, the nocturnal fall, when expressed as a percentage, is
approximately 20% in both normotensives and hypertensives, although the fall in absolute
terms is greater at higher pressures. Differences to this pattern are now recognised
(O'Brien et al, 1988) but factors which may alter this are not well understood, although
the apparent excess of altered diurnal variation in patients with some forms of secondary
hypertension has provided some clues.
Diurnal Blood Pressure Variation in Secondary Hypertension
Several workers have noted that the nocturnal fall in blood pressure is less marked in most
patients with secondary hypertension (Hany et al, 1987; Imai et al, 1990; Middeke &
Schrader, 1994), and have argued that this observation could aid the differential diagnosis
of secondary hypertension. However, there is marked variation in the pathophysiology of
these different forms of hypertension and in the reported effect on diurnal blood pressure
variation (Padfield & Stewart, 1991).
Primary aldosteronism or Conn's syndrome is the archetypal form of volume mediated
hypertension (Fraser et al, 1989) and as such, if volume changes related to posture were
important in the pathophysiology of the nocturnal dip, might be expected to have a
pronounced effect on the diurnal rhythm. However, data in the literature is conflicting,
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with two reports suggesting loss of the diurnal rhythm (Tanaka et al, 1983; Baumgart et
al, 1989a) not being confirmed by further work (Munakata et al, 1988).
Hypertension is common in Cushing's syndrome, occurring in 80% of cases (Fraser et al,
1989) and attenuation of the diurnal rhythm has been found both with the pituitary
dependent form, primary adrenal glucocorticoid excess (Imai et al, 1988b), and when
glucocorticoids are given exogenously in large doses (Imai et al, 1989).
Renal disease is thought to raise blood pressure via a complex interaction between sodium
or volume status and inappropriate production of renin and angiotensin II (Davies et al,
1973). Attenuation of the nocturnal dip in chronic renal failure appears to be a consistent
observation (Baumgart et al, 1989b; Imai et al, 1990; Portaluppi et al, 1990), and may be
directly related to the severity of renal dysfunction (Imai et al, 1988b; Baumgart et al,
1989a). In contrast, studies of renovascular disease vary, with Tanaka et al (1983)
suggesting an altered blood pressure rhythm in middle aged and elderly patients, while
Imai et al (1990) have found the rhythm of younger patients with fibromuscular
hyperplasia to be normal, suggesting that the observation in older patients, in whom
atherosclerotic disease predominates, may be an epiphenomenon, rather than a cause and
effect relationship. Baumgart et al (1989a), while demonstrating loss of the nocturnal dip
in chronic renal disease, only noted abnormal rhythms in renovascular disease when
overall renal function was compromised. Abel et al (1990) have suggested that the
autonomic neuropathy seen in chronic renal failure is responsible for the altered diurnal
rhythm in such patients.
The importance of the autonomic nervous system, and particularly the sympathetic
nervous system, is demonstrated by studies of varied clinical conditions. Complete
reversal of the diurnal rhythm is seen in autonomic failure (Mann et al, 1983) and the
nocturnal dip is attenuated or absent in diabetic autonomic neuropathy (Liniger et al,
1987; Hornung et al, 1989), and in cardiac transplant recipients, whose ventricles are
denervated (Reeves et al, 1986). An abnormal diurnal rhythm is also seen in patients with
phaeochromocytoma (Littler & Honour, 1974; Padfield et al, 1991), but detailed analysis
reveals that this is only the case in those with paroxysms of hypertension, suggesting that
the level of noradrenaline may be of more importance than that of adrenaline (Imai et al,
1988a; Imai et al, 1990). Despite these observations, there is no evidence to support the
view that the diurnal blood pressure variation in normotensive and essential hypertensive
subjects is entrained to sympathetic nervous system activity (Messerli et al, 1982).
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Limited studies on patients with coarctation of the aorta have shown normal diurnal blood
pressure variation whether untreated (Middeke & Schrader, 1994) or after surgical
correction (Sehested et al, 1990a) suggesting that this is a purely mechanical form of
hypertension.
Impact of Age and Severity of Hypertension on the Diurnal Rhythm
Blood pressure increases with age and several studies have shown the prevalence of
hypertension in an elderly population to be as high as 50% (The Working Group on
Hypertension in the Elderly, 1986: Vokonas et al, 1988). Vascular changes associated
with ageing lead to a decrease in vascular compliance and predominant systolic
hypertension in many elderly patients (Messerli & Schmieder, 1991). This, together with
changes in vascular responsiveness associated with ageing (Messerli & Schmieder, 1991),
results in an increase in short term blood pressure variability in elderly patients (Mancia et
al, 1980; Drayer et al, 1982). However, the effect on long term, or diurnal, variability
appears less pronounced (Drayer et al, 1982; Munakata et al, 1991) and the nocturnal fall
in blood pressure appears to persist in older age in population studies (Staessen et al,
1991; O'Brien et al, 1991c), although the haemodynamic components responsible may
differ (Minamisawa et al, 1994).
Short term blood pressure variability has also been shown to higher in hypertensives than
in normotensives (Watson et al, 1979; Mancia et al, 1980; Floras et al, 1988), although
when variability is corrected for the mean blood pressure this difference disappears
(Mancia et al, 1980). Gosse et al (1988b) have suggested that the diurnal variation in
blood pressure is determined more by the severity of the hypertension than by cause but
this has not been confirmed by other workers (Reeves et al, 1984) and was not apparent in
a study of patients with accelerated hypertension (Shaw et al, 1963).
Antihypertensive Treatment and the Diurnal Rhythm
The improved reproducibility (Trazzi et al, 1991) and possible lack of any placebo effect
(Conway et al, 1988; Mutti et al, 1991) has led to the rapidly increasing use of
ambulatory blood pressure monitoring in clinical trials of new anti-hypertensive drugs
(Conway et al, 1990; O'Brien et al, 1991a; White, 1992). Furthermore ambulatory
monitoring has the ability to indicate the duration of drug effect and the influence of drugs
on nocturnal blood pressure (O'Brien et al, 199Id) and on blood pressure variability
(Pickering, 1990e).
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There are now many published studies utilising ambulatory monitoring in the assessment
of antihypertensive drugs, but few compare the effect of drugs from different class. In a
retrospective survey of 2859 patients O'Brien et al (1991a) found that the nocturnal dip in
blood pressure was accentuated in subjects given angiotensin converting enzyme inhibitors
as compared to both untreated essential hypertensives and subjects given beta blockers.
Floras et al, (1982) have studied the duration of action of 4 different beta blockers, all
given in once daily dosage, and found that pindolol, the only drug with intrinsic
sympathomimetic activity, failed to lower blood pressure during sleep, thus attenuating the
nocturnal dip. However, reviews of the differing effects of antihypertensive drugs
conclude that the majority have little effect on the diurnal rhythm (Sirgo et al, 1988;
Pickering, 1990e) but there is a tendency to lower pressure more during the day.
Pickering (1990e) concludes that two agents, labetolol and methyl dopa, may have
preferential effects on day-time blood pressure, leading to a relative attenuation of the
nocturnal dip, and speculates that this is because these agents block both limbs of the
sympathetic nervous system, thus preventing the increase in blood pressure during day¬
time seen in response to sympathetic stimulation.
Introduction
In this study, the nature of the diurnal rhythm in patients with hypertension is explored in
detail. The distribution curve of the nocturnal dip from a large cohort of patients has been
analysed and examined for evidence of bimodality. The impact of age, severity of
hypertension, and antihypertensive treatment on the diurnal curve has been assessed and
long-term blood pressure variability of patients with secondary hypertension compared to
that of essential hypertensives.
Methods
This is a retrospective analysis of all patients referred for ambulatory blood pressure
monitoring over a 4 year period, from 1989 - 1993. Patients with both primary essential
and secondary hypertension, and normotensive subjects were included. As many patients
had multiple ambulatory recordings over this time period, only the first recording was
included in analyses of the pattern of diurnal rhythm. A separate analysis then studied
diurnal blood pressure parameters of those whose treatment had changed over time.
Data from every patient referred for ambulatory blood pressure monitoring were stored on
a DBase IV programme developed for the purpose. This enabled automatic editing of data
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in a standardised manner (readings which were either physiologically impossible or had a
pulse pressure less than half the mean pulse pressure over the 24 hour period (Conway et
al, 1988) were eliminated) and the concurrent storage of other demographic and treatment
details. A coding system was used to record the diagnosis of essential hypertension or of
a secondary cause where appropriate.
Mean twenty-four hour, day (defined as 7 am - 12 midnight) and night (12 midnight to 7
am) blood pressures, and the change in blood pressure from day to night expressed as a
percentage were automatically calculated and stored at the time of data entry. The mean
of all blood pressure readings obtained in each one hour period was also calculated and
stored.
Only patients in whom > 80% of readings had been successfully obtained were included
in the analysis.
The distribution curve of the nocturnal dip in patients with essential hypertension, treated
or untreated, was plotted and analysed for Normality using Shapiro-Wilks' W test
(Altman, 1991).
The influence of age and of severity of hypertension on diurnal blood pressure variation in
patients with essential hypertension was assessed by dividing the study group into
quartiles based on age and blood pressure level respectively. Differences in the nocturnal
dip were then analysed using analysis of variance.
Differences in blood pressure variation across different classes of anti-hypertensive drugs
have also been sought, with the absolute level across treatment groups compared, and the
impact of treatment on the dip analysed in patients in whom readings were available
before and after a change in therapy, using Student's paired t-test or analysis of variance
as appropriate.
Diurnal blood pressure variation in patients with secondary hypertension has been
compered to that of the essential hypertensive population using analysis of variance, with
age as a possible confounding co-variate. The impact of renal function on the nocturnal
dip has also been assessed in patients with essential hypertension. Diurnal blood pressure
variation in patients with normal serum creatinine was compared to that of patients with
mildly elevated (140 - 200 /rmol/1) and more significantly elevated (> 200 /imol/1)
creatinine levels using analysis of variance.
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Results
1. Diurnal Blood Pressure Variation in Essential Hypertension
From a data base of 2635 records, 1053 individual records from subjects with primary
essential hypertension (both treated and untreated) were identified, with a mean age of 51
± 0.44 years and clinic blood pressure of 153 ± 0.7/95 ± 0.4 mmHg. Five hundred and
sixty four (54%) were male and 489 (46%) female. Mean day-time BP was 146 ± 0.6/89
± 0.4 mmHg (range 215/132 to 106/56 mmHg) and night-time BP was 128 ± 0.6/74 ±
0.4 mmHg (range 204/138 to 82/42 mmHg). Nocturnal dip averaged 12.3 ± 0.2/16.2 ±
0.3 % (range 33.8/40.9 to -24/-38%).
Frequency histograms of the nocturnal dip were plotted for both systolic and diastolic BP
(Figures 4.1 and 4.2) and the data used to construct Normal plots (Altman, 1991) (Figures
4.1 and 4.2). In such plots, the horizontal axis shows the numerical value of the
observation, and the vertical axis gives the relative frequency in terms of the number of
standard deviations from the mean. Data which has a Normal distribution should create a
straight line, with departures of the sample data from Normality easily seen as departures
from this line.
Data were then analysed using the Shapiro-Wilk's W test for Normality. In this analysis,
the closer the W statistic is to unity the more Normal the distribution. On initial analysis,
W was 0.98 for the systolic dip and 0.96 for the diastolic, but with very small probability
values, indicating clear deviance from Normality. Inspection of the Normal plots
suggested that this was due to small numbers of subjects with marked increase in
nocturnal BP (Figures 4.1 and 4.2). From clinical experience, some individuals
demonstrate artefactual reversal of the normal day-night blood pressure dip due to factors
such as shift work, complete disruption of sleep or, in one case, an attack of renal colic
during the night. The analysis was therefore repeated with the lowest 1 % of readings (n
= 10) excluded. Repeat Normal plots then confirmed Normality, with little change in W
but high probability values (Figure 4.3).
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Figure 4.1 The Distribution of the Nocturnal Dip in Systolic Blood Pressure
Frequency histogram (upper panel) and Normal plot (lower panel) for diurnal variation in
systolic blood pressure. The frequency distribution is approximately Normal but,
although the W statistic is close to 1.0, the Normal plot demonstrates significant deviation
from Normality, predominantly due to outliers with extreme negative values.
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Figure 4.2 The Distribution of the Nocturnal Dip in Diastolic Blood Pressure
Frequency histogram (upper panel) and Normal plot (lower panel) for diurnal variation in
diastolic blood pressure. Again, the distribution appears approximately Normal but with
significant deviation from Normality due to negative outliers.
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Figure 4.3 Normal Plots of Diurnal Blood Pressure Variance
Normal plot for systolic (upper panel) and diastolic (lower panel) blood pressure after
removal of potentially erroneous outliers. The W value has not changed significantly but
the population is now shown to be Normally distributed.
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2, Effect of Age on Blood Pressure and Diurnal Blood Pressure Variation
The population described above was then divided into quartiles based on age (Table 4.1)
and the change across the groups analysed using analysis of variance (Figure 4.4).
Table 4.1 Quartiles based on age
Mean ± SEM 15-40 40-52 52 - 62 62 - 84
Number 263 263 263 264
Age 32 ± 0.4 47 ± 0.2 58 ± 0.2 69 ± 0.3
Day SBP 139 ± 1 144 ± 1 150 ± 1.2 152 ± 1.1
Day DBP 88 ± 0.7 93 ± 0.7 91 + 0.7 84 ± 0.7
Night SBP 121 ± 1 125 ± 1.1 131 + 1.3 136 ± 1.3
Night DBP 71 ± 0.7 77 ± 0.7 77 ± 0.7 73 ± 0.8




18.8 ± 0.48 17 ± 0.47 15.4 ± 0.53 13.5 ± 0.62
As expected from previous epidemiological work, systolic blood pressure rises
progressively with age, while diastolic blood pressure increases to middle age but then
falls at the extreme. However, a clear effect of age on the nocturnal dip in blood pressure
was apparent, with a progressive fall in each age range.
3. Effect of Severity of Hypertension on Diurnal Blood Pressure Variation
The data were then re-analysed after sub-dividing the population into quartiles based on
the severity of hypertension, as indicated by level of mean day-time blood pressure
(Tables 4.2a and 4.2b), and the change across the groups analysed using analysis of
variance (Figure 4.5).
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ANOVA plot demonstrating the effect of age on systolic (upper panel) and diastolic (lower
panel) diurnal blood pressure variation. The nocturnal dip fall progressively with
increasing age.
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Table 4.2a Quartiles based on severity of systolic hypertension
Mean ± SEM 106 - 134 134 - 144 144 - 157 157 - 215
Number 283 253 265 252
Age 46 ± 0.8 49 ± 0.9 53 ± 0.8 57 ± 0.8
Day SBP 126 ± 0.4 139 ± 0.2 150 ± 0.2 172 ± 0.7
Night SBP 111 ±0.6 121 ± 0.6 131 ± 0.8 152 ± 1.1
Nocturnal Dip 11.9 + 0.44 13.4 ± 0.44 12.6 ± 0.49 11.4 + 0.52
SBP (%)
Table 4.2b Quartiles based on severity of diastolic hypertension
Mean ± SEM 56-80 80-88 88-96 96 - 132
Number 253 265 272 263
Age 53 ± 1.1 50 ± 0.9 52 ± 0.8 50 ± 0.7
Day DBP 74 ± 0.3 85 ± 0.1 92 ± 0.1 104 ± 0.4
Night DBP 62 ± 0.5 71 ± 0.5 77 ± 0.5 87 ± 0.7
Nocturnal Dip
DBP (%)
15.1 ±0.63 16.3 ± 0.55 16.6 ± 0.51 16.6 ± 0.48
There appeared to be no relationship between severity of diastolic hypertension and the
night-time dip in diastolic pressure. A statistically significant effect of day-time systolic
blood pressure on the dip was apparent, accounted for in part by an excess of elderly
subjects in the group with the highest systolic pressure. Correcting for this, the statistical
significance is less (F = 3.1, p = 0.03). Moreover, the relationship is non-linear and as
such unlikely to be of any clinical significance.
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= 3.5; p = 0.014
11.4%
106-134 134-144 144-157 157-215
Mean Day-time Systolic BP (mmHg)
Mean Day-time Diastolic BP (mmHg)
ANOVA plots demonstrating the effect of the level of wake systolic BP on systolic diurnal
variation (upper panel) and wake diastolic BP on diastolic blood pressure variation (lower
panel). Although there is a statistically significant difference across quartiles of systolic
BP, this is non-linear and unlikely to be clinically relevant.
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Effect of Anti-hvpertensive Treatment on Diurnal Blood Pressure Variation
Data on drug therapy at the time of the ambulatory blood pressure recording were
available in 1029 of this patient group. To determine whether anti-hypertensive treatment
can influence diurnal blood pressure variation, an initial analysis compared treated patients
with untreated, regardless of drug class, quantity or dose. Six hundred and two patients
were untreated and 427 on treatment. The two groups were compared using Student's t-
test for unpaired data (Table 4.3). In view of the marked difference in age between the
two groups, data were re-analysed using analysis of variance, correcting for age (Table
4.3).
Table 4.3 Effect of Drug Therapy on Diurnal Blood Pressure Variation
Mean ± SEM Untreated Treated P (t test) P - Age Corrected
(ANOVA )
Number 602 427
Age 47 + 0.6 58 ± 0.6 < 0.000001
Day SBP 145 + 0.7 148 ± 0.9 0.004 NS
Day DBP 90 ± 0.5 87 ± 0.6 0.0001 0.003
Night SBP 125 ± 0.8 132 ± 1 0.000001 NS
Night DBP 74 ± 0.5 75 ± 0.6 NS NS
Nocturnal Dip 13.4 ± 0.27 11.5 ± 0.42 0.000005 0.005
SBP (%)
Nocturnal Dip 17.8 ± 0.31 14.2 ± 0.47 < 0.000001 0.0001
DBP (%)
Even after correcting for age diurnal blood pressure variation appears less pronounced in
treated patients.
Subjects on monotherapy were then examined separately in an attempt to determine
whether there was any difference in the effect of anti-hypertensive drugs. The nocturnal
dip of patients treated with beta blockers, diuretics, angiotensin converting enzyme
inhibitors and calcium antagonists were compared and analysed using analysis of variance
(Table 4.4 and Figure 4.6). A significant difference across treatment groups was
apparent, with calcium antagonist therapy apparently associated with attenuation of the
nocturnal dip. However, a difference in age across treatment groups was also apparent
and data was therefore re-analysed allowing for age as a covariate, following which the
effect of therapy on the systolic dip was just significant and that on the diastolic dip no
longer so. Moreover, both day and night systolic pressures were markedly higher in the
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calcium blocker group, suggesting that baseline hypertension may have been more severe
in this group. Although, as shown above, the blood pressure level per se does not
influence the diurnal variation, this may indicate that these groups are not strictly
comparable.
Table 4.4 Effect of Drug Mono-therapy on Diurnal Blood Pressure Variation
Mean ± SEM Beta Diuretic ACE Calcium
Blocker Inhibitor Antagonist
Number 45 53 44 42
Age 51 ± 2.1 64 + 1.4 53+1.6 59 ± 1.5
Day SBP 141 ± 2.7 144 ± 2.1 146 ± 2.5 155 ± 3.4
Day DBP 87 ± 1.5 84 ± 1.5 90 ± 1.4 90 ± 1.7
Night SBP 124 ± 2.9 127 ± 2.3 126 ± 2.9 142 ± 3.5
Night DBP 73 ± 1.9 72 ± 1.7 75 ± 1.7 80 ± 1.6
Nocturnal Dip
SBP (%)
12.6 ± 1.27 11.5 ± 1.02 13.2 ± 1.2 8.1 ± 1.29
Nocturnal Dip
DBP(%)
16 ± 1.41 13.9 ± 1.57 16 ± 1.27 10.4 ± 1.63
The entire data base was then examined to identify those patients whose treatment had
changed over time. Due to the relatively small numbers involved, no attempt was made to
examine each class of drug independently. The change in blood pressure and in diurnal
blood pressure variation has been assessed using Student's paired t test (Table 4.5a). For
comparison, those subjects who had undergone repeat monitoring at a different time point
with no change in treatment were subjected to the same analysis (Table 4.5b). The
standard deviation of the difference between the two measurements has been calculated as
a measure of the repeatability.
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Figure 4.6 The Effect of Drug Therapy on Diurnal Blood Pressure Variation
Treatment Group
Treatment Group
ANOVA plot comparing diurnal blood pressure variation in patients treated with
monotherapy by drug class (upper panel). The difference in age across drug class has also
been examined (lower panel). After correcting for age, the influence of drug class is less
significant, with F = 2.8, p = 0.004 for systolic BP and F = 2.2, p = 0.09 for diastolic BP.
ACEI = Angiotensin converting enzyme inhibitor. Ca++ = Calcium antagonist.
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Table 4.5a Change in Ambulatory Blood Pressure Parameters After a Change
in Antihypertensive Treatment
Cohort includes subjects whose treatment has been increased or decreased
Mean ± SEM Ambulatory Ambulatory Mean SD of the P
BP 1 BP 2 Difference Difference
(s.d.d.)
Number 137 137
Day SBP 154 ± 1.6 145 ± 1.4 9.1 17.3 < 0.0000001
Day DBP 93 ± 1.1 88 ± 0.9 5.8 10.7 < 0.0000001
Night SBP 136 ± 1.9 129 ± 1.6 8 19.4 0.000004
Night DBP 80 ± 1.2 75 ± 0.9 4.9 11.7 0.000002
Nocturnal Dip 11.4 ± 0.68 11.2 ± 0.63 0.2 7.9 NS
SBP (%)
Nocturnal Dip 14.6 ± 0.8 14.4 ± 0.73 0.2 9.2 NS
DBP (%)
Table 4.5b Change in Ambulatory Blood Pressure Parameters Over Time
With No Change in Antihypertensive Treatment
Cohort includes untreated subjects and treated patients whose treatment is unchanged.
Mean ± SEM Ambulatory Ambulatory Mean SD of the P
BP 1 BP 2 Difference Difference
(s.d.d.)
Number 164 164
Day SBP 142 ± 1.4 140 ± 1.3 2.1 11 0.014
Day DBP 88 + 0.9 87± 0.9 1.7 6.8 0.002
Night SBP 126 ± 1.5 123 ± 1.4 2.3 13.4 0.03
Night DBP 75 ± 1 73 ± 0.8 2.4 8.7 0.0006
Nocturnal Dip 11.4 ± 0.59 11.9 ± 0.53 -0.4 7.2 NS
SBP (%)
Nocturnal Dip 14.8 ± 0.68 15.8 ± 0.64 -1 9.1 NS
DBP(%)
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As expected, the change in both day and night blood pressure over time was highly
significant in those whose treatment had changed. However, diurnal blood pressure
variation did not change significantly. Smaller, statistically but not clinically significant
changes in day and night blood pressure were seen in those whose treatment did not
change. Again, there was no significant difference in the nocturnal dip.
5. Diurnal Blood Pressure Variation in Secondary Hypertension
Patients with secondary hypertension were identified and their initial ambulatory blood
pressure data compared to that of the essential hypertensive population (Table 4.6). Most
patients were on no therapy or conventional antihypertensive treatment (i.e. not specific
therapy aimed at the cause of secondary hypertension) at the point of study. Patients with
coarctation of aorta had all been operated on in childhood and were investigated as part of
follow-up review. Initial analysis indicated a significant difference in age between groups
and age was therefore included as a covariate.
Diurnal blood pressure variation is significantly attenuated in patients with
phaeochromocytoma, Cushing's syndrome and acromegaly. In contrast, diurnal variation
in patients with coarctation of the aorta is normal. Patients with hypothyroidism, now
recognised as treatable, secondary cause of hypertension (Bing et al, 1980; Streeten et al,
1988), also had relatively normal diurnal blood pressure variation.
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Table 4.6 Comparison of Ambulatory Blood Pressure Parameters in Essential
and Secondary Hypertension







Number 1053 21 15
Age 51 ± 0.4 49 ± 3.7 NS 43 ± 3 0.02
Day SBP 146 + 0.6 137 ± 3.6 0.03 139 ± 3.4 NS
Day DBP 89 ± 0.4 75 ± 1.4 0.000001 83 ± 2.9 0.03
Night SBP 128 ± 0.6 124 ± 4.8 NS 132 ± 6.4 NS
Night DBP 74 ± 0.4 63 ± 1.3 0.00001 75 ± 4.7 NS
Nocturnal Dip 12.3 ± 0.24 9.7 ± 1.78 NS 5.2 ± 4 0.0003
SBP (%)
Nocturnal Dip 16.2 ± 0.27 16.1 ± 1.84 NS 9.2 ± 4.85 0.0001
DBP(%)
Cushing's P Acromegaly P Coarctation P
Syndrome of Aorta
8 11 18
35 ± 4.5 0.001 53 ± 3.7 NS 22 ± 2.5 0.000001
137 ± 6 NS 139 ± 4.8 NS 131 + 3.2 NS
84 ± 4.2 NS 85 ±4.1 NS 74 ± 1.7 0.000001
127 ± 8.4 NS 130 ± 5.5 NS 112 ± 3 NS
74 ± 5.5 NS 76 ± 3.8 NS 59 ± 1.7 0.000006
7.6 ± 2.52 0.03 7 ± 1.52 0.024 14.5 ± 1.65 NS
12.3 ± 3.1 0.04 10.7 ± 1.68 0.046 20.2 ± 1.97 NS
Each secondary hypertension parameter has been compared to that of essential
hypertension, correcting for age, using one way analysis of variance. The p statistic in
the column following each cause of secondary hypertension refers to this analysis.
70
6. Influence of Renal Function on Diurnal Blood Pressure Variation
Results of serum biochemistry, including urea and creatinine, usually performed at the
Hypertension clinic within 1 month of blood pressure monitoring, were available in 688
patients. This population was subdivided on the basis of a normal, mildly elevated (140 -
200 /xmol/1) or more severely elevated (> 200 /xmol/1) serum creatinine (Table 4.7) and
mean blood pressure parameters compared using analysis of variance, again allowing for
age as a co-variate (Figure 4.7). Although day-time mean BP was similar in the three
groups, diurnal blood pressure variability was significantly attenuated in those with
abnormal serum creatinine. However, there was no evidence of a linear relationship, with
a similar reduction in the nocturnal dip of those with mildly and severely impaired renal
function, and correlation coefficients for serum creatinine and the nocturnal dip of -0.05
for systolic BP and -0.09 for diastolic BP.
Table 4.7 Blood Pressure in Essential Hypertension in Patients with Normal,
Mildly Impaired and Severely Impaired Renal Function







Number 564 88 36
Age 58 ± 0.5 57 ± 1.2 64 ± 1 5.4 0.005
Day SBP 152 ± 0.8 151 ± 2.4 160 ± 3.9 2.7 NS
Day DBP 89 ± 0.5 91 ± 1.5 89 ± 1.2 1.4 NS
Night SBP 135 ± 1 139 ± 2.4 148 ± 4.7 5.3 0.005
Night DBP 75 ± 0.5 81 ± 1.4 79 ± 1.6 9.2 0.0001
Nocturnal Dip
SBP (%)
11.2 ± 0.33 8.3 + 0.76 8.2 ± 0.98 7.6 0.0006
Nocturnal Dip
DBP(%)
15.1 ± 0.4 10.4 ± 0.81 11.6 ± 1.07 14 <0.00001
Urea (mmol/)l 6.4 ± 0.1 9.4 ± 0.3 14.7 ± 1.2 194 <0.00001
Creatinine
(/xmol/1)
99 ± 0.8 159 ± 1.7 510 ± 170 54 <0.00001
Parameters have been compared using analysis of variance, allowing for age as a co-
variate.
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Figure 4.7 The Impact of Renal Dysfunction on Diurnal Blood Pressure
Variation
Serum Creatinine (/xmol/1)
ANOVA plot comparing diurnal blood pressure variation in patients with normal
(creatinine < 140 /xmol/1), mildly impaired (creatinine 140 - 200 /xmol/1) and severely
impaired (creatinine > 200 /xmol/1) renal function. Diurnal variation appears blunted in
those with impaired renal function but this is non-linear.
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Discussion
This detailed analysis of over 1000 individual patients referred for ambulatory blood
pressure monitoring over a four year period has demonstrated Normal distribution of the
nocturnal dip of both systolic and diastolic blood pressure. This accords with an earlier
observation from a limited patient sample (Stewart & Padfield, 1992) and suggests that
any division of the hypertensive population into "Dippers" and "Non-dippers" must rely
on an arbitrary definition. Undue emphasis on populations so defined risks recreating
some of the errors inherent in the early days of hypertension research, when, as a result of
the belief that essential hypertension was a distinct disease entity, work concentrated on
trying to find the defect underlying hypertension. Referring to this propensity of
physicians to treat hypertension as a qualitative rather than quantitative phenomenon Sir
George Pickering damned the practice :
"It is .. fallacious and ....a hindrance to the true understanding of the facts with
which we are concerned. It is a perfect example of ....the mysterious viability of the
false." (Pickering, 1978)
Despite his efforts, the practice of dividing a population in two - normal and abnormal,
physiologic and pathologic - has persisted, other examples including low renin
hypertension (Padfield et al, 1975) and idiopathic hyperaldosteronism (Padfield et al,
1981). This may arise from clinicians need to make a fundamental decision when dealing
with patients: ill or healthy; treatment or no treatment. In the face of such training, it
should not surprise us that any new observation or abnormality leads to patients being
classified separately. The danger is that once misclassified and having received a name,
they come to be seen as an entity, a fault recognised in the last century by John Stuart
Mill :
"The tendency has always been strong to believe that whatever receives a name
must be an entity or being, having an independent existence of its own; and if no real
entity answering to the name could be found man did not for that reason suppose that
none existed, but imagined that it was something peculiarly abstruse and mysterious, too
high to be an object of sense." (Mill, 1869)
Having recognised the quantitative nature of the nocturnal dip, it becomes clear that any
study of the differences between different populations should concentrate on the absolute
figure rather than the qualitative study of dippers and non-dippers. Moreover, the
recognition that the frequency distribution of diurnal blood pressure variation
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approximates to Normality allows the use of parametric statistics in such analyses,
improving the power of the studies.
This observation has a further important consequence. Several authors have suggested
that ambulatory blood pressure monitoring could improve the diagnosis of secondary
hypertension (Hany et al, 1987; Imai et al, 1990; Middeke & Schrader, 1994), and this
study has confirmed that diurnal variation is attenuated in certain forms of secondary
hypertension when compared to essential hypertension. However, in any given population
of essential hypertensives, a substantial proportion will be classified as non-dippers, the
precise number being heavily dependent on the definition chosen, but averaging at 20 -
40% (Verdecchia et al, 1991). As secondary hypertension occurs in only 5 - 10% of
patients with hypertension, it is clear that the absence of a nocturnal fall in blood pressure
in any undiagnosed individual is much more likely to be associated with essential
hypertension than with a secondary cause. Moreover, the fall in blood pressure during the
night in patients with hypothyroidism and previously treated coarctation of the aorta is
similar to that of patients with primary essential hypertension, indicating that the absence
of a nocturnal dip is neither a sensitive nor a specific indicator of secondary hypertension.
Nonetheless, the study of patients with secondary hypertension does provide some clues as
to possible mechanisms involved in the control of the nocturnal fall in blood pressure.
Endocrine hypertension related to an excess of glucocorticoid or catecholamine appears to
be associated with blunting of the dip, while that related with deficiency of a hormone,
thyroxine, is not. Data in the literature relating to a further condition of hormone excess,
hyperaldosteronism, are inconsistent, with some (Tanaka et al, 1983; Baumgart et al,
1989a) but not all (Munakata et al, 1988) studies suggesting that it is related to absence of
the nocturnal dip. Although I did not have a sufficient number of patients with
hyperaldosteronism to warrant separate study here, the hypertension seen in a further
condition of hormone excess, acromegaly, was also associated with attenuation of the
blood pressure fall at night. Such hypertension involves the effects of excess growth
hormone on sodium balance, the renin-angiotensin system and the adrenal cortex (Fraser
et al, 1989) and is therefore likely to behave similarly, as a form of volume mediated
hypertension. It is thus possible that volume changes related to posture are partially
involved in the pathophysiology of the nocturnal dip.
Glucocorticoid excess, whether due to Cushing's syndrome (Imai et al, 1988b) or
exogenous glucocorticoid excess (Imai et al, 1989) is associated with loss of the nocturnal
fall in blood pressure, and we have confirmed this in a small group of patients with
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Cushing's syndrome. However, in patients with hypopituitarism who are taking
glucocorticoid replacement therapy the diurnal blood pressure profile is not altered by
reversing the pattern of therapy (Jyothinagaram et al, 1989) or by doubling the dose of
hydrocortisone given (see Chapter 5). Thus, it appears that only pathological quantities of
corticosteroid are capable of modifying the diurnal rhythm, making a physiological role
for Cortisol less likely.
Blunting of the nocturnal dip was most pronounced in patients with phaeochromocytoma
and this is in accord with other work (Littler & Honour, 1974; Padfield et al, 1991),
although one study has failed to reveal any difference compared with essential
hypertension (Imai et al, 1988a). However, many of these patients were on treatment and
those with marked nocturnal spikes of pressure were excluded from the analysis.
Nonetheless, the marked impact on diurnal rhythm in most patients with catecholamine
excess, together with observations made in patients with autonomic failure (Mann et al,
1983) or neuropathy (Liniger et al, 1987; Hornung et al, 1989) argues in favour of the
autonomic nervous system having an important role in control of the diurnal blood
pressure pattern.
Attenuation of diurnal blood pressure variability associated with renal dysfunction was
striking and, unexpectedly, apparent in those with even mildly impaired renal excretory
function. In patients with established kidney disease, the prevalence of hypertension
increases as renal failure progresses, with hypervolaemia resulting from salt and water
retention the predominant cause (Raine, 1994), and hyper-reninaemia an important
additional factor in a minority (Vertes et al, 1969). Previous studies have suggested that
loss of the nocturnal dip in chronic renal failure is related to severity of disease (Imai et
al, 1988b; Baumgart et al, 1989a), with one study of patients with chronic
glomerulonephritis suggesting that the diurnal blood pressure rhythm in patients not
treated with glucocorticoid remains normal until the glomerular filtration rate is below 20
ml/min. (Imai et al, 1988b). Clearly, however, the impact of renal function in patients
with essential hypertension may be very different from that in primary renal disease.
Although primary renal disease was not completely excluded in the patients studied here,
the majority were thought to have primary essential hypertension, with renovascular
disease present in some.
The interplay between blood pressure regulation, the development of hypertension and the
development of renal dysfunction is complex and still not completely understood.
Essential hypertension results in a fall in renal blood flow and a rise in renal vascular
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resistance, yet glomerular filtration rate generally remains normal (Raine, 1994).
Although accelerated hypertension can cause significant renal damage (Kincaid-Smith et
al, 1958), the extent to which renal impairment develops in less severe hypertension
remains controversial (Raine, 1994), hut renal failure due solely to benign hypertension
appears rare (Brown & Whitworth, 1992).
Hypertension and a gradual decline in renal function due to glomerulosclerosis are both
common accompaniments of ageing. However, the age of patients with mildly impaired
renal function in this study was similar to those with normal renal function, and the
statistical analysis corrected for age. The effect of age on diurnal blood pressure variation
is therefore unlikely to account for the differences observed here.
Hypertension is a a major risk factor for both large and small vessel atherosclerosis and
much of the renal dysfunction associated with benign hypertension is likely to be
ischaemic origin. No attempt was made in this study to exclude those with proven or
suspected reno-vascular disease, and several of the patients with the most profound
reduction in renal function are likely to have had reno-vascular disease. Data on diurnal
blood pressure variability in hypertension associated with renal artery stenosis are
conflicting. Two studies have suggested a negative association with diurnal blood
pressure variation (Tanaka et al, 1983; Middeke & Schrader, 1994), but neither gave data
on renal function in these patients. Baumgart et al (1989a) found diurnal blood pressure
variation in reno-vascular disease to be attenuated only in patients whose renal function
was compromised, while a study of patients with fibromuscular hyperplasia, in whom
there is no doubt that the arterial stenosis underlies the elevation in blood pressure,
demonstrated normal diurnal variation (Imai et al, 1990). This latter observation argues
strongly against any independent influence from reno-vascular disease per se.
Nonetheless, as 1 do not have data on the renal vasculature of all of our patients, I cannot
exclude the possibility that the presence of reno-vascular disease, with the profound
elevation of renin and angiotensin II associated with this condition, accounts for the
observed effect.
I have observed attenuation of diurnal blood pressure variation in patients with essential
hypertension and both modestly and severely impaired renal function. While factors such
as autonomic neuropathy (Abel et al, 1990) and sympathetic overactivity (Converse et al,
1992) may contribute to this in advanced renal failure, they are unlikely to account for this
observation in those with only mild disease. Mild hypervolaemia related to early renal
excretory dysfunction therefore seems the most plausible explanation for this effect.
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However, prospective study with well matched groups and full investigation of renal and
blood volume status would be needed to confirm this hypothesis.
A further possible explanation for the reduced nocturnal dip in blood pressure in
secondary hypertension is that such patients tend to have more severe hypertension, which
Gosse et al (1988b) suggested was an important determinant of the nocturnal fall.
However, I have found no evidence to support this in my study population, with similar
nocturnal fall in different quartiles of blood pressure.
Although study of patients with secondary hypertension has provided insight into the
pathophysiology of the nocturnal dip in blood pressure, the most noteworthy determinant
of diurnal blood pressure in this analysis was age, with a clear inverse linear relationship
between age and the nocturnal fall. Previous studies have suggested that the diurnal blood
pressure rhythm is similar in younger and older subjects (Drayer et al, 1982; Kennedy et
al, 1983; Munakata et al, 1991) but these are in relatively small patient groups, with less
variation in age between groups.
Reduction in diurnal blood pressure variation with age could have several potential
mechanisms. Older subjects tend to sleep less and have more fragmented sleep pattern
(Feinberg et al, 1967). One third of people over the age of 65 report waking too early
several times per week (Mant & Eyland, 1988). Particularly when relying on an arbitrary
definition of day and night, the shorter sleep period could result in some wake readings
being included in the night value, artefactually raising this. Moreover, the more
fragmented sleep pattern may attenuate the associated fall in blood pressure, and result in
greater sleep disruption from the monitoring process.
Studies of American Negroes have suggested that diurnal blood pressure variation is
smaller than in Caucasian controls (Harshfield et al, 1990; Murphy et al, 1991), but
African Negroes have a similar profile to American Caucasians (Murphy et al, 1991).
Detailed analysis of these ethnic differences have suggested that the effect is likely to be
environmental and largely accounted for by differences in the extent and nature of physical
activity in the different groups (Murphy et al, 1991). Similar mechanisms may explain
the decline in diurnal blood pressure variation with age. Older patients are less likely to
engage in strenuous physical activity and so, if matched for nocturnal pressure, will have
relatively lower day-time blood pressure.
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Assessment of the effect of antihypertensive treatment on blood pressure can only be
accurately assessed in a blinded prospective study but analysis of our data base has
enabled a search for potentially important differences between drugs. Clearly, if a potent,
short acting drug was given on retiring to bed, lowering blood pressure during this period
only, an accentuation of the diurnal rhythm could be achieved. However, all patients
analysed here were treated with conventional therapy, consisting either of a single agent
known to influence blood pressure over 24 hours, or divided doses of shorter acting
agents. When comparing treated to untreated patients, regardless of treatment type,
diurnal blood pressure variability was less in the treated group. Day-time systolic
pressure was similar in the two groups, but diastolic pressure higher in the untreated
patients. Differences in night time pressures could largely be accounted for by age,
suggesting that the effect on the diurnal rhythm is due predominantly to relatively lower
pressure during wake hours in the treated patients. This hypothesis would accord with
Pickering's conclusion from a review of studies of anti-hypertensive studies using
ambulatory monitoring (Pickering, 1990e). As drug therapy is still largely monitored and
adjusted using clinic or day-time blood pressure values, treatment will not have been
increased in those whose pressure was not reduced at night, and this observation may
therefore reflect a less pronounced effect of some agents on night-time pressure. Against
this, however, is the observation that in patients who had undergone repeat monitoring
after a change in treatment, there was a marked decrease in both day and night blood
pressure, with no overall effect on the diurnal rhythm.
Study of patients treated with a single drug only demonstrated attenuation of the nocturnal
dip predominantly in patients treated with a calcium antagonist. However such patients
were also older and had higher blood pressure on treatment, suggesting that their baseline
hypertension was more severe. As such, the groups are not strictly comparable and we
must be wary of drawing erroneous conclusions, particularly as prospective studies of
drugs in this class have shown no effect on the diurnal rhythm (Gould et al, 1982;
Lacourciere et al, 1990). Nonetheless, a recent case control study of patients treated with
different anti-hypertensive drugs found an increased risk of myocardial infarction in those
treated with calcium antagonists, suggesting that these drugs could have different and
potentially adverse effects on the cardiovascular system (Psaty et al, 1995). If such
patients had less blood pressure reduction during the night, this would be one potential
mechanism to explain this effect. However, a more plausible explanation is that selection
bias resulted in patients at more risk of cardiovascular disease receiving calcium channel
blockers, both in Psaty's study and in our own. This would explain both the excess of
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myocardial infarction associated with use of these drugs, and the reduced nocturnal dip, if
we accept this as a marker of cardiovascular risk.
Conclusions
This study has confirmed that the nocturnal fall in blood pressure is a Normally
distributed phenomenon in the population. It has also shown an inverse linear relationship
between age and diurnal blood pressure variability. There is no evidence that the dip is
related to severity of hypertension, and a significant effect related to anti-hypertensive
drug therapy appears unlikely. Attenuation of the nocturnal dip is common in secondary
hypertension, but not universal. Study of those conditions in which this is most apparent
suggests an important role for the autonomic nervous system, with the condition of
catecholamine excess, phaeochromocytoma, having a marked effect on the diurnal rhythm.
The possibility that volume changes related to posture also play a role is raised by the
observation that the diurnal rhythm is blunted in the volume mediated hypertension of
acromegaly and in patients with mildly impaired renal function. The nocturnal fall in
blood pressure is a complex, multifactorial process, but this study has provided important
insights into some of these mechanisms.
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CHAPTER 5
Cortisol as a Potential Modulator of the Diurnal Rhythm
Background
The secretion of corticosteroid has a circadian rhythm in normal individuals (Akerstedt &
Levi, 1978; Desir et al, 1980), and is thought to control the circadian variation of other
biological variables (Desir et al, 1980). The potential for a role of this hormone in the
control of the diurnal variation of blood pressure is therefore apparent. Studies of patients
with Cushing's syndrome (Imai et al, 1988h; Munakata et al, 1988) and on large doses of
exogenous steroids (Imai et al, 1989) have demonstrated the ability of corticosteroids to
abolish this rhythm. However, the mechanism of this is uncertain, and the extent to
which endogenous steroids are involved in the physiological control of blood pressure is
not clear.
The nocturnal fall in blood pressure is multifactorial, but withdrawal of sympathetic tone
is likely to have a major role. Plasma adrenaline and noradrenaline levels are influenced
by the circadian rhythm of Cortisol (Akerstedt & Levi, 1978) and hy glucocorticoid
administration (Stene et al, 1980). Moreover, glucocorticoids can influence the vascular
responsiveness to catecholamines (Kalsner, 1969; Krakoff et al, 1975) and may also act
centrally to increase sympathetic activity (Takahashi et al, 1983).
Excess glucocorticoid can also disturb normal sleep patterns. Up to two thirds of patients
with Cushing's syndrome complain of insomnia (Starkman et al, 1981). Sleep studies in
patients with endogenous Cortisol excess have demonstrated decreased or no slow wave
sleep (Krieger et al, 1976; Fehm et al, 1986) and exogenous glucocorticoid can alter the
amount of rapid eye movement sleep (Gillin et al, 1972; Fehm et al, 1986) and increase
intermittent wakefulness (Fehm et al, 1986). As blood pressure changes according to
sleep phase (Khatri & Freis, 1969), the effect of steroid on blood pressure may be enacted
indirectly via its effect on sleep.
Patients with secondary adrenocortical insufficiency require exogenous replacement of
steroid with hydrocortisone. It is conventional to administer a twice daily regime which
usually involves a larger dose in the morning with a smaller dose in the evening in an
attempt to mimic the circadian rhythm of Cortisol production. A typical schedule is 20 mg
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taken on rising and 10 mg taken in the evening. However it is likely that individual dose
requirement varies. Under replacement may cause vague symptoms of ill health or
fatigue, while mild over-replacement, although clinically silent, may produce metabolic
complications over the longer term. Unlike primary adrenocortical insufficiency
(Addison's disease), where plasma ACTH serves as a marker for Cortisol over-
replacement, such over-replacement is difficult to detect.
Jyothinagaram et al (1989) have shown that reversing the periodicity of a normal
replacement regime in such patients, with the higher dose given at night, has no effect on
the diurnal blood pressure rhythm, suggesting that the blood pressure rhythm is not
closely entrained to physiological Cortisol levels.
Introduction
With the premise that pathological, but not physiological, doses of hydrocortisone may
significantly influence the blood pressure profile, this study was designed to ascertain
whether modest changes in exposure to corticosteroid can influence the diurnal rhythm.
This work was performed with the assistance of Mr. David Leitch, a medical student
working on a Scottish Home and Health Department Vacation Grant, who helped with
patient recruitment and biochemical analyses.
Patients and Methods
This study was conducted in compliance with ethical committee review and all patients
gave written informed consent.
Fifteen hypopituitary patients requiring hydrocortisone replacement therapy under regular
review in the local Pituitary clinic were studied (Table 5.1). All had had pituitary
neoplasms and all but two became hypopituitary secondary to tumour resection. No
patient was on cardio-active medication. Three patients were unable to tolerate overnight
blood pressure monitoring and were therefore excluded from further study.
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Table 5.1 Demographic details
Subject Age Sex Normal dose of
Hydrocortisone
1 53 M 20 mg + 10 mg
2 48 M 20 mg + 10 mg
3 57 M 20 mg + 10 mg
4 31 F 5 mg + 2.5 mg
5 61 M 20 mg + 10 mg
6 53 M 30 mg + 10 mg
7 42 F 20 mg + 10 mg
8 52 M 10 mg + 10 mg
9 54 F 10 mg + 5 mg + 5 mg
10 59 M 20 mg + 10 mg
11 32 F 20 mg + 10 mg
12 27 M 15 mg + 5 mg
Mean (± S.D.) 47 ± 12 75% M 25% F 17.5 + 8.5
This was a 2 week, open, randomised, two period study. Patients were randomised to
initial study on their normal maintenance dose of hydrocortisone, followed by repeat study
after one week on double their normal steroid dose, or to initial study after taking the
increased dose for one week, with repeat study one week after dosing was returned to
normal. All medication, other than the hydrocortisone, was kept constant throughout the
study period.
All subjects had their blood pressure monitored over 24 hours, with readings every 30
minutes, using the SpaceLabs 90207 ambulatory monitoring system (O'Brien et al,
1991b). Patients were also fitted with a wrist activity meter to enable accurate
quantification of sleep time (Webster et al, 1982). In light of the known effects of
corticosteroids on sleep, patients were also asked to comment on their quality of sleep,
using a visual analogue scale to quantify this. This consisted of a 20 cm line, with
subjects asked to mark with a cross a value between zero and ten, where a value of 10 was
taken to be a normal night's sleep and zero to be no sleep whatsoever. Percentage sleep
disturbance was then calculated by measuring the distance along the scale from zero to the
cross to the nearest centimetre.
Two 12 hour urine samples were collected during each period of ambulatory monitoring to
measure day (8 am - 8 pm) and night (8 pm - 8 am) free Cortisol excretion. An aliquot of
each sample was then analysed using the Amerlex Cortisol radio-immunoassay.
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Statistical Analysis
Differences between day, night and 24-hour Cortisol excretion on the two different doses
of hydrocortisone were compared using Wilcoxan rank sum test for paired data. Linear
analogue scale sleep scores were also analysed using Wilcoxan's method.
Changes in ambulatory blood pressure parameters were examined using Student's paired t-
test.
Pearson's correlation coefficient was used to assess the strength of the association between
exposure to glucocorticoid and the nocturnal blood pressure fall, expressed as percentage
change from day to night. The blood pressure dip was correlated with both day and night
Cortisol excretion.
Results
Cortisol excretion was significantly higher on the larger dose of hydrocortisone,
confirming increased exposure to Cortisol (Table 5.2).






Day 263 463 0.02
Night 99 229 0.01
Although subjects reported greater than 25% sleep disturbance on 13 of the 24 (54%)
visits, using their normal night's sleep as a standard for comparison, sleep time and
quality were unaffected by the change in hydrocortisone dosage (Table 5.3). However, an
order effect was apparent, with sleep quality on linear analogue scale increasing from a
mean of 65% to 77% (p = 0.047) from the first to the second ambulatory recording
period.
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Table 5.3 Sleep time measured by wrist actigraph and sleep quality measured
by linear analogue scale
Normal Dose High Dose
Mean Median Mean Median P
Sleep Time
(Minutes)




72 78 70 72 NS
Neither total blood pressure nor the diurnal blood pressure profile was significantly
affected by the increased dose of steroid (Table 5.4, Figure 5.1).
Day-time Cortisol excretion appeared to be negatively correlated with the nocturnal dip,
with Pearson's correlation coefficient -0.45/-0.5 for systolic and diastolic blood pressure
(Figure 5.2), although this was not statistically significant. The strength of association
fell on the higher dose of hydrocortisone to -0.23/-0.46. There was no evidence of any
association with night-time Cortisol, with correlation coefficient < 0.1.
Table 5.4 Ambulatory blood pressure profile.
Variable (Mean ± S.E.M.) Normal Dose High Dose
24-hour Systolic BP 123+4 124+4
24-hour Diastolic BP 76+3 76 + 3
Mean Wake Systolic BP 127+4 129+4
Mean Wake Diastolic BP 80 + 3 80 + 3
Mean Sleep Systolic BP 115+4 114+4
Mean Sleep Diastolic BP 69 + 3 68 + 3
Nocturnal SBP Dip (%) 10.9 + 1.7 11.2 + 1.9
Nocturnal DBP Dip (%) 14.1+2.2 14.5+2.2
There was no significant difference between blood pressure on normal and high dose
hydrocortisone.
84
Figure 5.1 The Impact of Increased Steroid Exposure on Ambulatory Blood
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Ambulatory blood pressure profile of patients on normal dose (solid symbols) and high
dose (open symbols) hydrocortisone. Hourly mean BP ± S.E.M. has been plotted against
time. The curves are almost identical indicating no effect on either the level or diurnal
variation of BP.
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Figure 5.2 Relationship of Cortisol Exposure to Diurnal Blood Pressure
Variation
i
r = -0.45 for Systolic Dip
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Correlation of urinary free Cortisol and the nocturnal dip in blood pressure with diurnal
variation in systolic BP indicated by circles and diastolic BP by triangles. There is an
apparent negative correlation between the nocturnal dip and day-time Cortisol exposure but
this is not statistically significant.
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Discussion
An effect on the blood pressure profile has only been demonstrated with hugely
pharmacological doses of exogenous glucocorticoid (Munakata et al, 1988; Imai et al,
1989) or in untreated Cushing's disease or syndrome (Imai et al, 1988b). That such
pathological exposure to glucocorticoid can influence the diurnal rhythm is not questioned,
but the dose level and duration at which this first occurs remains unknown and the
mechanism uncertain.
In this study, despite a significant increase in exposure to corticosteroid over 24 hours,
this modest increase in hydrocortisone (which remains within the range seen
physiologically) did not influence the diurnal blood pressure rhythm in hypopituitary
patients in the short term. While it is possible that the neutral effect of hydrocortisone on
blood pressure demonstrated here represents a type 1 statistical error related to the small
number of patients studied, the fact that there was a slight increase in the nocturnal dip on
the higher dose of steroid makes this less likely. This, together with the observation that
reversing the day and night dose of hydrocortisone has no impact on diurnal variation in a
similar group of patients (Jyothinagaram et al, 1989), makes a role for Cortisol in the
physiological control of blood pressure variability unlikely. However, the negative
correlation seen between day-time Cortisol excretion and the nocturnal dip, although not
statistically significant, makes it impossible to exclude such a relationship altogether.
In addition, patients with hypopituitarism may not be entirely representative of a healthy
population. They suffer from multiple hormone deficiencies which are incompletely
replaced. In particular, most are deficient in growth hormone which is also known to
influence blood pressure (Fraser et al, 1989). They are also deficient in
adrenocorticotrophic hormone which has a modulating influence on Cortisol metabolism at
tissue level in addition to its principal action on the adrenal gland, and may have
independent effects on blood pressure regulation (Fraser et al, 1989). Nonetheless, such
patients provide the only means by which changes in Cortisol exposure within the
physiological range can be explored, and any difference in the blood pressure response
would be controlled for in a cross-over study. Moreover, the patients studied here had all
been maintained on hormone replacement therapy and been stable and clinically well for a
period of years. As such, we would have expected cardiovascular responsiveness to
glucocorticoid to be little different from the normal population.
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The influence of corticosteroid on sleep pattern is a possible explanation for the
modulating effect on blood pressure. To allow for this we measured sleep time
objectively with wrist activity meters and sleep quality subjectively by linear analogue
scale, and found these parameters unaffected by the increased dose of hydrocortisone.
However, self-reported monitoring of sleep quality is relatively insensitive and minor
effects on the pattern of sleep can only be detected by continuous EEG monitoring during
sleep (Fehm et al, 1986). Thus, it is not possible to completely exclude an effect of
glucocorticoid on sleep pattern in this or other studies. Clearly, if this is the mechanism
by which higher doses of steroid influence the nocturnal blood pressure fall, the increased
exposure to hydrocortisone obtained in this study was not sufficient to influence the sleep
pattern.
Conclusions
Increased exposure to Cortisol occurring within the physiological range does not appear to
have any significant effect on the diurnal blood pressure rhythm, making a physiological
role for Cortisol in the control of the nocturnal dip unlikely.
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CHAPTER 6
Diurnal Blood Pressure Variation in Accelerated Phase Hypertension and
Following Acute Hospitalisation
Background
Diurnal blood pressure curves appear sinusoidal when presented graphically. However,
when the effects of environmental stimuli and physical activity are reduced to a minimum,
the profile becomes relatively flat, with the fall during sleep persisting, making the curve
appears as a square wave (Athanassiadis et al, 1969; Mann et al, 1979). Blood pressure
changes also appear less pronounced in hospitalised patients when compared to patients
studied in their natural environment (Young et al, 1983), with higher levels of blood
pressure and of blood pressure variability seen at home. Both the average level of blood
pressure and blood pressure variability have been shown to fall during periods of bed rest
as compared to activity (Rowlands et al, 1980) but the effect of acute hospitalisation on
nocturnal blood pressure and on diurnal blood pressure variability has not been studied
previously. As many of the conditions commonly quoted as being associated with
abolition of diurnal blood pressure variability have been studied only in hospitalised
patients, this potential confounding factor is clearly of some importance.
Information on blood pressure variability in malignant or accelerated hypertension is
particularly lacking, with only one study in the literature examining the diurnal rhythm in
patients hospitalised with this condition. As the blood pressure of such patients frequently
falls significantly following hospital admission and bed rest, before the use of anti¬
hypertensive drugs, the potential for hospitalisation to influence the diurnal rhythm is
marked.
Malignant Hypertension
Malignant hypertension was originally defined by Volhard and Fahr (1914) as a condition
characterised by severe hypertension, impaired renal function and rapid progression to
uraemic death, associated with fibrinoid necrosis and intimal proliferation of renal
arterioles. This definition was later refined by Keith et al (1939) when they identified the
importance of retinal haemorrhages, exudates and papilledema in hypertensive patients.
Possibly due to better detection of hypertension and improved treatment of mild and
moderate disease, malignant phase hypertension is now a relatively rare disease (Kincaid-
Smith, 1985).
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While effective treatment for malignant hypertension is now available, the
pathophysiology is still incompletely understood. Although a complication of established
hypertension, the height of the blood pressure alone does not distinguish benign from
malignant phase. Prior to the introduction of effective anti-hypertensive therapy, there
was little difference between the blood pressure levels of patients with severe benign
hypertension and malignant hypertension (Kincaid-Smith et al, 1958). Malignant
hypertension is an angiotensin dependent form of hypertension with high renin and
angiotensin II levels (Laragh et al, 1960). The initial elevation in angiotensin II may in
part result from renal arterial narrowing and, once initiated, a vicious circle develops in
which increasing renal damage results in increased release of renin and a consequent
further rise in blood pressure (Kincaid-Smith, 1980). Although it can arise from
hypertension of any cause providing the pressure rises high enough or increases rapidly,
there is underlying renal disease in at least 50% of cases (Kincaid-Smith, 1991).
Malignant hypertension is characterised by fibrinoid necrosis of small arterioles of the
kidney and throughout the body. Fibrinoid necrosis in the retina results in the
development of soft exudates, flame-shaped haemorrhages and, eventually, papilledema.
It is now appreciated that there is a spectrum of severe hypertension and the term
accelerated hypertension is used to describe the clinical condition of severe hypertension
associated with exudates and/or haemorrhages in the retinal fundus, encompassing both
malignant phase hypertension (traditionally diagnosed only in the presence of
papilledema), which may be associated with encephalopathy and renal failure, and lesser
degrees of severe hypertension (Ahmed et al, 1986). Untreated, this condition has a
mortality of around 80% at two years (Leishman, 1959).
In a study of hospitalised patients on bed rest Shaw et al (1963) found that patients with
malignant hypertension, diagnosed on the basis of fundal changes, had no nocturnal fall in
blood pressure, while a control group of patients with benign essential hypertension had a
normal nocturnal fall. This study utilised a static automatic blood pressure monitor which
measured blood pressure at half hourly intervals for 24 hours and subjects were therefore
confined to bed for the period of study. The average blood pressure of patients with
benign hypertension (217/127 mmHg) was similar to those with malignant (238/135
mmHg) and there was no correlation between the severity of hypertension and the change
in blood pressure during sleep. The authors concluded that the severity of the
hypertension did not account for the difference between the two groups and hypothesised
that the pathological changes in small vessels in malignant phase hypertension resulted in a
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relatively fixed peripheral vascular resistance, preventing the fall in blood pressure during
sleep. This remains the only study examining nocturnal blood pressure in patients with
malignant or accelerated hypertension.
Introduction
Accelerated hypertension is said to abolish the normal diurnal variation in blood pressure
but the only study to examine this phenomenon was performed over 30 years ago, using a
newly developed automatic blood pressure monitor which tied patients to their beds,
preventing full mobility. To confirm this observation, determine whether it is a specific
phenomenon related to the pathophysiology of the accelerated phase, and assess the extent
to which acute hospitalisation and bed rest could account for any abnormality in diurnal
blood pressure variability, patients with accelerated hypertension have been studied as
soon as practicable following diagnosis. The ambulatory blood pressure profile has been
compared to that of patients with benign essential hypertension and to patients admitted to
hospital with other acute medical conditions. Two such control groups were studied: (i)
patients with acute stroke who were hypertensive on admission to hospital, and (ii) a
random selection of patients admitted with other acute medical problems.
Patients and Methods
Accelerated hypertension was defined as severe hypertension, with grade III or IV
retinopathy (haemorrhages and exudates ± papilledema). Eleven such patients were
identified within 24 hours of diagnosis and agreed to undergo ambulatory blood pressure
monitoring. Nine were studied as hospital in-patients and two as out-patients. All
received routine medical and nursing care but were not on strict bed rest. Ten were either
already on anti-hypertensive medication or were started on treatment during the recording
period. Demographic details are given in Table 6.1. All underwent full investigation to
look for a secondary cause of their hypertension. Six patients had renovascular
hypertension (atheromatous renal artery stenosis), one renal parenchymal disease and 4
essential hypertension. Renal function as assessed by serum biochemistry was normal in 3
(urea 5+0.8 mmol/1, creatinine 111+6.1 /xmol/l), borderline high in 3 (urea 8.9+1.7
mmol/1, creatinine 145+4.7 jrmol/1) and significantly abnormal in 4 (urea 21.6 + 7.6
mmol/1, creatinine 448 + 184 /rmol/1) with no result available from one patient.
Six patients underwent repeat ambulatory blood pressure monitoring after treatment, when
fundal signs had resolved, 1 to 15 months (mean 5) after the initial diagnosis.
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Out-patients attending the Hypertension Clinic with henign essential hypertension who had
been referred for ambulatory blood pressure monitoring (n = 135) were used as the out¬
patient control group. Ninety (67%) were on anti-hypertensive treatment. Demographic
details are given in Table 6.1a.
Sixteen patients with acute stroke found to be hypertensive on admission to hospital (ward
BP > 160/90 mmHg) also agreed to undergo ambulatory blood pressure monitoring
within 24 hours of admission. Five of the 16 were on anti-hypertensive treatment which
was continued after admission. A further group of 10 patients admitted to the acute
medical wards were also studied shortly after admission. Any patient who was
haemodynamically stable, not requiring emergency drug treatment likely to influence
blood pressure, and fit to give informed consent, was considered for this study group.
Three patients were admitted with non-specific chest pain, 2 with suspected pulmonary
thrombo-embolism, 2 with congestive cardiac failure, 2 with urinary tract infection and
one with Wernicke's encephalopathy. Three were on drugs which could affect blood
pressure. Demographic details are given in Table 6. lb.
Data acquisition and statistical analysis
Ambulatory blood pressure monitoring was performed using the Accutracker 1 monitor in
6 patients and the SpaceLabs 90207 in 5 patients with accelerated hypertension. All
control group recordings were obtained with the SpaceLabs 90207. Blood pressure
readings were obtained at least every thirty minutes for 24 hours in every patient. In
stroke patients, the monitor was fitted to the non-paretic arm (Yagi et al, 1986). Day-time
blood pressure was defined as 7 am to 12 midnight and night-time as midnight to 7 am.
The prevalence of non-dipping in patients with accelerated hypertension, defined as night¬
time BP < 10% lower than day-time BP for both systolic and diastolic pressure, was
compared to that of the control groups using the Chi squared test. Diurnal blood pressure
variation, defined as the mean day-night BP difference expressed as a percentage, was also
analysed, using Student's t-test. The change in diurnal variation in those patients with
accelerated hypertension in whom a second recording was available after treatment was
assessed using Student's paired t-test.
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Table 6.1a Demographic Details - Accelerated and Essential Hypertension
Mean ± S.E.M. Accelerated Essential P
Hypertension Hypertension
Number 11 135
Age 61 + 12 53 + 1.2 NS
Sex 6 M, 5F 63M, 72F NS
Clinic systolic BP 192+9.1 172 + 1.7 0.003
Clinic diastolic BP 115 + 8.7 105 + 1.1 0.025
Table 6. lb Demographic Details - Control Groups
Mean ± Accelerated Acute P Medical
S.E.M. Hypertension Stroke Admissions P
Number 11 16 10
Age 61 + 12 66 + 3.4 NS 59+2.8 NS
Sex 6 M, 5F 9 M, 7F NS 7M, 3F NS
Clinic 192+9.1 176+4.8 NS 138+4.9 0.00007
systolic BP
Clinic 115 + 8.7 101+3.4 NS 86+4.2 0.0008
diastolic BP
The age and initial blood pressure of the accelerated hypertension group has been
compared to each of the control groups using Student's t-test and the proportion of
patients in each sex compared using Chi squared.
Results
Ambulatory blood pressure parameters for patients with accelerated hypertension and for
each control group are given in Tables 6.2a and 6.2b.
Eight of the 11 (73%) patients with accelerated hypertension were non-dippers, compared
to only 33 of the 135 (24%) with essential hypertension (x2 = 11.7, p = 0.0006).
Diurnal blood pressure was blunted in patients with accelerated phase hypertension
(Figure 6.1), with a nocturnal dip of 1.7/5.5% compared to 10.2/15%. There was no
significant correlation between the severity of the hypertension and the nocturnal dip in
either patient group: correlation coefficients for day mean BP and nocturnal dip were -
0.28/-0.12 in accelerated hypertension and -0.11/0.01 in benign essential hypertension.
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Table 6.2a Ambulatory BP Data in Accelerated and Benign Hypertension.





24 hour 183 + 10.1 155 + 1.4 0.00001
Systolic BP
24 hour 98±7.3 90+0.9 0.04
Diastolic BP
Day mean 184+9.9 160 + 1.5 0.0001
Systolic BP
Day mean 100+7.4 95 + 1 NS
Diastolic BP
Night mean 181 + 10.9 144+1.9 0.000001
Systolic BP
Night mean 94 + 7.4 80+1.1 0.002
Diastolic BP
Nocturnal Dip - 1.7 + 1.8 10.2+0.7 0.0008
Systolic BP (%)
Nocturnal Dip - 5.5+2.2 15+0.8 0.0008
Diastolic BP (%)
Table 6.2b Ambulatory BP Data in Accelerated Hypertension Compared to
Acute Hospital Admissions
Mean ± Accelerated Acute P Medical P
S.E.M. Hypertension Stroke Admissions
24 hour 183 + 10.1 163+3.9 0.04 130+4 0.0001
Systolic BP
24 hour 98 + 7.3 96 + 3.3 NS 80+3.2 0.04
Diastolic BP
Day mean 184+9.9 165 + 3.8 0.049 133+3.8 0.0002
Systolic BP
Day mean 100+7.4 97 + 3.4 NS 82 + 3.2 0.048
Diastolic BP
Night mean 181 + 10.9 158+4.8 0.04 123+4.8 0.0001
Systolic BP




1.7 + 1.8 4.4+1.7 NS 7.2+2.1 NS
Nocturnal Dip - 5.5 + 2.2 5.1+2.2 NS 9.2+2.1 NS
Diastolic BP (%)
Ambulatory blood pressure parameters of the accelerated hypertension group have been
compared to each of the control groups using Student's t-test.
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Ambulatory blood pressure profile in patients with accelerated phase hypertension (solid
symbols) and benign essential hypertension (open symbols). Mean hourly blood pressure
± S.E.M. has been plotted against time for each group. The curve from patients with
accelerated phase hypertension is seen to be relatively flat, while the normal nocturnal fall
in blood pressure can be appreciated in patients with benign essential hypertension.
95
In the 6 patients with repeat ambulatory monitoring, day mean BP had fallen from
194/114 to 161/94 and diurnal blood pressure variation increased from 2/4.1% to
10.2/15.9% (Table 6.3, Figure 6.2).
Nine of the 16 stroke patients (56%) and 5 of the 10 (50%) hospital admissions were non-
dippers, which is similar to the prevalence seen in the patients with accelerated
hypertension (x2 = 0.4, NS, Figure 6.3). Diurnal blood pressure variation in both stroke
patients and acute admissions was more pronounced than in those with accelerated
hypertension (Table 6.2b, Figure 6.4) but this difference was not statistically significant in
either group.
Table 6.3 Ambulatory blood pressure data from patients with accelerated
hypertension after treatment
Accelerated Accelerated





24 hour 193 ±11.6 157+6.8 NS
Systolic BP
24 hour 113 + 7.7 90+ 6.7 NS
Diastolic BP
Day mean 194+11.9 161+6.4 NS
Systolic BP
Day mean 114 + 8.2 94+6.8 NS
Diastolic BP
Night mean 190 + 11.6 145+7.5 0.04
Systolic BP
Night mean 109 + 7.3 79 + 6.3 0.04
Diastolic BP
Nocturnal Dip - 2+2.7 10.2 + 1.6 0.02
Systolic BP (%)
Nocturnal Dip - 4.1+3.6 15.9+2 0.04
Diastolic BP (%)
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Figure 6.2 Effect of Successful Treatment of Accelerated Phase Hypertension
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Hourly mean blood pressure ± S.E.M. in patients with accelerated hypertension before
(solid symbols) and after (open symbols) treatment. Return of the normal nocturnal drop
in blood pressure is readily appreciated.
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Figure 6.3 Proportion of Non-Dippers in Accelerated Hypertension and After
Acute Hospitalisation
Proportion of Non-dippers (%)
The proportion of non-dippers in patients with accelerated hypertension (acc. hyper), acute
stroke and miscellaneous other medical conditions (misc.) are compared. Although the
proportion of non-dippers in patients with accelerated hypertension is greater, this is not
statistically significant.
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Figure 6.4 Diurnal Blood Pressure Variation in Accelerated Hypertension and
After Acute Hospitalisation




Systolic BP ^ Diastolic BP
Diurnal blood pressure variation, expressed as the percentage change from day to night, is
compared in patients with accelerated hypertension (acc. HT), acute stroke and
miscellaneous other medical conditions (misc.). Again, although diurnal variation is less
in patients with accelerated hypertension, the difference is not statistically significant.
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Discussion
Significant blunting of the diurnal blood pressure profile in patients with accelerated phase
hypertension has been confirmed, and the observation that this profile returns towards
normal with successful treatment of the accelerated phase, as demonstrated by resolution
of fundal changes, suggests that it may be a specific complication of this condition. Renal
impairment is a common complication of accelerated hypertension (Kincaid-Smith, 1991)
and was the most common cause of death in such patients before successful treatment was
available (Kincaid-Smith et al, 1958). Moreover, seven of the 11 patients studied here
had renal disease complicating their hypertension and possibly contributing to the
development of the accelerated phase. As renal impairment per se appears capable of
influencing the diurnal rhythm ( Baumgart et al, 1989b; Abel et al, 1990) (Chapter 4) this
may be the mechanism by which diurnal blood pressure variability is modified in a
relatively short time frame. However, with the small numbers studied here, and without
more accurate measurement of renal function, this hypothesis could not be tested further
in this patient group.
Nine of the 11 patients studied were admitted to hospital with some urgency to receive
treatment of severe hypertension and have therefore been studied in unfamiliar
circumstances. Whilst not on strict bed rest, activity during day-time is also likely to have
been significantly reduced. Comparing blood pressure variability to out-patients
undertaking normal activity may therefore be inappropriate and two further control groups
were studied - patients admitted to hospital acutely with common medical conditions and
patients with acute stroke.
Study of blood pressure changes in patients requiring acute medical care is hampered by
the potential for emergency therapy to influence the blood pressure. Patients chosen for
study were all therefore relatively stable, admitted primarily for further investigation or
for treatment unlikely to influence blood pressure acutely. Two patients with congestive
cardiac failure were included in this group but neither required intra-venous therapy to
control their symptoms. This group was normotensive but blunting of the diurnal blood
pressure rhythm was still apparent, albeit less pronounced. The prevalence of non-dipping
and the amplitude of the diurnal rhythm did not differ significantly from that of patients
with accelerated hypertension.
The impact of hospitalisation on blood pressure may be more pronounced in patients with
elevation of blood pressure on arrival. As over 80% of stroke patients are hypertensive
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on admission to hospital (Wallace & Levy, 1981; Loyke, 1983; Oppenheimer &
Hachinski, 1992) such patients were also studied here. Any patient admitted with acute
stroke and found to have a blood pressure over 160/90 mmHg on arrival on the receiving
ward was considered for study. Patients so gravely ill that they were not expected to
survive 24 hours were not included.
Study of the blood pressure changes at the time of acute stroke is complex. Hypertension
is the major risk factor for cerebrovascular disease (MacMahon et al, 1990) and many
patients presenting with a cerebrovascular accident will therefore have pre-existing
hypertension. Moreover, stroke itself results in acute changes in blood pressure, with an
acute rise in the first few days (Wallace & Levy, 1981) followed by a gradual fall over
subsequent weeks (Wallace & Levy, 1981; Loyke, 1983; Britton et al, 1986). The impact
of stroke on ambulatory blood pressure and the diurnal blood pressure rhythm is less
clear. However, Shimada et al (1990) have recently shown that ambulatory blood
pressure better predicts asymptomatic cerebrovascular disease detected by magnetic
resonance scanning and that such disease is more common in non-dippers (Shimada et al,
1992). Thus, patients with stroke resulting from hypertension may be expected to have
reduced diurnal blood pressure variation. In keeping with this, patients in this study
admitted to hospital with stroke had significant attenuation of diurnal blood pressure
variability. The extent attributable to acute hospitalisation and reduced activity, rather
than reflecting the pathophysiology of acute stroke, cannot be determined by this study.
Conclusions
Blunting of the diurnal blood pressure rhythm is common in accelerated phase
hypertension and returns towards normal with successful treatment. However, similar
changes are seen in other acute hospital admissions. This observation is thus likely to be
multifactorial, related in part to the stress of hospitalisation, reduced activity during day¬




Diurnal Blood Pressure Variation in a Healthy Working Population and its
Influence on Target Organ Damage
Background
Although hypertension is an important risk factor for stroke (Medical Research Council
Working Party, 1985) and ischaemic heart disease (Kannel, 1987), the benefits of treating
mild hypertension in the individual patient are small: in the MRC trial of mild
hypertension 850 patient years of treatment were required to prevent 1 stroke (Medical
Research Council Working Party, 1985). As anti-hypertensive treatment may even be
harmful (MRC Working Party on mild to moderate hypertension, 1981), targeting those
individuals who will benefit most from therapy is desirable. One of the major perceived
advantages of ambulatory blood pressure monitoring is that it may provide a more
accurate estimate of an individual's cardiovascular risk. However, the measure best able
to achieve this remains unresolved. Exercise blood pressure, whether measured as the
response to static or dynamic exercise, has also been shown to relate to hypertensive
target organ damage.
When assessing the importance of risk factors or the impact of an intervention on risk we
are primarily interested in clinical outcome, particularly mortality. However, this is often
impractical and cross-sectional and epidemiological studies frequently use surrogate
measures of disease. Several methods of assessing the extent of hypertensive target organ
damage have been developed, including the assessment of vascular changes in the retina
(Parati et al, 1987), protein excretion in the urine (Opsahl et al, 1988), changes in cardiac
structure and function (Devereux et al, 1983; Parati et al, 1987, White, 1990), and, more
recently, ultrasonic assessment of carotid artery morphology (Salonen & Salonen, 1991;
Roman et al, 1992) and nuclear magnetic resonance imaging of brain (Shimada et al,
1990). Of these, assessment of left ventricular size is by far the best validated and most
widely used, while the measurement of urinary microalbuminuria is perhaps the most
widely available.
Measurement of left ventricular mass (LV Mass)
Left ventricular hypertrophy (LVH) is one of the major biological responses to chronic
pressure overload (Badeer, 1964) and its development has long been known to indicate an
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adverse prognosis (Sokolow & Perloff, 1961). Although severe LVH can be determined
from the electrocardiogram, providing a powerful predictor of future cardiovascular
morbidity and mortality (Kannel et al, 1969; Kannel et al, 1970), this is a specific but
insensitive measure (Reichek & Devereux, 1981) and does not accurately quantify cardiac
mass. The development of a simple non-invasive method of assessing LV mass was
therefore a major advance, and while several alternative approaches to the measurement
have been assessed, a calculation based on M-mode measurements of left ventricular
dimensions at end-diastole according to the Penn convention (Devereux & Reichek, 1977)
remains the best validated and most widely used measure. This convention, contrary to
conventional measurement criteria, dictates that the thickness of the endocardial lines are
excluded from wall thickness measurement and included in the assessment of left
ventricular internal diameter. LV mass is then calculated using cube function geometry
according to the equation -
LV Mass = 1.04[(LVIDd + PWTd + IVSTd)3 - (LVID)3] - 13.6 g.
where LVIDd = left ventricular internal diameter at end-diastole, PWTd = posterior left
ventricular wall thickness at end-diastole and IVSTd = intra-ventricular septal thickness at
end-diastole.
As sex and body size significantly influence body size, LV mass should be corrected for
body size, conventionally by indexing for body surface area (Devereux et al, 1984). Sex
specific criteria for the diagnosis of LVH have been developed from population studies,
with cut-off values of 134 g/m^ for men and 110 g/m^ for women (Hammond et al,
1986). Age may also influence left ventricular mass but data from the Framingham study
suggests that this may not be an important effect in otherwise healthy individuals free of
cardiovascular disease (Dannenberg et al, 1989).
This methodology appears to provide an anatomically valid measure of LV mass
(Devereux & Reichek, 1977; Devereux et al, 1986) with acceptable reproducibility
(Wallerson & Devereux, 1987) and has been shown to predict future cardiovascular events
and mortality (Casale et al, 1986; Levy et al, 1990). Its accuracy is however dependant
on assumptions about left ventricular geometry and it is less accurate in abnormally
shaped ventricles (Devereux, 1987), particularly when major regional wall motion
abnormalities are present following myocardial infarction.
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However, the pattern of left ventricular hypertrophy can vary (Grossman et al, 1975;
Savage et al, 1987; Ganau et al, 1992) and recent work using both LV mass and relative
wall thickness (Reichek & Devereux, 1982) has suggested that the variable geometric
adaptation of the left ventricle in patients with hypertension can be matched to systemic
haemodynamics and ventricular loading conditions (Ganau et al, 1992). The typical
pattern of concentric hypertrophy (increased left ventricular mass and increased relative
wall thickness) appears to be less common than either concentric left ventricular
remodelling (normal LV mass index with increased relative wall thickness) or eccentric
hypertrophy (increased LV mass index but normal relative wall thickness) (Ganau et al,
1992; Devereux et al, 1993). As left ventricular mass may be more closely related to
ventricular cavity size than systolic blood pressure, and as many other factors influence
cardiac hypertrophy (Ganau et al, 1990), it is possible that these alternative patterns of
ventricular remodelling (particularly concentric remodelling) provide a more sensitive and
precise index of hypertensive target organ damage.
Relationship of Left Ventricular Mass to Ambulatory Blood Pressure
Clinic BP is only weakly correlated with LVH (Savage et al, 1990) and it is now clear
that average blood pressure obtained over 24 hours is a better predictor of LV mass
(Rowlands et al, 1982; Drayer et al, 1983; Devereux et al, 1983; White et al, 1989;
Gosse et al, 1989; Verdecchia et al, 1990). However, these studies disagree as to which
component of the 24 hour profile correlates most closely with LVH (Table 7.1).
Devereux et al (1983) found that day-time pressure, particularly during working hours,
correlated more closely than BP during sleep, while Rowlands et al (1982), using an
invasive, intra-arterial monitoring system, and White et al (1989) found similar
correlations during the day and the night. Drayer et al (1983) analysed night-time,
defined as 10 pm - 6 am, rather than sleep, and found a closer relationship with day-time
pressures. Gosse et al (1989), with a larger number of patients, found similar
correlations. In contrast, Verdecchia et al (1990), in the largest study to date, also
analysed night (8 pm - 7 am) rather than sleep, but showed a closer correlation with this
period. Indeed, in this study hypertensive patients whose BP during the night fell by
more than 10% had similar LV mass to normotensive subjects, suggesting that changes in
BP during sleep may be of greater importance than the level of pressure throughout the
day.
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Table 7.1 Major Studies Examining the Relationship Between Day and Night
Ambulatory Blood Pressure and Left Ventricular Hypertrophy (Correlation
Coefficients)
Drayer used left ventricular mass as a measure of LVH. All other studies used the left
ventricular mass index (LV mass/body surface area).
Author n Clinic BP Day BP Night BP 24-hour BP
Rowlands (1982) 50 0.45*** 0.57*** 0.56*** Q ^ •!»
Drayer(1983) 12 0.55 0.82** 0.7* 0.81**
Devereux (1983) 100 0.24* 0.5*** 0.1 0.38***
White (1989) 30 0.13 0.39 0.42* 0.54**
Gosse (1989) 23 0.6** Q 72*** 0.56**
Verdecchia (1990) 150 0 44*** 0.51*** 0.54*** 0.57***
Correlation coefficients indicating the strength of association between systolic blood
pressure and left ventricular mass. The correlation coefficient for diastolic BP was less in
each case, but followed the same pattern.
*p<0.05, **p<0.05, ***p, <0.005
As anti-hypertensive drugs can induce regression of LVH (Rowlands et al, 1982) these
studies did not include subjects with more severe hypertension, on treatment, in whom it
was judged unethical to discontinue therapy. As a result only patients with relatively mild
hypertension were studied; average clinic BP in Verdecchia's study was 160/98
(Verdecchia et al, 1990). These results are not therefore truly representative of a
hypertensive population.
Monitors used in earlier studies were bulky and noisy compared to current equipment and
it is therefore possible that disturbance to sleep was greater in these studies, providing a
less reliable estimate of sleep pressure. In addition, the method of analysing the 24 hour
profile in these studies differed. Some relied on patient reporting of sleep time, which is
likely to be imprecise, while others arbitrarily divided the 24 hours into "day" and
"night". It is therefore not possible to draw definite conclusions about the possible
predominance of day-time or night-time BP on the development of LVH from these
studies.
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Relationship of Exercise Blood Pressure to LV Mass
Several studies have also demonstrated that left ventricular size correlates more closely to
exercise BP than to resting BP (Table 7.2). In Ren's study of hypertensive patients, not
only was the relationship of LV mass to exercise BP better than to clinic BP, but in
addition all subjects found to have an exercise BP greater than 190 mmHg also had left
ventricular hypertrophy (Ren et al, 1985). Ferrara and colleagues (1989) used an
electronic sphygmomanometer to measure BP and found a marked difference in the
strength of the relationship between resting and exercise BP. Nathwani et al (1985)
measured the response to sub-maximal exercise in young subjects with mild hypertension
and also found exercise BP to be a better predictor of LV mass. They also noted that the
this relationship was independent of, and additive to, the effect of regular physical
activity. Gottdiener et al (1990) studied normotensive subjects and found left ventricular
hypertrophy in 14 of 22 subjects with an excessive BP response (systolic BP >210
mmHg) compared to only 1 of 22 with a normal response. Subjects in this study who had
a marked BP response to exercise and large left ventricles were found to consume no more
oxygen (an objective measure of fitness and conditioning) than those with a normal BP
response and normal ventricle. One interpretation of these latter two studies is that the
close relationship between exercise BP and left ventricular enlargement reflects the role of
the heart in generating maximal haemodynamic force, rather than simply indicating the
effect of raised BP during exercise on cardiac structure (Devereux, 1990). In other
words, the left ventricular hypertrophy may precede, and be a prerequisite for, the
exaggerated BP rise with exercise. This view remains theoretical only.
Table 7.2 Major Studies Examining the Relationship Between Exercise BP
and Left Ventricular Mass (Correlation Coefficients)
Author n Exercise Resting Exercise
Methodology Blood Pressure Blood Pressure
Ren (1985) 67 Treadmill 0.16 0.58***
Nathwani (1985) 20 Treadmill 0.21 0.57**
Gosse (1986) 61 Bicycle 0.40** 0.53***
Gosse(1989) 23 Bicycle 0.60** 0.67***
Ferrara (1989) 16 Bicycle 0.20 0.52*
Gottdiener (1990) 39 Treadmill 0.40** 0.65***
*
p < 0.05, ** p < 0.01, *** P < 0.001
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Further Echocardiographic Measurements
In addition to left ventricular size, echocardiography can provide an estimate of both
systolic and diastolic function. Providing that left ventricular geometry is normal, a
reasonable estimate of systolic function is provided from M-mode measurement of the left
ventricle by calculating fractional shortening (McDonald et al, 1972) using the formula :
Fractional shortening (%) = LVlDdiastole - LVIDsxstole
LVIDdiastole
Although more complex formulae using two-dimensional echocardiographic data provide
more accurate estimates of left ventricular ejection fraction (Schiller et al, 1989), their use
is of most value when left ventricular geometry is distorted, particularly in the assessment
of systolic function in patients with ischaemic heart disease.
Diastolic function can also be assessed from careful M-mode study (St.John Sutton et al,
1982) but this is complex and has largely been superseded by Doppler echocardiographic
assessment of left ventricular inflow velocities (Taylor & Waggoner, 1992). While the
simple ratio of peak early (E) and atrial (A) filling velocities has been used by many
investigators to indicate diastolic function, its complexity is such that this is a gross over
simplification (Appleton et al, 1988) and full Doppler evaluation should therefore include
the E velocity and A velocity, the E/A ratio, deceleration time of the peak velocity and the
isovolumic relaxation time (Taylor & Waggoner, 1992).
Diastolic dysfunction appears to be an important early consequence of hypertensive left
ventricular hypertrophy, preceding the development of LVH (Fouad et al, 1984). Clinic
BP is related to measures of left ventricular filling (Genovesi-Ebert et al, 1991), although
less predictably than to left ventricular mass (Genovesi-Ebert et al, 1991). There is little
information on the relationship of ambulatory blood pressure data or the diurnal BP
rhythm to diastolic tilling parameters. However two small studies have suggested that the
24 hour ambulatory BP is related to left ventricular filling characteristics (Phillips et al,
1989; White, 1990), although a more recent study found no relationship (Prisant et al,
1992).
Measurement of Urinary Protein Excretion (Microalbuminuria)
Overt proteinuria, which occurs in up to 16% of middle-aged patients with hypertension
(Samuelsson et al, 1985; Bulpitt et al, 1986) is associated with increased cardiovascular
morbidity and mortality (Kannel et al, 1984; Samuelsson et al, 1985; Bulpitt et al, 1986).
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More sensitive methods of detecting urinary albumin have now been developed and
microalbuminuria is defined as urinary excretion of albumin which is persistently above
normal although below the sensitivity of conventional urine test strips, in the absence of
infection or structural abnormalities in the renal tract (Winocour, 1992).
Wider clinical use of microalbuminuria as a potential marker of cardiovascular risk has
been hampered by lack of consensus over methods of collecting the urine sample and
expressing the result (Hutchison et al, 1988; Marshall, 1991). Furthermore, there is
considerable postural and diurnal variation in individual subjects (Marshall, 1991).
Twenty-four hour, timed, and early morning urine samples have all been used, and the
results expressed as an absolute value or as an albumin/creatinine ratio (Hutchison et al,
1988; Marshall, 1991). Measurement of a timed urine sample remains the most accurate
measurement but is bedevilled by problems with inaccurate collection, and it is clearly not
an ideal screening test. Using timed overnight urine collection, an albumin excretion rate
of greater than 20 /xg/min is diagnostic of microalbuminuria and an early morning urine
albumin;creatinine ratio of greater than 3.0 reliably predicts an overnight excretion rate of
greater than 30 /xg/min (Marshall, 1991). Measurement of this ratio therefore appears to
be a reliable screening test (Marshall, 1991). If the ratio is < 3.5 mg/mmol, the patient
can be classified as normoalbuminuric, while a ratio greater than 10 mg/mmol indicates
significant albuminuria which, in a diabetic, warrants further investigation (Marshall,
1991).
In diabetes mellitus, the occurrence of microalbuminuria predicts the development of
nephropathy (Mogensen & Christensen, 1984) and early mortality from cardiovascular
disease (Mogensen, 1984). The importance of blood pressure in the development and
progression of renal disease is now appreciated (Mathiesen et al, 1990) and early control
of hypertension is the mainstay of management.
The clinical relevance of microalbuminuria in normotensive subjects and patients with
essential hypertension is less clear. However, its presence appears to predict death from
cardiovascular disease in elderly subjects (Damsgaard et al, 1990) and possibly also
coronary and peripheral vascular disease in the general population (Yudkin et al, 1988).
This could indicate either that microalbuminuria and proteinuria reflect generalised
cardiovascular disease, or that it is associated with an excess of cardiovascular risk
factors, or both (Winocour, 1992).
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Microalbuminuria is more common in a hypertensive population (Yudkin et al, 1988;
Giaconi et al, 1989; Gosling & Beevers, 1989) and, in some studies, is linearly related to
the level of blood pressure (Parving et al, 1974; Opsahl et al, 1988; Yudkin et al, 1988;
Damsgaard et al, 1990; Winocour et al, 1992), suggesting a causal relationship.
Winocour (1992) has suggested that the presence of microalbuminuria in essential
hypertension should lead to more active management of the hypertension.
There is some evidence that ambulatory blood pressure better correlates with
microalbuminuria in essential hypertension (Opsahl et al, 1988; Giaconi et al, 1989) but
little is known about the impact of the diurnal blood pressure rhythm. However, loss of
the nocturnal dip is associated with higher prevalence of microalbuminuria in diabetics
(Bauduceau et al, 1991; Lindsay et al, 1995) and patients with advanced renal disease
have blunting of their diurnal BP rhythm (Abel et al, 1990; Middeke & Schrader, 1994).
Introduction
Both cardiac target organ damage, as assessed by echocardiography, and renal damage, as
assessed by urinary microalbuminuria, are correlated with blood pressure, but the
importance of nocturnal blood pressure elevation and the diurnal rhythm remains
uncertain. In this study all members of a large, heterogeneous working population were
asked to attend for blood pressure screening and both exercise BP response and the 24
hour ambulatory blood pressure profile of all hypertensive subjects and a randomly
selected group taken from the whole population were compared to left ventricular anatomy
and function, and to urinary albumin excretion.
Patients and Methods
With the co-operation of a large electronics group based locally (GEC-Ferranti), the entire
working population of approximately 1300 was invited to attend for blood pressure
screening. Employing both manual and professional staff, across all social strata, this
population should have provided a cohort representative of the general working
population. All subjects found to be hypertensive and a randomly selected subset were
then invited to attend for more detailed study.
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Stage 1 - Screening
A trained nurse co-ordinated a screening programme based in the company medical centre.
Every employee based locally was invited to attend via department newsletters and notices
posted throughout the factory.
Each individual had their age, sex, height and weight recorded. A note of any current
medication was made and subjects on anti-hypertensive medication excluded from further
study. After 5 minutes rest, blood pressure was measured in the right arm with the
subject sitting and arm resting on a desk. The blood pressure was measured three times,
using a semi-automatic electronic sphygmomanometer (Takeda UA-751) and the mean of
these measurements recorded as the clinic blood pressure. These machines have been
shown to be reliable and valid instruments (Bruce et al, 1988) and have the advantage of
removing observer bias from the measurement procedure (Jamieson et al, 1990). Subjects
were deliberately not given the results of screening, but were told that all subjects found
to have high blood pressure would be notified at the end of the study.
Stage 2 - Randomisation
A randomly selected sub-group, weighted to include all hypertensive subjects, was then
invited to attend for further study. Assuming the standard deviation for the measurement
of LV mass index to be 30 g/m^ (Verdecchia et al, 1990) and a difference of 20 g/m^ to
be clinically significant, I estimated that 110 randomly selected subjects would be needed
to detect a statistically significant difference (p < 0.05) in the LV mass between those
whose pressure falls during sleep and those who fail to "dip", with 80% power.
This protocol was designed to overcome some of the disadvantages of previous studies
which, by not including subjects with more severe hypertension, were not representative
of an entire hypertensive population. Most previous studies have consisted largely of
patients referred to hypertension clinics with known or suspected hypertension. As
knowledge of blood pressure level or a previous diagnosis of hypertension may influence
the clinic pressure (Rostrup et al, 1988), possibly due to modification of the "white coat"
response (Pickering, 1992a), I wished to ensure that we were studying subjects blinded to
their own blood pressure level. Thus I hoped to be studying a "virgin" population, with
no known history of cardiovascular disease or hypertension.
I was concerned that it may be unethical not to inform the subject or his general
practitioner of the result of screening if they were found to have moderate to severe
hypertension (diastolic BP > 110). To overcome this problem, the only subject in this
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category was invited to attend for ambulatory monitoring and echocardiography shortly
after the screening visit, and then informed of the diagnosis. To try and ensure that the
investigator remained blinded to the results of the screening, a randomly selected subject
was invited to attend for further investigation at the same time as the newly-diagnosed
hypertensive.
Stage 3 - Detailed Investigation
Each randomised subject was invited to attend for more detailed investigation, consisting
of 24-hour ambulatory blood pressure monitoring, measurement of blood pressure in
response to sustained hand grip, collection of early morning urine sample for
microalbuminuria, and two-dimensional, M-mode and Doppler echocardiography.
Ambulatory blood pressure monitoring was performed using the SpaceLabs 90207
monitor, programmed to measure BP at 30 minute intervals throughout 24 hours, with
simultaneous wrist activity monitoring to allow an objective measurement of sleep time.
All subjects returned to work after the monitor was fitted and were asked to continue with
normal activities.
A urine sample was collected immediately after rising the next day and urinary
albumin/creatinine ratio was estimated using an in-house radio-immunoassay.
Exercise blood pressure was measured after removal of the monitor 24 hours later. Blood
pressure was measured at rest, using the Takeda UA-751 semi-automatic electronic
sphygmomanometer and again after three minutes of isometric exercise, using the protocol
described by Lenders et al (1988). Isometric exercise was performed using a calibrated
strain gauge hand grip dynamometer. Each subject's maximal voluntary strength was
ascertained at the outset as the maximum force achieved on three attempts. The subject
was then asked to maintain sustained hand grip to 30% of maximum for three minutes and
blood pressure measurement was repeated on completion.
Echocardiography was performed the same day using an Acuson XP/10 with 2.5 to 3.5
MHz probe. All studies were performed with subjects in the left lateral decubitus
position. Standard two-dimensional parasternal and apical views were obtained to ensure
normal left ventricular geometry and systolic function in all subjects. A two-
dimensionally guided M-mode echocardiogram of the aortic valve and left atrium was
recorded from the parasternal long axis view (Figure 7.1), and of the left ventricle from
the short axis view just below the mitral valve apparatus (Figure 7.2).
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Figure 7.1 Echocardiography Measurement of the Aorta and Left Atrium
The M-mode cursor was positioned at the level of the aortic valve on the two-dimensional
long axis view (upper panel, M-mode cut indicated by the white line). Aortic root diameter
and left atrial size were then measured from the M-mode following ASE recommendations
(lower panel). The Acuson B-mode modality, shown here, which colours the image and
accentuates endocardial boundaries, was used for most measurements.
LV = left ventricle, LA = left atrium; Ao = ascending aorta
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Figure 7.2. Echocardiographic Measurement of Left Ventricular Mass
The M-mode cursor was positioned across the left ventricular cavity at the level of the
papillary muscles on the two-dimensional short axis view (upper panel, M-mode cut
indicated by the white line). Septal and posterior wall thickness and left ventricular cavity
dimension in diastole were measured from the M-mode, using the Penn convention (lower
panel).
RV = right ventricle, LV = left ventricle, IVS = interventricular septum, PW = posterior wall
of left ventricle.
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Colour Doppler study of the left ventricular outflow tract and mitral valve was performed
to exclude significant aortic or mitral regurgitation and a two-dimensionally guided pulsed
Doppler examination of left ventricular inflow velocities was made from the apical four
chamber view with the Doppler sample volume positioned at the level of the mitral leaflet
tips in diastole (Figure 7.3). Studies were stored on video for later analysis using Acuson
proprietary software. To minimise the effect of respiratory variation each measurement
was averaged over 6 frames. All M-mode measurements were made according to the
guidelines of the American Society of Echocardiography (Sahn et al, 1978), with the
exception of the parameters used to calculate left ventricular mass, which were calculated
at end-diastole using the Penn convention (Devereux & Reichek, 1977; Devereux et al,
1986).
All echocardiograms were performed by myself or by an experienced technician, and all
were analysed by myself.
Statistical Analysis
Baseline demographic parameters from the screening population and the groups studied
were compared using Student's t-test or Chi squared test as appropriate.
For simplicity of presentation, groups were then divided into dippers and non-dippers,
defined as those with less than 10% drop in both systolic and diastolic BP from wake to
sleep, and the two sub-groups compared by parametric or non-parametric analysis as
appropriate.
The blood pressure profile of subjects found to have left ventricular hypertrophy (defined
as left ventricular mass index > 110 g/m^ for women and > 134 g/m^ for men
(Hammond et al, 1986)) was also compared to those with normal LV mass. Left
ventricular geometry was further defined using the method described by Ganau et al
(1992), and the ambulatory BP profile in each subset compared to that of the normal
group.
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Figure 7.3 Doppler Measurement of Left Ventricular Diastolic Function
The Doppler cursor was positioned at the level of the mitral leaflet tips in the left ventricular
cavity from the two-dimensional apical four chamber view (upper panel, pulsed wave sample
volume location is indicated by the white dot). Maximum early (E wave) and late (A wave)
left ventricular inflow velocities were then measured from the pulsed Doppler flow profile
(lower panel). Deceleration time (DT, time period indicated by vertical white lines) and,
when it was possible to simultaneously visualise left ventricular inflow and outflow,
isovolumic relaxation time (IVRT, time period again indicated by white lines) were also
measured (lower panel).
RV = right ventricle, LV = left ventricle, RA = right atrium, LA = left atrium.
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Pearson correlation coefficients were calculated to determine the extent to which each BP
measure relates to target organ damage. Stepwise multiple regression models were used
to determine which BP measures predicted target organ damage, taking account of the
other BP measures. The criteria used for entry and retention into the models was p <
0.10.
Principal components analysis is a method of data reduction which produces a small
number of derived variables (the principal components) from a larger number of originals,
such that these principal components are uncorrelated and retain most of the varance of the
originals (Everitt, 1994). This analysis was performed on all blood pressure
measurements to determine which accounted for the majority of the variance and the
extent of additional information provided by each measure.
Results
Population Screened
The entire workforce of GEC Ferranti on two local sites was invited to attend for
screening between February and May 1992. One thousand and five subjects from a
workforce of approximately 1300 were screened (response rate 77%) of whom 35 were
known hypertensives on treatment and three were receiving beta-blockers for ischaemic
heart disease. The baseline data from the remaining 967 subjects, used for this study, is
given in Table 7.3. The distribution of clinic BP is shown in Figure 7.4 and is seen to be
approximately Normally distributed, with minor positive skew.
One hundred and sixty-two subjects (110 randomly selected + all subjects with screening
diastolic BP > 95 mmHg) were invited to attend for more detailed study. One hundred
and thirty four (83%) completed the analysis phase. The baseline parameters of the
randomly selected subgroup were not significantly different from that of the total
population (Table 7.3) although, as expected, blood pressure was higher in the study
population which included all hypertensives. None of the 28 patients who failed to attend
were female but otherwise their demographic details were not significantly different from
the group studied, with a mean age of 37 ± 2, body mass index of 26.5 ± 0.8 and mean
clinic BP of 142±2.8/89±2.4 mmHg.
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Table 7.3 Baseline Demographic Parameters - The GEC Ferranti Work Force
Variable Screened Random Weighted Population
(± S.E.M.) Population Subgroup Subgroup Studied
Number 967 110 162 134
Age 37 + 0.4 36 + 1 38+0.9 39 + 1
Female sex (%) 182 (19%) 19 (17%) 21 (13%)* 20 (15%)
Height (cm) 173+0.3 173+0.8 173+0.6 172+0.7
Weight (kg) 76+0.4 75 + 1.2 77 + 1 76 + 1.1
Body mass index 25.3+0.1 24.9+0.4 25.7+0.3 25.5+0.3
(g/m2)
Clinic Systolic BP 128+0.5 128+1.3 136 + 1.5*** 135 + 1.7***
Clinic Diastolic BP 79+0.3 78+0.9 85 + 1.1*** 84+1.2***
Pulse Rate 69+0.4 69+1.1 71 + 1** 69 ±1
Each subgroup has been compared to the screening population to ensure comparability.
*
p < 0.05, ** p = 0.02, *** p < 0.00001
Eight subjects from the randomly selected subgroup would be classified as hypertensive on
the basis of their clinic BP, using World Health Organisation (WHO) Criteria of BP >
160/95 (Subcommittee of WHO/ISH Mild Hypertension Liaison Committee, 1993).
As baseline parameters in the total population studied were no different from the random
subgroup (other than for BP), and as the number of subjects with significant hypertension
or left ventricular hypertrophy in the random subgroup would be limited, all further
analyses were performed on the total population studied. Forty-five (34%) of this group
were classified as hypertensive using the WHO criteria.
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Figure 7.4 Frequency Distribution of Clinic Blood Pressure in GEC Ferranti
Workers
40 . , ,
Clinic Systolic BP
Clinic Diastolic BP
The distribution of clinic blood pressure in a working population. Both systolic blood
pressure (upper panel) and diastolic blood pressure (lower panel) are seen to be
approximately Normally distributed, with slight positive skew indicating a small excess of
subjects with raised blood pressure.
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Ambulatory BP Monitoring
Data from 24-hour ambulatory blood pressure recording was available in 132 subjects
from the entire cohort, of whom 94 had been randomly selected from the complete
population (Table 7.4). Ambulatory BP monitoring was not available from two subjects.
One was markedly obese with short arms and even an obese cuff could not be comfortably
fitted to her arm. Blood pressure monitoring was not tolerated by the remaining subject,
who complained of arm pain and removed the monitor shortly after leaving the clinic.
The number of patients classified as hypertensive using ambulatory BP of >_ 140/90 was
38 (29%). Only six subjects (5%) were classified as non-dippers.
Table 7.4 Ambulatory BP Monitoring
Variable Mean ± S.E.M.
24 hour Mean Systolic BP 126+ 1.1
24-hour Mean Diastolic BP 79±0.9
Mean Wake Systolic BP 132 + 1.2
Mean Wake Diastolic BP 84±0.9
Mean Sleep Systolic BP 112 + 1
Mean Sleep Diastolic BP 67+0.9
Nocturnal Dip (%) SBP 14.9+0.5
Nocturnal Dip (%) DBP 20.4+0.6
Exercise BP Response
Exercise blood pressure data was obtained in 115 subjects (Table 7.5). In the remainder
the electronic sphygmomanometer failed to measure BP at peak exercise. As this device
can take up to 20 seconds to obtain a reading only one attempt at a reading was obtainable
in each subject. A rest period of at least 30 minutes would have been required before
repeating this study which was not feasible within the time frame of this study.
Where peak BP after exercise was less than that baseline, the BP difference was scored as
zero.
Table 7.5 Blood Pressure Response to Isometric Exercise
Variable Mean ± S.E.M. Range
Exercise Systolic BP - Peak 156 + 2.2 102-216
Exercise Diastolic BP - Peak 104 + 1.5 68 - 159
Systolic BP Difference 22 + 1.4 0-66
Diastolic BP Difference 19+1.1 0-63
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Outcome Variables
Technically adequate echocardiograms were obtained in 120 subjects (88%) which is
comparable to other population based studies (Levy et al, 1987; Pearce et al, 1992).
Details are given in Tables 7.6a and 7.6b. Twelve (9%) had left ventricular hypertrophy
by conventional criteria.
Urine samples were returned by 129 subjects (Table 7.6c). Two subjects (1.6%) had an
albumin/creatinine ratio >3.5 consistent with possible significant microalbuminuria. No
subject had a ratio greater than 10. Both subjects with significant microalbuminuria had
significantly elevated ambulatory blood pressure (mean wake BP 154/103 and 155/99
mmHg) but with the diurnal rhythm preserved (nocturnal dip 10.4/11.7 and 27.3/22.9 %).
Table 7.6a Results of M-mode Echocardiography
Variable Mean ± S.E.M.
Intraventricular Septum - Systole (cm) 1.24±0.02
Intraventricular Septum - Diastole (cm) 0.79+0.02
LV Posterior Wall - Systole (cm) 1.52+0.02
LV Posterior Wall - Diastole (cm) 0.9+0.02
LV Internal Diameter - Systole (cm) 3.45+0.06
LV Internal Diameter - Diastole (cm) 5.12+0.05
Fractional Shortening (%) 33.5+0.6
Left Ventricular Mass (g) 180.5+6
Left Ventricular Mass Index (g/m^) 94.7+2.8
Relative Wall Thickness 0.36+0.01
Aorta (cm) 3+0.04
Left Atrium (cm) 3.6+0.04
Table 7.6b Results of Doppler Echocardiography
Variable Mean ± S.E.M.
Peak Early LV Filling (Emax) 0.67+0.01
Peak Atrial Filling (Amax) 0.51+0.01
E/A ratio 1.38+0.04
Isovolumic Relaxation Time 113.5+2.3
Deceleration Time 149.1+2.1
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Table 7.6c Results of Urine Analysis
Variable Mean ± S.E.M.
Albumin (mg) 11.4± 1.9
Creatinine (mmol) 14.2+0.5
Albumin/Creatinine Ratio 0.8 + 0.08
The blood pressure profile and outcome variables of the patients classified as non-dippers
were compared to that of the dippers (Table 7.7). Blood pressure was higher throughout
the 24 hours in the non-dippers, although this reached statististical significance during the
night only. Left ventricular mass index was also higher in non-dippers, but this difference
was not statistically significant.
Table 7.7 Dippers and Non-Dippers Compared
Variable + S.E.M. Dippers Non-Dippers P
Number 128 6
Age 39 ± 1 45+5 NS
24-h Mean Systolic BP 125 ± 1 138 ± 9.6 0.01
24-h Mean Diastolic BP 78 ± 0.8 89 ± 6.4 0.01
Mean Wake Systolic BP 131 ± 1.1 141 ± 9.8 NS
Mean Wake Diastolic BP 83 ± 0.9 90 ± 6.4 NS
Mean Sleep Systolic BP 111 ±0.9 133 ± 8.3 < 0.00001
Mean Sleep Diastolic BP 66 ± 0.8 95 ± 5.6 < 0.00001
Nocturnal Dip (%) SBP 15.3 ± 0.4 4.9 ± 2.4 < 0.00001
Nocturnal Dip (%) DBP 21 ± 0.5 5.9 ± 1.5 < 0.00001
Exercise Systolic BP -Peak 155 ± 2.3 165 ± 9 NS
Exercise Diastolic BP - Peak 103 ± 1.5 106 ± 4.6 NS
LVMI 93 ± 2.9 125 ± 24.3 NS
E/A Ratio 1.4 ± 0.04 1.4 ± 0.3 NS
Fractional Shortening 33.7 ± 0.6 26.9 ± 0.6 NS
Albumin/Creatinine Ratio 0.8 ± 0.09 0.9 ± 0.1 NS
Patients with LVH, who also had lower E/A ratios in keeping with early diastolic
dysfunction, were slightly older than those with normal left ventricles, and had higher BP
during the day and night (Table 7.8). However no difference in the diurnal blood
pressure profile was apparent, with similar fall in BP during sleep in each group (Figure
7.5, Table 7.8).
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Figure 7.5 Comparison of Diurnal Blood Pressure Variation in Subjects with
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Ambulatory blood pressure profile of subjects with normal (solid symbol) and increased
(open symbol) left ventricular mass. Ambulatory BP is seen to be higher in those with
increased LV mass but the diurnal profile is similar.
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Table 7.8 Blood Pressure Parameters in Left Ventricular Hypertrophy
Variable ± S.E.M. Normal LVH P
Number 108 12
Age 38 ± 1 45 ± 4.3 0.04
LVMI 88 ±2.1 162 ± 4.3 < 0.00001
Fractional Shortening 33.8 ± 0.64 30.7 ± 2.5 NS
E/A Ratio 1.4 ± 0.04 1.1 ± 0.17 0.04
24-h Mean Systolic BP 125 ± 1 134 ± 4.3 0.01
24-h Mean Diastolic BP 78 ± 0.9 85 ± 3.3 0.015
Mean Wake Systolic BP 130 ± 1.1 141 ± 5.1 0.006
Mean Wake Diastolic BP 83 ± 0.9 90 ± 3.7 0.016
Mean Sleep Systolic BP 110 ± 1 119 ± 3.7 0.01
Mean Sleep Diastolic BP 65 ± 0.8 73 ± 3.2 0.003
Nocturnal Dip (%) SBP 15.1 ± 0.5 15.2 ± 1.6 NS
Nocturnal Dip (%) DBP 20.8 ± 0.6 18.5 ± 2.3 NS
Exercise Systolic BP - 155 ± 2.4 168 ± 8.2 NS
Peak
Exercise Diastolic BP - 103 ± 1.6 113 ± 5.9 NS
Peak
Left ventricular mass index was then plotted against relative wall thickness (Figure 7.6) to
further stratify LV geometry. The scattergram was then divided into four fields using
upper 95% confidence limits for LVMI, quoted by Ganau et al (1992). of 111 g/m^ for
men and 106 g/m^ for women, and for relative wall thickness of 0.41 for both men and
women. This is therefore a less restrictive definition of left ventricular hypertrophy.
Seventy-four subjects (63%) had normal left ventricular geometry, 15 (13%) had
concentric left ventricular hypertrophy, 14 (12%) had eccentric left ventricular
hypertrophy and 15 (13%) had concentric left ventricular remodelling. Again, no
difference in the diurnal BP profile was apparent, despite higher BP with each pattern of
abnormal LV geometry (Table 7.9).
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Scatter plot of left ventricular mass against relative wall thickness, with solid symbols
indicating male and open symbols female subjects. The diagram has been divided into
four fields by upper 95% confidence limits of left ventricular mass index (111 g/m^ in
men and 106 g/m^ for women, solid and dashed vertical lines respectively) and of relative




































Table 7.9 Patterns of Abnormal LV Geometry
Variable Normal Concentric Eccentric Concentric
± S.E.M. LVH LVH Remodelling
Number 76 15 14 15
Age 36 ± 1.2 43 ± 2.8* 44 ± 3* 37 ± 2.8
24-h Mean 121 ± 1 133 ± 3.4** 134 ± 2.7*** 127 ± 2.8*
Systolic BP
24-h Mean 75 ± 0.9 85 ±2.7** 86 ± 2.4*** 81 ± 2.2*
Diastolic BP
Mean Wake 127 ± 1.1 140 + 4*** 140 ± 2.8*** 133 ± 3.2*
Systolic BP




108 ± 1 117 ± 3.2* 119 ± 2.6** 113 ± 2.3*
Mean Sleep 63 ± 0.9 72 ± 2.6** 72 ± 2.4** 68 ± 1.9*
Diastolic BP
Nocturnal Dip (%) 14.8 + 0.6 16.2 ± 1.6 15.2 ± 1.4 14.6 ± 1.2
Systolic BP
Nocturnal Dip (%) 20.7 ± 0.7 20.1 ± 2.1 21.1 ± 1.5 20.6 ± 1.5
Diastolic BP
Abnormal geometry has been compared to the normal group, with statistical significance
indicated by asterisks : *p < 0.05, **p < 0.0001, ***p < 0.00001.
Relationship of Blood Pressure to Outcome Variables
The major outcome variables were correlated to the BP measurements to determine which
had the greatest impact on cardiac and renal target organ damage. Results are detailed in
Table 7.10.
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Table 7.10 Strength of Relationship of BP Measurements to Outcome
Variables
Variable LVMI E/A Ratio Albumin/
Creatinine
Ratio
Clinic Systolic BP 0.44* -0.41* 0.16
Clinic Diastolic BP 0.37* -0.54* 0.21*
24 hour Mean Systolic BP 0.48* -0.41* 0.26*
24-hour Mean Diastolic BP 0.42* -0.58* 0.27*
Mean Wake Systolic BP 0.48* -0.45* 0.24*
Mean Wake Diastolic BP 0.42* -0.59* 0.26*
Mean Sleep Systolic BP 0.41* -0.25* 0.28*
Mean Sleep Diastolic BP 0.39* -0.47* 0.30*
Nocturnal Dip (%) SBP 0.07 -0.28* -0.07
Nocturnal Dip (%) DBP -0.04 -0.09 -0.12
Exercise Systolic BP - Peak 0.44* -0.28 0.12
Exercise Diastolic BP - Peak 0.46* -0.36* 0.03
Systolic BP Difference 0.23* 0.04 -0.03
Diastolic BP Difference 0.23* 0.13 -0.07
Pearson's correlation coefficient. Values marked * are significant at p < 0.05.
Correlation coefficients for alternative measures of left ventricular diastolic function
(isovolumic relaxation time and deceleration time) were all less than 0.25.
Left atrial size and the diameter of the left ventricular outflow tract appeared unrelated to
the BP level, with no significant correlation apparent (all < 0.1).
Multiple linear regression analysis was then performed to determine which BP measures
predicted each measure of major target organ damage. For this analysis, a diagnosis of
hypertension on the basis of clinic, ambulatory or exercise BP, or of non-dipping, were
included as BP measures, in addition to the qualitative measures, and are selected in
preference to the quantitative measure when seen to have a more direct influence on the
outcome measure. The following definitions were used
HI. - Clinic BP > 160/95 mmHg
H2. - Mean wake ambulatory BP > 140/90 mmHg
H3. - Exercise systolic BP > 190 mmHg
H4. - Non-Dipper = Nocturnal dip in BP form wake to sleep < 10% for both
systolic and diastolic BP.
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The most important predictor variables for each target organ measure are listed, with p-
values in brackets.
1. Left ventricular mass index : H2 (0.021), H4 (0.006), Exercise systolic BP peak
(0.0001)
2. ElA ratio : H4 (0.038), 24-h mean systolic BP (0.075), Mean sleep systolic BP
(0.001), 24-h mean diastolic BP (0.0001)
3. Isovolumic relaxation time : H4 (0.007), 24-h mean systolic BP (0.0001), clinic
diastolic BP (0.006), 24-h mean arterial pressure (0.0001)
4. Deceleration time : HI (0.003), H2 (0.004), Clinic systolic BP (0.0001), Exercise
systolic BP difference (0.018)
5. Albumin!Creatinine ratio : H4 (0.054), Exercise diastolic BP peak (0.023), Mean
sleep mean arterial pressure (0.0001)
The analysis was then repeated after adjusting the measures of target organ damage for
age, sex and body mass index, giving the following results :
1. Left ventricular mass index : H2 (0.038), Exercise systolic BP peak (0.0005), Clinic
diastolic BP (0.0001)
2. ElA ratio : H2 (0.025), H4 (0.062), 24-h mean systolic BP (0.001), Exercise systolic
BP peak (0.081), 24-h mean diastolic BP (0.0001)
3. Isovolumic relaxation time : H4 (0.007), 24-h mean systolic BP (0.0001), clinic
diastolic BP (0.006), 24-h mean arterial pressure (0.0001)
4. Deceleration time : H4 (0.02), Mean sleep systolic BP (0.045), Exercise systolic BP
difference (0.0007), nocturnal dip in diastolic BP (0.0007), 24-h mean arterial pressure
(0.0001), sleep mean arterial pressure (0.066)
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5. Albumin/Creatinine ratio : Mean sleep systolic BP (0.0001), nocturnal dip in systolic
BP (0.011), clinic diastolic BP (0.011), 24-h mean diastolic BP (0.022), mean sleep
diastolic BP (0.006), 24-h mean arterial pressure (0.0007).
Thus, while conventional or ambulatory BP values are most closely related to target organ
damage, the diurnal BP profile, particularly when designated as being a non-dipper, does
appear to have an independent influence on target organ damage, particularly on the
indices of diastolic dysfunction. Sleep BP appears to be the most important predictor of
microalbuminuria.
Principal Components Analysis of BP Measures
This analysis is used to summarise the variation in all the blood pressure measurements in
fewer dimensions. Each dimension is independent and is calculated as a linear sum of the
measures. Principal components were calculated for every BP measurement parameter (18
in total). Ninety-five per cent of the information was contained in the first 5 principal
components Fifty-seven per cent of the variation was accounted for by all measures of
ambulatory blood pressure, except the nocturnal dip, with less emphasis on the exercise
BP value. Nineteen per cent was accounted for by the nocturnal dip, 10% by the peak
exercise BP, 4% by the increase in BP on exercise, and 4% by clinic BP. Thus, while the
ambulatory BP values are most closely related to the extent of target organ damage,
almost a fifth of the remaining variation is accounted for by the nocturnal dip. A small
amount of additional information is provided by exercise BP data and the clinic BP,
presumably because each provides an additional measure of blood pressure reactivity.
Discussion
The relative importance of different blood pressure measurements in predicting
cardiovascular morbidity has been debated for many years. Blood pressure and its
variability can be considered as consisting of two basic components : the basal level, and
the phasic fluctuations which take place around this (Pickering, 1991). The relative
importance of each, both regarding prediction of future hypertension and in predicting
outcome in those with hypertension remains uncertain. Sir Horace Smirk (1944)
pioneered the concept of basal blood pressure, arguing that it was this, rather than blood
pressure reactivity which predicted outcome (Smirk et al, 1959: Smirk, 1964). At the
other extreme several workers have found exercise blood pressure, i.e. the response of
blood pressure to physical stress, to correlate better than casual blood pressure with left
ventricular hypertrophy (Ren et al, 1985; Nathwani et al, 1985; Ferrara et al, 1989;
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Gottdiener et al, 1990) suggesting that this measure of blood pressure reactivity is a better
indicator of cardiovascular risk.
Clinic blood pressure, although ideally representing basal blood pressure, has a significant
phasic component - the "white coat" effect (Mancia et al, 1983a). The variation in the
extent of this, together with the imprecision inherent in a technique which allows
relatively few measurements to be made, probably accounts for its poorer relationship
with target organ damage. Ambulatory blood pressure is a mixture of both components,
with sleep blood pressure approximating to basal, and wake blood pressure representing
the mean of the basal pressure and tonic reactions throughout the day. The possible
importance of the latter has been emphasised by Devereux et al (1983), who found the
ambulatory blood pressure during work to be more closely related to LV mass than either
total 24-hour or sleep BP. Other workers, although not separating "day" from "work"
have found "day" to more closely relate to LV mass (Drayer et al, 1983; Gosse et al,
1989). In contrast, in the largest such study published, Verdecchia et al (1990) found
night-time BP to more closely relate to LV mass, with an inverse correlation between the
nocturnal BP decline and cardiac size. Later work by the same author has suggested that
this may be the case predominantly in women (Verdecchia et al, 1995) but, due to the
relatively small number of female subjects in the current study, I have not been able to test
this hypothesis further here.
Many earlier studies have had small sample sizes and/or included convenient, rather than
representative, samples. Most have included subjects referred to a hypertension clinic
with a diagnosis based on repeated clinic measurement, and some have included patients
on anti-hypertensive treatment or after a period of weeks off treatment. Thus, the
relationship between blood pressure and target organ effects may have been blurred by
patient risk factor modification in light of their diagnosis of hypertension, and by current
or residual treatment effects. This study, by including randomly selected subjects
(weighted to include all those with raised clinic BP) from a large population base, who
were unaware of their blood pressure level and who had never received anti-hypertensive
medication, should have avoided this potential problem.
In previous studies there has also been wide variation in the blood pressure monitoring
equipment used, in the number of readings taken, and in the definition of day and night.
All these factors may affect the relative importance of differing parts of the ambulatory
blood pressure profile. In this study, blood pressure has been measured every 30 minutes
throughout the 24 hours, which has been shown to provide an accurate estimate of true BP
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when compared to intra-arterial values (Di Rienzo et al, 1983), and activity meters have
been used to obtain an objective estimate of sleep time. This technique, which appears
physiologically more sound than choosing an arbitrary definition of day and night, has
been shown to result in a greater nocturnal drop in blood pressure (Stewart et al, 1993),
and may be more reproducible (see Chapter 3).
Earlier studies have also tended to concentrate on one measure of blood pressure and
compare this to the clinic pressure, making an appreciation of other alternative measures
impossible. In this study, by performing multivariate analysis which includes clinic,
ambulatory and exercise blood pressure I have attempted to assess the relative importance
of each. This work is unique in measuring both ambulatory blood pressure and exercise
blood pressure. In addition, all subjects wore wrist activity monitors, allowing objective
definition of wake and sleep, so allowing more accurate assessment of the diurnal blood
pressure profile. Although I made no attempt to separately measure blood pressure at
work, all subjects were studied on a normal working day, and returned to work after
being fitted with their monitor. Furthermore, all subjects had had casual blood pressure
measured during the screening phase, using an electronic sphygmomanometer to remove
observer bias (Bruce et al, 1988), by a trained nurse, minimising the white coat response
(Mancia et al, 1987).
Echocardiographic left ventricular mass, Doppler indices of diastolic function, and urinary
albumin/creatinine ratios were used as measures of target organ damage. To improve the
sensitivity of the analysis of cardiac target organ damage, left ventricular structure was
further subdivided on the basis of left ventricular geometry (Ganau et al, 1992).
By screening a local working population and studying a random subset in detail,
previously undiagnosed and untreated subjects, who remained unaware of their blood
pressure level throughout the study, were examined. As such, a major potential source of
bias has been removed. Although a relatively young and healthy population, and therefore
not typical of the general population, subjects studied were from all social groups,
involving both manual and professional workers. There was a satisfactory response rate,
both to the original screening programme (77%) and for more detailed study (83%),
suggesting that the group studied was representative of the entire working population.
Thirty-six of 134 subjects studied were classified as hypertensive based on a clinic BP of
> 160/95 mmHg, while 38 had an ambulatory blood pressure greater than 140/90 mmHg.
Only six were non-dippers and they were significantly more hypertensive than the dippers,
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particularly during the night. Indices of target organ damage were not significantly
different between the groups, although left ventricular mass index was higher in the non-
dippers. Exercise blood pressure was also slightly higher in the non-dippers, arguing
against the view that the greater diurnal blood pressure variation in dippers is due to
larger increases in blood pressure with exercise during the day (Fumo et al, 1992). An
absolute difference in the level of activity cannot however be excluded.
Using criteria suggested by Hammond et al (1986), based on a population survey of
working adults, 12 subjects had left ventricular hypertrophy. These were slightly older
and had lower E/A ratios, suggesting early diastolic dysfunction and therefore
haemodynamically important LVH. Wake blood pressure was slightly, but not
significantly, higher in this group, while sleep blood pressure was significantly increased.
The diurnal profile was almost identical. With further subdivision of subjects based on
more detailed analysis of left ventricular geometry, a similar pattern was apparent, with
significantly higher pressures during wake and sleep in those with abnormal geometry,
and no difference in the nocturnal dip.
In keeping with earlier studies, ambulatory blood pressure was more closely related to LV
mass, although the difference between clinic BP and ambulatory BP was less pronounced
than that noted by others (Devereux et al, 1983; Verdecchia et al, 1990). There are
several possible explanations for this. Blood pressure was measured by a nurse in
subjects' work environment, minimising the pressor effect related to the measuring
procedure. Indeed, recent studies have suggested that nurse-measured BP may be more
reproducible than ambulatory BP (Reeves et al, 1992) and. when measured electronically,
better predict an increase in left ventricular mass over time (Spence et al, 1991).
Furthermore, all subjects in this study were unaware of their blood pressure level and
none had previously been diagnosed as hypertensive. As the white coat response may be a
reflex learnt in response to the measuring procedure and the diagnosis of hypertension
(Pickering, 1990a), this confounding variable may have had little impact in this study.
Thus, the clinic BP measurement in this study may have been representative of that
individual's true BP level, approximating to the basal value, and as such providing a
better measure of cardiovascular risk than the clinic BP referred to in other work.
Relying on an objective measure of sleep time, mean wake BP was most closely related to
both left ventricular mass and the E/A ratio, a measure of diastolic function. The
relationship with sleep blood pressure was less marked but remained significant. In
contrast, the albumin/creatinine ratio, an alternative measure of target organ damage, was
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more closely related to sleep blood pressure. Interestingly, this is in accord with data
which we have obtained from patients with non-insulin dependant diabetes mellitus
(Lindsay et al, 1995) and may indicate differences in the relationship between the blood
pressure profile and target organ damage in different systems. In keeping with this
possibility, sleep blood pressure has also been shown to be a more important predictor of
cerebral target organ damage (Shimada et al, 1990; Shimada et al, 1992). However, as
microalbuminuria was measured from an early morning urine sample, that is from urine
produced overnight, an alternative explanation for the higher correlation with sleep blood
pressure may be that this was the blood pressure to which the system was exposed at the
time of urine production.
The nocturnal dip, used as a measure of diurnal blood pressure variation, correlated only
with the E/A ratio. However, on multiple linear regression analysis, the diurnal rhythm
was shown to be independently associated with target organ damage, and accounted for
19% of the variation in the blood pressure measurements.
Conclusions
This study has demonstrated that, even when clinic BP is measured carefully, using every
possible method to reduce observer bias and the white coat effect, ambulatory blood
pressure measurements are more closely related to hypertensive target organ damage.
While wake BP appears to be the major determinant of cardiac hypertrophy, an
independent effect of sleep blood pressure is apparent. Knowledge of the diurnal blood
pressure rhythm also appears to impart additional prognostic information. In contrast,
exercise blood pressure, once the effect of ambulatory blood pressure has been allowed
for, imparts relatively little additional information.
The use of ambulatory blood pressure monitoring appears capable of improving the
precision of the estimate of an individual's cardiovascular risk. Mean wake blood
pressure is probably the best single measure, but knowledge of sleep blood pressure and
the diurnal blood pressure rhythm imparts additional prognostic information.
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CHAPTER 8
Sleep Apnoea and Nocturnal Hypoxia : Possible Modulators of Diurnal Blood
Pressure Variation in Essential Hypertension
Background
Hypertension and sleep apnoea commonly co-exist; 60% of patients with sleep apnoea
syndrome are hypertensive (Guilleminault et al, 1976) and around 30% of treated
hypertensives have apnoic episodes during normal sleep (Kales et al, 1984; Lavie et al,
1984; Fletcher et al, 1985). Sleep apnoea is now known to be a common condition,
affecting 2-4% of middle-aged men and 1-2% of middle aged women (Jennum & Sjol,
1992; Young et al, 1993). Previously thought to be a disease of the obese, it is now
recognised that only about 50% of patients have a body mass index of > 30 kg/m^
(Douglas, 1994). Thus, many people with mild sleep apnoea are at present undiagnosed
and unaware of their condition.
Patients with sleep apnoea experience hundreds of apnoic episodes throughout sleep and
each episode is associated acutely with an initial fall in blood pressure, followed by a
gradual rise as the oxygen desaturation falls. On average systolic blood pressure rises
about 1 mmHg for every 1% fall in Sa02 (Stradling, 1989a; Parish & Shepard, 1990).
The fall in Sa02 is associated with a rise in catecholamine production resulting in
vasoconstriction and a rise in total peripheral resistance which may account for the rise in
BP (Tilkian et al, 1976; Fletcher et al, 1987). Not surprisingly therefore sleep apnoea has
been identified as a condition in which diurnal blood pressure variation is reduced or
absent (Tilkian et al, 1976).
Severe sleep apnoea appears to cause significant day-time hypertension in some patients
and, particularly in younger patients, the hypertension can be "cured" when the sleep
apnoea is treated effectively (Burack et al, 1977; Lund-Johansen & White, 1990).
However the majority of patients will remain hypertensive during the day despite effective
treatment of their apnoea (Guilleminault et al, 1981). In a recent trial of nasal continuous
positive airway pressure (CPAP) treatment in hypertensive patients with sleep apnoea, a
fall in blood pressure was more closely linked to weight loss than to elimination of sleep
apnoea by CPAP (Rauscher et al, 1993). Smoking, alcohol abuse and particularly obesity
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are all risk factors for both hypertension and sleep apnoea syndrome and the association
may simply reflect co-morhidity (Jeong & Dimsdale, 1989).
Occult sleep apnoea has been proposed as a possible cause of some cases of "essential"
hypertension but this suggestion remains much more controversial. Snoring, a
predominant symptom in sleep apnoea syndrome and a possible marker for occult cases,
has also been proposed as a possible risk factor for hypertension and vascular disease
(Hoffstein et al, 1988; Waller & Bhopal, 1989). Hoffstein (1994) has recently
demonstrated that snoring is a marker for sleep apnoea but has no independent association
with blood pressure.
If hypoxaemia due to sleep apnoea is implicated in the pathogenesis of systemic
hypertension, other conditions causing hypoxaemia would also be expected to result in
hypertension. The one study to look specifically at this question compared patients with
sleep apnoea and restrictive chest wall disease and demonstrated a significantly greater
incidence of day-time hypertension in the sleep apnoea group (Shiner et al, 1990). They
did not however measure nocturnal blood pressure.
A more common cause of hypoxaemia in the general population is chronic obstructive
pulmonary disease (COPD) and some of these patients experience transient hypoxaemia
during sleep which is not due to sleep apnoea (Catterall et al, 1983). Patients who
experience nocturnal oxygen desaturation have higher BP than those who do not, and a
hypoxic challenge will increase the BP in the former group only (Fletcher et al, 1989).
There is also some evidence that COPD patients have significantly greater rates of
systemic hypertension and left ventricular hypertrophy than controls (Kassis, 1977).
Some patients in this study had evidence of LVH but not hypertension and it may be that
significant nocturnal hypertension accounted for this.
Patients with COPD have a greater than expected mortality during sleep (McNicholas &
Fitzgerald, 1984) and episodes of nocturnal oxygen desaturation have been shown to
increase myocardial oxygen demand, as measured by the heart rate-blood pressure
product, by as much as maximal exercise in patients with severe disease (Shepard et al,
1984). Although not a primary end-point, this study compared mean intra-arterial blood
pressure during the night to the resting BP but not the average day-time ambulatory BP :




In light of these observations, I hypothesised that any causal link between occult sleep
apnoea and essential hypertension would act primarily on the nocturnal blood pressure and
could therefore account for the attenuated diurnal blood pressure rhythm seen in a
proportion of essential hypertensives. If nocturnal hypoxia, rather than apnoea, was the
stimulus to the blood pressure rise, loss of the nocturnal dip should also be present in
patients with COPD. I have therefore examined the inter-relationship between nocturnal
oxygen saturation, blood pressure and diurnal blood pressure variation in essential
hypertension and in patients with COPD. Diurnal blood pressure variability was also
examined in patients known to have symptomatic sleep apnoea syndrome.
Patients and Methods
This was a cross-sectional observational study. It was conducted in compliance with
ethical committee review and all patients gave written informed consent.
Three groups of patients were studied. Demographic details are given in Table 8.1.
1. Essential Hypertension
Sixty-eight patients referred from the hypertension clinic for ambulatory blood pressure
monitoring were studied, of whom 66, 45 male, successfully completed the overnight
monitoring. Twelve (18%) subjects were classified as obese (BMI > 30). Thirty-five
were untreated and 31 treated with a variety of anti-hypertensive drugs, the majority
taking 2 or more agents.
To determine whether this patient group was representative of the hypertensive clinic
population I compared their characteristics to those of all patients attending our clinic with
a diagnosis of essential hypertension (n = 362). The control group was older (55 ±14)
with a similar systolic but lower diastolic BP (157 ±23/91 ± 12). However BMI was
almost identical (27±4.6 g/m^), with a similar proportion of obese individuals (24%).
Thus the group studied appears to be representative of a hypertensive population with, in
particular, no excess of obese individuals.
2, Chronic Obstructive Pulmonary Disease
Twenty patents with moderate or severe COPD were invited to participate, of whom 14, 9
male, completed the study. These patients were older and smaller but of similar body
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mass index to the hypertensive patients. Only two (14%) were obese. No patient was on
anti-hypertensive drug therapy but 8 (57%) were on diuretics and 6 (43%) on
maintenance, low-dose oral corticosteroid. All patients were studied when clinically
stable, with no acute exacerbation requiring hospitalisation or an increase in oral steroid in
the previous three months. Any patient with access to domiciliary oxygen was asked not
to use it during the study period.
3. Sleep Apnoea Syndrome
Ten patients, 8 male, with known moderate or severe sleep apnoea were also studied as
part of a placebo-controlled cross-over study of continuous positive airway pressure
ventilation. Data from the placebo limb (which consisted of a single tablet taken at night)
are included here. These patients were of similar age but significantly more obese (BMI
36±11, 60% obese) than the hypertensives. Three were on anti-hypertensive medication
at the time of study and 6 of the remaining 7 had significantly elevated clinic pressures.
Table 8.1 Demographic details of patient groups studied
Variable
(Mean ± S.E.M.)
Hypertensive COPD P Sleep
Apnoea
P
Number 66 14 10
Age 50± 1.5 68 + 1.8 <.00001 50 + 3.4 NS
Height (cm) 171 ±1.1 164 + 3.2 0.02 174+2.5 NS
Weight (kg) 80.5 + 1.9 68.9+5 0.015 108.8 + 10.9 0.00003
BMI (kg/m^) 27.5+0.6 25.3 + 1.4 NS 36 + 3.4 0.04
Clinic Systolic BP 154+2 134 + 3 0.0002 152 + 5 NS
Clinic Diastolic BP 100+1 78 + 2 <.00001 96+5 NS
P values refer to comparison of each group to the hypertensive control population.
Methods
As hospitalisation may influence sleeping habit and diurnal blood pressure patterns (see
Chapter 6), all patients were studied in their own homes.
In all essential hypertensives and COPD patients a full drug history, a history of snoring,
both from the patient and, where applicable, from their partner, and details of current
smoking habit and alcohol consumption were noted. Height and weight were recorded
and neck circumference (a measure of upper body obesity) was measured at the level of
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the cricothyroid membrane. Spirometry was also performed in the hypertensive patients
to ensure that no patient had hypoxaemic pulmonary disease.
All patients then underwent 24 hour ambulatory BP monitoring using the SpaceLabs
90207 monitor, which has been extensively validated by others (O'Brien et al, 1991b;
Groppelli et al, 1991). BP was measured every 30 minutes throughout the 24 hours.
To study changes during sleep accurately a method to discriminate between sleep and
wake is needed as patients' reporting of sleep time may be unreliable. The only certain
method of doing this is to study patients in a sleep laboratory with continuous EEG
monitoring. However this is labour intensive and the patient is not sleeping in his/her
natural surroundings and may not therefore sleep properly. To overcome this problem all
patients were fitted with a wrist activity meter (Gaehwiler), a solid state device worn on
the wrist like a watch which records activity at pre-set intervals (e.g. 30 sec.). Activity
values were determined at 125 ms. intervals and the total activity over the measuring
interval stored as a one-byte word. After completion of the recording data are down¬
loaded onto a personal computer. As activity normally falls dramatically with the onset of
sleep, sleep time can be determined. Such devices have been shown to provide an
accurate estimation of sleep time (Mullaney et al, 1980). The activity derived sleep time
was then used to determine mean blood pressure during wake and sleep, and the diurnal
blood pressure variation, defined as the percentage change in BP from wake to sleep.
This method has been shown to be both more physiologically sound and possibly more
reproducible that reliance upon any arbitrary definition of day and night (see Chapter 3).
After fitting the ambulatory monitoring equipment patients were instructed in the use of a
pulse oximeter (Ohmeda 3740, modified to disable all alarms). This machine is portable
and easy to use. Its sister device, the Ohmeda 3700, which has identical internal software
but a larger case and display panel, has been evaluated previously and shown to be
suitable for unattended overnight recording of oxygen saturation (Warley et al, 1987). On
retiring to bed, the oximeter was switched on and a finger clip was positioned on the
middle or index finger of the hand, using the arm which did not have the blood pressure
cuff attached. The machine display was then checked to ensure that there was an adequate
signal. On waking, the device was switched off and returned. Up to 8 hours of data were
stored in the internal memory of the device. This was down-loaded onto personal
computer and analysed using a DBase IV programme developed for the purpose. Median
oxygen saturation (Sa02) and the number of dips in Sa02 during sleep were calculated.
Using the limits described by Stradling & Crosby (1990), a dip was counted as significant
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when Sa02 fell by more than 4% below the previous updated high. No further dip could
then be scored until the saturation subsequently rose by more than 3%. Thus no
assumptions are made about baseline but any new fall greater than 4% is scored as a dip.
The number of dips is then divided by the duration of the monitoring period to give the
hourly dip rate. This has been shown to correlate closely with the apnoea index as
measured by polysomnography, with a dip rate of greater than 5 per hour suggestive of
sleep apnoea.
All hypertensive patients found to have nocturnal hypoxaemia suggestive of sleep apnoea
were invited to attend for formal polysomnography. Age and sex matched controls with
normal nocturnal saturation patterns were also invited to attend.
Patients with previously diagnosed sleep apnoea underwent 24 hour ambulatory BP and
activity monitoring only.
Analysis
All data were analysed on a personal computer using the Minitab statistical software
package.
The inter-relation among the continuous variables in the hypertensive patients was first
examined with Pearson's correlation coefficients. The influence of median oxygen
saturation, Sa02 dip rate, age, height, weight and neck circumference, alcohol
consumption, smoking habit and snoring history on the BP profile was then assessed by
multiple linear regression analysis, using wake BP, sleep BP and diurnal BP variation as
dependent variables.
Ambulatory blood pressure data was used to determine diurnal BP variation and classify
patients as dippers or non-dippers, with a normal BP dip defined as a fall of > 10% of
mean wake BP during sleep for both systolic and diastolic BP. The proportion of non-
dippers in the hypertensive, COPD and sleep apnoic groups was then compared using the
Chi-squared test. The absolute nocturnal dip was also analysed using Student's t-test.
Pulse oximetry data was compared using the Mann Whitney U test.
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Results
1. Diurnal Blood Pressure Variation
Ambulatory blood pressure data from the three groups studied is given in Table 8.2. Five
of the 66 essential hypertensives (8%) were non-dippers. Three of the COPD patients
(21%) (Yates corrected Chi-sq. = 1.16, NS) and 2 of the sleep apnoea patients (20%)
(Yates corrected Chi-sq. = 0.07, NS) were classified as "non-dippers". The nocturnal dip
in blood pressure of the patients with sleep apnoea was slightly reduced but not
significantly different from the essential hypertensives (Figure 8.1). The diurnal blood
pressure profile was maintained in COPD, but with nocturnal dip less than that of patients
with essential hypertension (Figure 8.2).
Table 8.2 Ambulatory Blood Pressure Data.
Variable Hypertensive COPD P Sleep P
(Mean ± S.E.M.) Apnoea
Wake Systolic BP 150±1.9 133+4.2 0.0003 137 + 3.8 0.01
Wake Diastolic BP 96+1.3 76+2.3 <0.00001 87 + 3.2 0.01
Sleep Systolic BP 129+1.8 119+4.7 0.04 122+5.6 NS
Sleep Diastolic BP 79+1.2 66 + 2.7 0.00006 72+4.3 NS
Nocturnal Dip (%) 14.4+0.6 10.5 + 1.6 0.015 11.1+2.3 NS
SBP
Nocturnal Dip (%) 17.9 + 0.8 13.3 + 1.9 0.015 17.2 + 3.1 NS
DBP
P values refer to the comparison of the hypertensive patients to the other two groups.
2, Oxygen saturation
Median oxygen saturation of the 66 patients with essential hypertension was 95%, with a
mean Sa02 dip rate of 2.4/hour (range 0.1 - 24.7/hour). Seven patients (11%) had Sa02
dip rates > 5/hour, suggestive of significant sleep apnoea (Figure 8.3). Of these, 6 were
on anti-hypertensive treatment and 6 were male. All had normal diurnal BP variation,
with a mean drop in BP during sleep of 16.1/19.1%. All patients classified as non-
dippers had normal oxygen saturation patterns, with mean Sa02 dip rate 1/hour (range
0.14-2.65).
Oxygen saturation of the COPD patients was lower, although the dip rate was not
significantly different (Table 8.3) Two patients (14%) with Sa02 dip rates > 5/hour both
had normal diurnal BP variation with nocturnal dips of 8.9%/19.5% and 11.5%/13.7%.
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Twenty-four hour ambulatory blood pressure profile of patients with essential
hypertension (Ess. HT = solid symbols) compared to those with symptomatic sleep
apnoea (SAS = open symbols).
Hourly average blood pressure ± S.E.M. is plotted against time.
The normal diurnal blood pressure is apparent in the essential hypertensives but appears
mildly blunted in sleep apnoea (though not statistically significant).
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Twenty-four hour ambulatory blood pressure profile of patients with essential
hypertension (Ess. HT = solid symbols) compared to those with chronic obstructive
pulmonary disease (COPD = open symbols).
Hourly average blood pressure ± S.E.M. is plotted against time.
The normal diurnal blood pressure is apparent in the essential hypertensives but appears
blunted in COPD.
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Linear representation of overnight pulse oximetry studies. Each Sa02 measurement,
representing the lowest Sa02 detected during the preceding 12 seconds, is plotted against
time.
The marked variability of the subject in the upper panel (who is subject 1 in Table 8.4),
with frequent drops in oxygen saturation, is readily appreciated. This subject had 195
dips in Sa02 > 4%. The lower panel (from Control Subject 1 in Table 8.4) illustrates a
normal recording, with some baseline variability, but almost all in the range 92-96%.
There were, however, 5 dips in Sa02 > 4%.
142
Table 8.3 Overnight Pulse Oximetry Data
Essential Hypertension COPD
Variable (%) Median Mean Median Mean P
Median Sa02 95 95 90 89 <0.00001
Max. Sa02 98 98 95 94 <0.00001
Min. Sa02 89 88 79.5 76 0.0001
No. of Dips
Sa02> 4%/hour
0.92 2.4 1.3 2.6 NS
3. Linear Regression Analysis - Essential Hypertension
Using single Pearson correlation coefficient analysis, only age and wake systolic BP were
significantly correlated (r = 0.28, p = 0.02), with the correlation coefficients for Sa02
and the BP parameters all less than 0.06. On multiple linear regression analysis, there
was a strong relationship between age and the Sa02 dip rate (0.34, p < 0.005), and a
relationship between neck circumference and Sa02 which approached significance (r =
0.22, p = 0.08). No relationship between blood pressure and nocturnal hypoxaemia
could be demonstrated.
4. Linear Regression Analysis - COPD
There was no significant correlation between either demographic parameters or oximetry
data, with only BMI and wake diastolic BP approaching significance (r = 0.37, p =
0.19).
5. Polysomnography
Six of the 7 patients found to have an Sa02 dip rate > 5/hour and 3 of 7 matched
controls agreed to attend for formal polysomnography using the standard methods of the
Scottish National Sleep Laboratory (Douglas et al, 1992). Results are given in Table 8.4.
Lower minimum Sa02 and more hypopnoeas were detected by polysomnography, in
keeping with its greater sensitivity. All but one patient who had a positive domiciliary
study had witnessed apnoeas, while no patient with a negative study had a witnessed
apnoea. Subject 3, who had a negative polysomnography study, slept for only 42% of the
study night (less than 3 hours), and spent only 6% of the night in deep (slow wave) sleep
The accuracy of this study is therefore questionable. An apnoea/hypopnoea index of >
15 during formal polysomnography is characteristic of sleep apnoea (Douglas et al, 1992),
thus, excluding subject 3, 4/5 (80%) of domiciliary studies were true positives, with one
false positive (note that the domiciliary study was borderline positive and
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polysomnography borderline negative). One of 3 control studies (33%) appears to have
been a false negative, but again polysomnography was borderline positive. Thus, while
far from 100% accurate, the domiciliary pulse oximetry study appears to have achieved a
satisfactory standard for the purposes of this study.
Table 8.4 Results of Overnight Sleep Study
The first two columns give the data from the domiciliary study and the following columns

















1 79 24.7 61 33 175 7.5 47.1
2 76 18.3 69 34 186 9.2 59.8
3 73 12.4 78 0 25 0 8.9
4 84 5.2 88 8 53 1.9 14.4
5 82 6.1 91 26 170 4.9 37
6 78 5.3 65 27 100 5.4 25.5
Control 1 90 0.63 83 0 67 0 13.2
Control 2 89 1.27 85 0 67 0 12.9
Control 3 89 1.65 88 0 94 0 16
Discussion
By obtaining 24 hour BP profiles in patients' own home, with simultaneous monitoring of
oxygen saturation during sleep, I have overcome some of the limitations of previous
studies examining the possible association of hypertension and sleep apnoea. The use of
ambulatory BP monitoring removes any potential observer bias, and confirmed that all
patients had sustained hypertension. Furthermore, by using activity monitors to measure
sleep time objectively, I have been able to differentiate wake and sleep BP, and thus
examine the potential relationship of sleep apnoea to both sustained diurnal hypertension
and to the diurnal BP rhythm. Finally, this methodology was designed to enable all
investigations to be performed in patients' own home. As there is evidence that
hospitalisation per se may have an effect on diurnal blood pressure variation, this removed
a further potential source of error inherent in studies performed in a hospital ward or sleep
laboratory.
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I have relied upon pulse oximetry for the diagnosis of sleep apnoea. While recognising
that this provides information on hypoxaemia alone, with no information on apnoeas, this
approach has been shown to be valid (Stradling et al, 1989b) and is approved by the
British Thoracic Society (British Thoracic Society, 1990). However, as up to one third of
patients with sleep apnoea may have significant apnoea without hypoxia (Douglas et al,
1992), and as such apnoeas may be responsible in part for the blood pressure elevation,
full polysomnography studies were arranged in a subset of patients and appear to validate
our results. The advantages of being able to study blood pressure changes in a subject's
own environment may outweigh the loss of sensitivity inherent in my method.
Ambulatory non-invasive blood pressure monitoring is, of necessity, intermittent and in
this study blood pressure was recorded every 30 minutes. Thus, it is possible that acute,
transient elevations in blood pressure during the night, associated with apnoeas, were
missed. Nonetheless, intermittent recording, with measurements every 30 minutes or less,
has been shown to correspond closely to beat-to-beat intra-arterial recording (Di Rienzo et
al, 1983), suggesting that this estimate of mean blood pressure during sleep is accurate.
Non-invasive measurement of blood pressure variability is less accurate and I am not able
to exclude a significant increase in nocturnal blood pressure variability in the patients with
apnoea.
Nocturnal hypoxaemia does not appear to be associated with the level of either wake or
sleep BP nor to blunting of the diurnal BP profile in essential hypertensives.
Hypertension and the apnoea index are both positively correlated to age. Furthermore,
the correlation of neck circumference to apnoea, while not achieving statistical
significance, is similar to that previously reported as the strongest independent predictor
of sleep apnoea in middle aged men (Stradling & Crosby, 1991). Whilst related to
generalised obesity (Stradling & Crosby, 1991), neck circumference appears to be a
stronger marker for the pattern of obesity most closely related to sleep apnoea (Davies &
Stradling, 1990; Stradling & Crosby, 1991). Although not clearly demonstrated here,
obesity is also associated with both hypertension (Levy & Kannel, 1988) and attenuation
of the diurnal BP profile (Jamerson & Julius, 1991). Thus, the increased prevalence of
sleep apnoea in hypertensive patients may simply reflect the presence of the confounding
variables of age and obesity.
If there was a causal association between sleep apnoea and hypertension, this would have
to act primarily via an effect on BP during sleep and a blunting of the normal diurnal BP
profile would be expected. The absence of such a relationship, both in a group of
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essential hypertensives and in patients with symptomatic sleep apnoea, argues strongly
against any such association.
Patients with COPD, who were significantly more hypoxic overnight, did appear to have
minor blunting of the diurnal blood pressure profile, and the prevalence of non-dipping
was higher than that seen in essential hypertension, though not significantly so. There
were however several potential confounding variables in this group. They were
significantly older that the hypertensive patients, and there is some evidence that the
diurnal rhythm may attenuate with age (Munakata et al, 1991) (see Chapter 4). Almost
half were on long-term oral corticosteroid which may also influence blood pressure
variability (Munakata et al, 1988). Patients with COPD may not sleep as soundly as
normal subjects (Catterall et al, 1983) and, anecdotally, monitoring was less well tolerated
in these patients, with 6 of 20 subjects unable to tolerate the domiciliary sleep study.
Perhaps most importantly, these patients had markedly limited activity during the day and
failure of blood pressure to rise normally during wake hours could account for the smaller
diurnal variation. The small sample size makes it difficult to determine the extent to
which these factors have biased our results, but the absence of any clear relationship
between oxygen saturation and blood pressure argues against a pathophysiological link.
Despite the absence of any association between the apnoea index and the blood pressure
profile, I have found the prevalence of sleep apnoea in hypertensive patients to be over
double that seen in a random male population sample (10.6% vs 4.6% (Stradling &
Crosby, 1990)), although substantially less than the 22-35% previously reported in male
hypertensives (Kales et al, 1984; Lavie et al, 1984; Fletcher et al, 1985; Williams et al,
1985). I have included both male and female patients in this study but, as the prevalence
in male patients was only marginally higher (13.3%), this is unlikely to account for this
difference. However, most patients with nocturnal hypoxaemia were on drug treatment,
and the prevalence in treated, male, hypertensives (23.8%) is similar to that previously
reported.
This apparent discrepancy in the prevalence of sleep apnoea in treated and untreated
patients has been noted previously (Warley et al, 1988; Hirshkowitz et al, 1989) and an
adverse effect of anti-hypertensive drugs on ventilatory control remains a possible
mechanism for the observed apparent excess of sleep apnoea which cannot be excluded by
this work. Patients in early studies were mainly treated hypertensives (Kales et al, 1984;
Lavie et al, 1984; Fletcher et al, 1985) and three more recent studies of untreated patients
found the prevalence of nocturnal hypoxaemia and/or apnoea in hypertensive patients to be
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no higher than in a control group (Warley et al, 1988; Hirshkowitz et al, 1989; Stradling
& Crosby, 1990). One of these (Hirshkowitz et al, 1989) also studied treated
hypertensives and found that they did have a higher incidence of sleep apnoea. The
earlier reports may therefore have been finding an artefactually raised prevalence of sleep
apnoea due to the effects of anti-hypertensive drugs.
Diuretics, particularly in the face of inadequate potassium replacement, can cause a mild
metabolic alkalosis. Such alkalosis has been shown to decrease ventilation in dogs
(Sullivan et al, 1985), though the effect in man is unknown. Beta-blockers (Boudoulas et
al, 1983) and methyl-dopa (LaHive et al, 1988) have both been postulated to cause a
reduction in upper airway patency due to effects on smooth muscle tone. A direct central
depressant effect on ventilatory centres is also a possibility.
Przybylski et al (1986) hypothesised that hypertension and sleep apnoea syndrome are
both manifestations of arterial chemoreceptor hyper-responsiveness and that increased
chemoreceptor activity may lead to both increased sympathetic outflow and instability of
ventilatory control. If true, it may be that some patients are particularly vulnerable to the
effects of blood pressure lowering drugs on ventilation. As an angiotensin converting
enzyme inhibitor has been reported to cause a reduction in apnoic episodes (Peter et al,
1989), determining which hypertensive patients are in this category could have important
therapeutic implications.
Since starting this work, two studies analysing ambulatory blood pressure data in patients
with sleep apnoea have been published. Noda et al (1993) studied 21 men with known
sleep apnoea and found 9 (43%) to have normal diurnal blood pressure, 8 (38%) to have
mildly attenuated blood pressure variability and 4 (19%) to have significantly reduced
diurnal blood pressure variability. The latter group had the most severe sleep apnoea.
They compared this data to a control group of normotensive male subjects and concluded
that the blood pressure profile was significantly different in those with most severe sleep
apnoea. No attempt was made to control for obesity or other potential confounding
variables. This and the small numbers in each sub-group make this difficult to interpret.
The study of Hla et al (1994) is more important. This was a population based study of
147 subjects, including a subset whose medical history suggested a high likelihood of
sleep apnoea. Although not clearly stated, it appears that ambulatory BP monitoring and
polysomnography were performed on two separate occasions. Designed predominantly to
determine whether sleep apnoea was independently associated with hypertension, no
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parameter of the diurnal BP rhythm was studied. Blood pressure was higher in subjects
with sleep apnoea (though still in the normal range) but the diurnal rhythm was maintained
and almost identical in the two groups. Nocturnal blood pressure variability, defined as
the co-efficient of variation of the mean arterial pressure, was higher in those with sleep
apnoea. The association between sleep apnoea and hypertension persisted after correction
for age, sex and obesity. However, obesity was defined simply as BMI > 27 kg/m^ with
no attempt made to correct for the type of obesity. This is of potential importance as
Stradling & Crosby (1991) have previously shown neck circumference to be the single
most important predictor of sleep apnoea in a large community based survey, and different
patterns of obesity are known to impart different levels of cardiovascular risk. Thus,
while appearing to show an independent association between sleep apnoea and
hypertension, the potential for obesity as a major confounding variable persists.
Conclusions
The absence of any association between sleep apnoea and nocturnal hypertension or
diurnal blood pressure variation in essential hypertension, and normal diurnal variation in
BP in patients with symptomatic sleep apnoea, makes any pathophysiological link between
the two conditions unlikely. Minor blunting of the diurnal blood pressure rhythm in
COPD patients with significant hypoxia makes it impossible to exclude an effect of
hypoxia on nocturnal BP but there was no clear linear relationship. The increased
prevalence of sleep apnoea in essential hypertension is probably caused by the
confounding variables of age and obesity. A potential adverse effect of anti-hypertensive




Diurnal Blood Pressure Variation in Patients with Left Ventricular
Dysfunction and Effect of Treatment with Long and Short-acting ACE
Inhibitors
Background
Potential Role of the Heart as a Modulator of Diurnal Blood Pressure Variation
An active role for the heart in the control of blood pressure has been suggested by the
observation that left ventricular mass may become elevated before blood pressure rises in
individuals destined to become hypertensive with time (Mahoney et al, 1988; de Simone et
al, 1991). Studies of patients with established left ventricular hypertrophy have also
suggested blunting of the diurnal rhythm independent of the level of blood pressure (Gosse
et al, 1988a; Verdecchia et al, 1990; Kuwajima et al, 1992). Moreover, the diurnal
rhythm is modified in cardiac transplant recipients (Reeves et al, 1986; Sehested et al,
1990b), whose ventricles are denervated, and in patients with central autonomic
denervation (Shy-Drager syndrome) (Mann et al, 1983). Autonomy of the blood pressure
rhythm from other physiological cardiac rhythms has been confirmed by the observation
that day-night blood pressure variation persists in patients with ventricular demand
pacemakers (Davies et al, 1984), whose heart rates are constant.
Thus, the heart may have an independent role in the control of the diurnal blood pressure
rhythm, and if so, an altered rhythm in patients with left ventricular dysfunction may be
expected. In keeping with this hypothesis, in a study of normotensive patients with
moderate-to-severe, chronic congestive cardiac failure secondary to ischaemic heart
disease, Caruana and colleagues (1988) demonstrated a reduction in blood pressure
variability, and suggested that the amplitude of the 24-hour blood pressure curve was
related to the degree of left ventricular functional impairment, such that those with worst
left ventricular function have the smallest day-night BP variation. Similarly, in a study of
patients with end-stage heart failure, referred for cardiac transplantation, van de Borne et
al (1992) found that severity of heart failure correlated with a reduction in the amplitude
of both heart rate and blood pressure diurnal rhythm.
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Angiotensin Converting Enzyme Inhibitors - Efficacy, Effect on Diurnal Rhythm and
Potential Adverse Effects
Both long- and short-acting angiotensin converting enzyme (ACE) inhibitors are effective
therapy for the treatment of heart failure and have been shown to improve prognosis (The
SOLVD Investigators, 1991; Fonarow et al, 1992). However there appear to be
important clinical differences, regarding both efficacy and side-effect profile, between
different ACE inhibitors. Lisinopril (a long-acting ACE inhibitor) has been shown to
result in a statistically greater increase in both exercise duration and left ventricular
ejection fraction than captopril (a short-acting ACE inhibitor) (Giles et al, 1989).
Lisinopril does however also cause a larger increase in blood urea, but not creatinine, the
significance of which is uncertain (Giles et al, 1989). Packer et al (1986), using large,
fixed doses of ACE inhibitors in patients with severe heart failure, found more prolonged
hypotension and a deterioration in creatinine clearance in patients treated with enalapril
(duration of action between that of lisinopril and captopril) than with the shorter-acting
captopril. Enalapril and captopril can both cause a reduction in glomerular filtration rate
(GFR), despite an increase in effective renal plasma flow, and the decline in GFR
correlates with the chronic fall in BP seen in these patients (Cleland & Dargie, 1987),
suggesting that a prolonged fall in BP may be deleterious.
A comparative study of lisinopril and captopril using ambulatory monitoring in
hypertensive patients has shown significantly greater blood pressure reduction with
lisinopril, not apparent on clinic blood pressure measurement (Whelton et al, 1990), with
blood pressure tending to rise between doses of captopril. Unlike hypertensive patients,
such prolonged reduction may be deleterious in a patient with heart failure. The only
study to examine the effect of ACE inhibition on the diurnal blood pressure profile of
patients with heart failure studied small numbers of patients and was uncontrolled
(Osterziel et al, 1992). In this study there was a tendency (albeit non-significant) for the
diurnal curve to flatten on treatment, and this effect was greater with the long-acting drug,
lisinopril. This study also examined the effect of treatment on biochemical indices of
renal function, demonstrating a small, though non-significant, reduction in creatinine
clearance with lisinopril.
Introduction
While it appears likely that severe left ventricular impairment is associated with blunting
of the diurnal blood pressure profile, the mechanism remains uncertain and it is not clear
whether those with mild or moderate heart failure are similarly affected. Moreover, the
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effect of treatment with ACE inhibitors on the diurnal rhythm, and the importance of such
effects on renal function, is not known. In this study the 24 hour blood pressure profile
of patients with mild to moderate cardiac failure was studied before and after therapy with
a long- and a short-acting angiotensin converting enzyme inhibitor, and the influence of
severity of heart failure on diurnal profile was assessed. The effect of such treatment on
glomerular filtration rate was also studied.
Methods
This study was conducted in compliance with ethical committee review and all patients
gave written informed consent.
Study Design
This was a 15 week, prospective, double blind, randomised, two-period cross-over study
with single-blind run-in and washout periods to compare the effect of lisinopril and
captopril on the 24 hour blood pressure profile and on renal function in patients with heart
failure. Although originally conceived as a single-centre study, problems with recruitment
of suitable patients led to two other centres taking part. However, all data was collected
in an identical manner and analysed by myself.
All patients had a clinical diagnosis of heart failure, in NYHA functional class I, II or III,
treated with loop diuretic (>40 mg frusemide per day or equivalent) and were in sinus
rhythm. The diagnosis of heart failure was confirmed by a radionuclide ejection fraction
< 35% in all patients. Patients with recent myocardial infarction (< 2 months), cardiac
surgery (< 3 months) or stroke (< 6 months) were excluded, as were patients with
valvular heart disease or predominant cor pulmonale. Those with renal dysfunction,
defined as serum creatinine > 250 /rmol/1, GFR < 35 ml/min/1.73m2 or > 0.5 g/1
proteinuria, or clinically significant hepatic or haemopoietic disorders were also excluded.
Patients already taking an ACE inhibitor or other vasodilator (unless used for the
treatment of chronic stable angina), beta-blockers, or non-steroidal anti-inflammatory
drugs (other than low dose aspirin) were also excluded. All other drug therapy was kept
constant throughout the study period.
Drug Administration
After a one week placebo run-in period, eligible patients were randomised and received
either a test dose of lisinopril 2.5 mg and placebo, or a test dose of captopril 6.25 mg and
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placebo. Patients who developed symptomatic hypotension after test dosing were
excluded from further study. If the test dose was tolerated, patients were then discharged
on lisinopril 10 mg once daily and placebo matching captopril three times daily, or
captopril 25 mg three times daily and placebo matching lisinopril once daily. After 6
weeks treatment active treatment was changed to placebo and continued for a two week
washout period. Patients then received a further test dose of the alternative therapy and, if
tolerated, were maintained on that therapy for a further 6 weeks.
Patient Evaluation
All patients underwent radionuclide ventriculography prior to or during the initial placeho
run-in phase providing an objective index of left ventricular function. The primary
variables evaluated were non-invasive 24-hour ambulatory blood pressure profiles and
glomerular filtration rate measured isotopically. Secondary end-points included patients'
responses to a symptom questionnaire and change in New York Heart Association
functional status. Serum biochemistry, haematology and urine dipstick analysis of
proteinuria were measured at each visit for safety analysis.
Ambulatory blood pressure was measured non-invasively using the SpaceLabs 90207
monitor (O'Brien et al, 1991b), with blood pressure readings made every 30 minutes
throughout the monitoring period. For the purposes of analysis, day-time was defined as
7 am-12 midnight (Stewart et al, 1993) and the 24-hour, day-time and night-time mean
blood pressures calculated, excluding biologically impossible or implausible readings
(Conway et al, 1988). Diurnal blood pressure variation was expressed as percentage
change from day to night for each of systolic, diastolic and mean arterial pressure. Blood
pressure was monitored for the 24 hours immediately prior to test dosing and for a further
24 hours after test dose. Further 24 hour BP monitoring was then undertaken after each 6
week treatment period.
Glomerular filtration rate was measured radio-isotopically after a single intra-venous
injection of "^technetium diethylenetriamine penta-acetic acid (99niTc-DTPA), followed
by repeated blood sampling over 4 hours (Fawdry et al, 1985), in the week before each
test dose and at the end of each 6 week treatment period.
Control Group
The diurnal blood pressure profile at baseline was compared to that of a normal, healthy,
working population studied previously (see Chapter 7).
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Statistical Methods
An estimate of the sample size required to demonstrate a clinically significant difference in
blood pressure was made using the method of Donner (1995) for crossover studies,
assuming the most conservative situation, i.e. that there is no correlation between
measurements within an individual between the two treatment periods. Using data from
earlier studies indicating the standard deviation of systolic blood pressure to be 6.99
mmHg, it was estimated that 24 patients would be required to complete the study, with
80% power at the 5% level of significance.
The blood pressure profile was compared to that of the control group using Student's t-test
for independent samples. Baseline comparability and between group differences were
assessed using Student's paired t-test or Wilcoxan matched pairs test as appropriate.
The strength of association between left ventricular ejection fraction and measures of
blood pressure were examined using Pearson's correlation coefficient. The change in
renal function over the period of study was compared to the change in blood pressure
using Spearman's rank correlation coefficient.
Statistical significance was taken as p< 0.05.
Results
Patient characteristics
Forty-eight patients were screened for entry into the study, 41 of whom completed the one
week placebo run-in period and entered the cross-over phase of the study. Of the patients
not randomised 3 had an ejection fraction > 35%, 3 withdrew consent and one developed
atrial fibrillation. Of the 41 patients entering the cross-over phase, 21 were randomised to
Sequence L (Lisinopril -» Captopril) and 20 were randomised to Sequence C (Captopril
-» Lisinopril). In total, 13 patients failed to complete the study, seven patients in
Sequence L and six patients in Sequence C. Two patients were withdrawn because of
worsening or inadequately controlled heart failure, one patient died suddenly, with the
death ascribed to ischaemic heart disease, one patient died after acute myocardial
infarction, and one patient sustained a disabling stroke. Two patients withdrew
complaining of side effects from medication and one patient withdrew after an acute
anxiety attack. Five patients were withdrawn for other reasons.
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Thus, 28 patients completed the study, 14 in each sequence group. The results presented
here are for these patients only. Baseline demographic details are given in Tables 9.1 and
9.2.
Although there were minor differences between the two sequence groups in terms of
demographic parameters, these were not statistically significant and, as this was a cross¬
over study, should have no influence on the analysis of the study.
Four patients had a history of chronic ischaemic heart disease, 3 a history of previous
myocardial infarction and 2 patients had undergone coronary artery by-pass surgery. One
patient was hypertensive.
All patients were treated with the loop diuretic frusemide, 22 (79%) maintained on 40 mg
daily and 6 (21%) on 80 mg daily. Twenty patients (71%) were on low dose aspirin
therapy, 11 (39%) on isosorbide mononitrate, 4 (14%) on digoxin and 5 (18%) on a
calcium antagonist.
Table 9.1 Baseline Demography
Variable (mean ± S.E.M.) Sequence L Sequence C Total
Number of Patients 14 14 28
Age 63+2.6 64.4+1.7 63.7 + 1.5
Gender - male 11 (79%) 10 (71%) 21 (75%)
Gender - female 3 (21%) 4 (29%) 7 ((25%)
Height 171+2.6 167.9+2.5 169.4+1.8
Weight 80.3+4.2 71.6+3 75.9+2.7
Ejection fraction 24.7 + 1.9 23.5+2 24.1 + 1.4
Duration of heart failure (months) 13.2+6.3 11+5.3 12.1+4.1
NYHA Grade I 6 (43%) 4 (29%) 10 (36%)
NYHA Grade II 7 (50%) 7 (50%) 14 (50%)
NYHA Grade III 1 (7%) 3 (21%) 4(14%)
There were no significant differences between groups.
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Table 9.2 Baseline Outcome Variables
Variable (mean ± S.E.M.) Sequence L Sequence C Total
Clinic Systolic BP 124±5 134+4.7 128 + 3.5
Clinic Diastolic BP 72±3.2 81+2.5 76+2.1
24-hour Mean Systolic BP 116+4.4 119+2.9 117+2.6
24-hour Mean Diastolic BP 72+2.6 72+2.1 72 + 1.6
Day-time Mean Systolic BP 120+4.4 123+3 121+2.7
Day-time Mean Diastolic BP 75+2.6 75+2.3 75 + 1.7
Night-time Mean Systolic BP 110+4.5 110+3.3 110+2.8
Night-time Mean Diastolic BP 67+2.7 66+2.3 66+1.8
Nocturnal SBP Dip (%) 9+1.8 11.4+2 10.1 + 1.3
Nocturnal DBP Dip (%) 12.1+2.2 13.9 + 2.2 13 + 1.6
GFR (ml/min/1.73m^) 81.6+5.8 71+5 75.8 + 3.9
There were no significant differences between the groups.
Outcome Measures
Diurnal blood pressure variation was preserved in the patients with heart failure, but
appeared blunted in comparison to a healthy population (Table 9.3, Figure 9.1). Night¬
time blood pressure in the two groups was remarkably similar, with the greater nocturnal
dip in the control group predominantly due to higher day-time pressure. The working
population was significantly younger than those with heart failure (36 ±1.1 vs 64 ± 1.5
years) which is likely to partially, but not completely, explain this difference.
Table 9.3 Comparison of Ambulatory BP Profile in Heart Failure Patients to
a Healthy, Working Population.
Variable (mean ± S.E.M.) Control Heart failure P
(n = 94) (n = 28)
Day-time Mean Systolic BP 127 + 1.1 121+2.6 0.02
Day-time Mean Diastolic BP 79+0.9 75 + 1.7 0.02
Night-time Mean Systolic BP 109+1 109 + 2.6 NS
Night-time Mean Diastolic BP 64+0.8 65 + 1.7 NS
Nocturnal SBP Dip (%) 13.9+0.5 10.1 + 1.3 0.003
Nocturnal DBP Dip (%) 19.1+0.7 13 + 1.5 0.0006
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Twenty-four hour blood pressure profile of patients with heart failure (CCF, solid
symbols) compared to that of a healthy, working population (Control, open symbols).
Hourly average BP + S.E.M. is plotted against time. Day-time BP is seen to be lower in
the heart failure population, with night-time values similar to controls.
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In this population, left ventricular ejection fraction appeared to have no significant
association with diurnal blood pressure variation, either at baseline or after treatment
(Figure 9.2).
Following treatment, blood pressure fell significantly in both treatment groups,
predominantly due to a reduction in day-time pressure (Table 9.4, Figures 9.3 and 9.4).
However, the blood pressure reduction was greater in the lisinopril group, with a
significant fall during the night in this group only. Predominantly as a result of the
greater fall in day-time pressures, diurnal blood pressure variation was significantly
reduced in the lisinopril group only. Despite this, comparison of the final blood pressure
in each treatment group reveals significantly lower blood pressures in the lisinopril group
during day-time only (Table 9.5, Figure 9.5). The nocturnal dip was lower in the
lisinopril group but not significantly so.
Glomerular filtration rate did not change significantly in either group (Tables 9.4 and
9.5). However, there was a small fall in the lisinopril group and a small increase in the
captopril group, possibly suggesting a trend towards greater deterioration in renal function
in the lisinopril group. There was no significant correlation between the change in blood
pressure and that of GFR (Table 9.6).
Table 9.4 Change in Blood Pressure and GFR After 6 Weeks Treatment with
an ACE Inhibitor
Lisinopril Captopril
Variable (mean) pre post P pre post P
Clinic Systolic BP 130 120 0.0002 128 128 NS
Clinic Diastolic BP 76 72 NS 76 76 NS
24-hour Systolic BP 118 110 0.00001 117 113 0.006
24-hour Diastolic BP 72 66 0.00001 72 69 0.002
Day-time Systolic BP 122 113 0.000003 121 117 0.002
Day-time Diastolic BP 75 69 0.000001 75 72 0.001
Night-time Systolic BP 109 105 0.01 109 105 NS
Night-time Diastolic BP 64 61 0.02 65 62 NS
Nocturnal Dip SBP(%) 10.2 6.9 0.01 10.1 9.5 NS
Nocturnal Dip DBP(%) 14.4 10.6 0.03 13.2 12.7 NS
GFR (ml/min/1.73m2) 77.4 73 NS 74.3 76.3 NS
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Ejection fraction, measured radio-isotopically, has been correlated with systolic (circles)
and diastolic (triangles) diurnal blood pressure variation. The apparent negative
correlation is not statistically significant.
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Table 9.5 Comparison of Blood Pressure and GFR after Treatment
Variable (mean ± S.E.M.) Lisinopril Captopril P
Clinic Systolic BP 120±3.6 128+4.3 0.002
Clinic Diastolic BP 73 ±2.1 76 + 2.1 NS
24-hour Systolic BP 110 ±2.3 113+2.6 0.007
24-hour Diastolic BP 66 ±1.5 69+1.7 0.005
Day-time Systolic BP 113+2.3 117 + 2.6 0.003
Day-time Diastolic BP 69+1.5 72 + 1.7 0.003
Night-time Systolic BP 105+2.6 106+2.8 NS
Night-time Diastolic BP 61 + 1.7 63 + 1.9 NS
Nocturnal Dip SBP(%) 6.9 + 1.6 9.2 + 1.6 NS
Nocturnal Dip DBP(%) 10.6 + 1.8 12.4+2 NS
GFR (ml/min/1,73m^) 73+4.3 76+5.1 NS
Table 9.6 Strength of Association Between Change in Blood Pressure and
Change in GFR
Lisinopril Captopril
BP Variable Spearman Rank Spearman Rank
Correlation Correlation
Clinic Systolic BP 0.15 -0.1
Clinic Diastolic BP -0.9 -0.11
24-hour Systolic BP 0.13 -0.18
24-hour Diastolic BP 0.14 -0.01
Day-time Systolic BP 0.11 -0.16
Day-time Diastolic BP 0.12 0.14
Night-time Systolic BP 0.15 -0.16
Night-time Diastolic BP 0.09 -0.12
Nocturnal Dip (%) -0.19 0.04
Nocturnal Dip (%) -0.06 0.21
No correlation was significant at the 5% level.
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Twenty-four hour blood pressure profile of patients with heart failure at baseline (solid
symbols) and after 6 weeks treatment with lisinopril (open symbols). Hourly average BP
± S.E.M. is plotted against time. The reduction in BP with lisinopril treatment,
predominantly in day-time, is readily appreciated. The greater reduction in day-time than
night-time BP results in some attenuation of the diurnal variability.
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Twenty-four hour blood pressure profile of patients with heart failure at baseline (solid
symbols) and after 6 weeks treatment with captopril (open symbols). Hourly average BP
± S.E.M. is plotted against time. There is a slight reduction in the ambulatory BP curve
with captopril, but diurnal variability is preserved.
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Figure 9.5 Comparison of Diurnal Variation in Blood Pressure after 6 Weeks
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Twenty-four hour blood pressure profile of patients with heart failure after 6 weeks
treatment with the long-acting ACE inhibitor, lisinopril (solid symbols), and the short-
acting agent, captopril (open symbols). Hourly average BP ± S.E.M. is plotted against




There was a small but statistically significant increase in serum creatinine in patients
treated with lisinopril only (Table 9.7).




pre post P pre post P
Creatinine (/xmol/1) 102 ±3.2 109±3.6 0.01 107+4.2 107 + 3.2 NS
Urea (mmol/1) 6.1 ±0.3 6.5+0.5 NS 5.9+0.4 6.3+0.4 NS
There was no statistically significant difference between the variables in the two treatment
groups at baseline or after treatment.
Median NYHA grade was 2 in both treatment groups at baseline, falling to 1.5 in the
captopril-treated group and unchanged in the lisinopril-treated patients. This difference
was not statistically significant. Responses to the patients questionnaire were broadly
similar.
Discussion
This study has demonstrated persistence of the diurnal blood pressure profile in patients
with mild to moderate heart failure, and this profile was maintained after treatment with
an ACE inhibitor. The amplitude of the nocturnal dip was reduced when compared to that
of a normal, working population. However, as no attempt was made to match these
populations, this observation must be treated with some caution. In this study, the
amplitude of diurnal blood pressure variation did not appear to be related to the severity
of heart failure as measured by radionuclide ventriculography. This contrasts with two
earlier studies (Caruana et al, 1988; van de Borne et al, 1992) both of which studied
patients with more severe heart failure. Thus, it is possible that this relationship is only
manifest in end-stage heart failure, when activity levels are significantly reduced, and
where the influence of cardiac output on blood pressure is likely to be greater. Moreover,
sleep patterns are disturbed in the later stages of heart failure (Dowell et al, 1971; Hanly
et al, 1989) and this may lead to higher pressures during the night in those most severely
affected.
In keeping with previous studies (Packer et al, 1986; Oster & Materson, 1992) blood
pressure fell in most patients when treated with an ACE inhibitor. Potentially important
163
differences in the blood pressure profile between treatments were apparent, with lower
clinic and day-time mean BP on lisinopril, confirming the observation of others (Giles et
al, 1989; Osterziel et al, 1992). This presumably reflects the much shorter plasma half-
life of captopril (about 1 hour) compared to that of lisinopril (about 12 hours). However,
against initial expectations, there was only a modest decrease in the night-time blood
pressure, which, although significant for lisinopril only, was similar for both drugs. Thus
the fall in day-time BP led to a reduction in the nocturnal dip in both groups, reaching
statistical significance with lisinopril only. If the reduced diurnal profile was a function of
left ventricular function per se, we might have expected the converse with treatment
known to have a beneficial effect on haemodynamics (Chatterjee et al, 1985; Fonarow et
al, 1992), ejection fraction (Giles et al, 1989), and prognosis (The SOLVD Investigators,
1991). This would appear to argue against the view that the left ventricle contributes
directly to the maintenance of the normal blood pressure profile. The greater reduction in
pressure over 24 hours with lisinopril may indicate greater reduction in left ventricular
after-load, explaining the improved exercise performance in patients treated with this
agent (Giles et al, 1989).
Renal blood flow appears to be the principal determinant of glomerular filtration in
patients with congestive cardiac failure (Cody et al, 1988). Thus, there is a concern that
the fall in blood pressure may have deleterious effects in some patients. Indeed, several
workers have noted that there is a greater deterioration in renal function with the longer
acting ACE inhibitors, which are associated with a larger fall in blood pressure (Packer et
al, 1986; Giles et al, 1989; Osterziel et al, 1992). The clinical significance of this is
uncertain (Oster & Materson, 1992). Many studies have relied upon serum creatinine or
creatinine clearance as measures of renal function, which are unreliable: it has been
estimated that a 28% difference between results is needed to detect a change in renal
function (Brochner-Mortensen, 1978). In this study glomerular filtration rate has been
monitored isotopically, using a method shown to be both accurate and reliable (Fawdry et
al, 1985). To determine whether the fall in blood pressure seen with ACE inhibition is
directly related to change in GFR, ambulatory blood pressure parameters have been
compared to the change in GFR. In particular, as lowest blood pressures are normally
attained during sleep, the hypothesis was that a fall in nocturnal blood pressure would lead
to a fall below renal perfusion pressure and consequent deterioration of GFR. However,
there was no significant change in GFR in either group, and no evidence of any clear
relationship in change in GFR to any measure of blood pressure or to the diurnal rhythm.
As noted previously, the fall in pressure during the night was much less than that seen
during the day and is unlikely to be primarily responsible for the change in renal function.
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The renal effects of ACE inhibitors in heart failure are dependant upon inhibition of both
the circulating and tissue renin-angiotensin systems (Hirsch et al, 1990). The initial
decline in renal function seen after starting an ACE inhibitor in the patient with heart
failure may be related to a transient fall in renal blood flow (Mujais et al, 1984), related
to the fall in blood pressure, which corrects over the course of the first few days of
treatment (Mujais et al, 1984), perhaps because of less constriction of the afferent
arteriole. During long-term therapy renal plasma flow actually increases and GFR
remains stable (Mujais et al, 1984; Cleland et al, 1986). However this will not occur if
the blood pressure decreases to the level at which renal blood flow becomes directly
proportional to perfusion pressure, that is if the renal perfusion pressure is reduced to the
range in which auto-regulation becomes dependant on an intact tissue renin-angiotensin
system (Hricik & Dunn, 1990). This has been estimated to occur at a mean arterial
pressure below 60 mmHg (Cleland et al, 1984). In this study, the night-time mean
arterial pressure averaged 78 mmHg in the captopril-treated patients and 77 mmHg in the
lisinopril-treated patients, remaining well above critical perfusion pressures. It is possible
that part of the explanation for the relatively higher pressures during sleep in patients with
severe heart failure, and for the smaller than expected fall in nocturnal pressures seen after
treatment in this study, is auto-regulation independent of the renin-angiotensin system,
designed to prevent a fall in blood pressure below critical perfusion pressure.
Conclusions
The diurnal blood pressure rhythm is preserved but blunted in patients with mild-to-
moderate congestive cardiac failure, and the amplitude of day-night variation is not related
to severity of left ventricular dysfunction. The nocturnal dip in blood pressure is reduced
further by angiotensin converting enzyme inhibition, largely as a result of a greater
decrease in day-time than night-time blood pressure. This change in the blood pressure
profile is greater with the longer acting drug, lisinopril, possible indicating greater off¬
loading of the left ventricle. There was no evidence of a clinically important effect on
renal function after ACE inhibition with either drug, and no obvious relationship between




It is almost a century since Hill (1898) described the variability of blood pressure over the
course of a day, noting the nocturnal fall in pressure with sleep, yet the clinical
importance of the nocturnal pressure remains uncertain. Early work by Perloff et al
(1983), using a prototype non-invasive ambulatory blood pressure monitor, demonstrated
that ambulatory readings provide prognostic information over and above the clinic
pressure, but this device required subjects to self-inflate the arm cuff, preventing nocturnal
measurement. The development of a technique for monitoring ambulatory pressure
continuously over 24 hours using an indwelling intra-arterial catheter - the Oxford
technique (Bevan et al, 1969) - soon led to the description of the dramatic change in blood
pressure during sleep (Littler et al, 1975). However the invasive nature of this technique
limited it to small numbers of research studies. It is only in the last decade that
technological advances have led to the development of monitors which are sufficiently
miniaturised and reliable to allow routine monitoring of non-invasive blood pressure over
24 hours in large numbers of patients. In this period the technique has rapidly moved
from research tool to accepted clinical procedure.
Clinical acceptance of this technique has in part depended upon demonstration of the
accuracy of these monitors, and the development of protocols for device validation
(O'Brien et al, 1990c) has been an essential component of this. However, when starting
this work, a major limitation of these protocols, emphasised subsequently (O'Brien et al,
1993), was the lack of device validation in specific patient groups. In particular, the
impact of cardiac arrhythmia on the accuracy of electronic blood pressure measuring
equipment had never been tested. As atrial fibrillation, the commonest clinically
significant arrhythmia in the community (Lip & Beevers, 1995), is known to make
conventional blood pressure measurement more difficult (Sykes et al, 1990), knowledge of
monitor accuracy in this patient sub-group is of some importance. The study of 30
patients with chronic, controlled atrial fibrillation described in Chapter 2 confirmed these
reservations. Neither the SpaceLabs 90207 nor the Accutracker ambulatory monitor
achieved a satisfactory level of accuracy, and both devices failed to register any pressure
in a substantial proportion of patients. One semi-automatic electronic
sphygmomanometer, the Copal UA-251, did achieve reasonable accuracy, but clearly such
devices are of no value in the monitoring of nocturnal blood pressure. As a result of this
166
work, patients with atrial fibrillation were excluded from both routine clinical study with
ambulatory monitors and from the subsequent studies described here.
With the more widespread application of ambulatory blood pressure monitoring, different
patterns of diurnal blood pressure variability have come to be recognised. In particular, a
substantial proportion of subjects have been found not to have the normal nocturnal fall in
blood pressure, leading O'Brien et al (1988) to coin the term "non-dippers" to
differentiate this sub-group from the more common "dippers". The same authors noted an
apparent excess of stroke in the former group, suggesting that this distinction may be of
prognostic importance (O'Brien et al, 1988). Subsequent work has suggested that left
ventricular hypertrophy (Gosse et al, 1988a; Verdecchia et al, 1990) and cerebrovascular
disease (Shimada et al, 1992) are also more common in non-dippers. Moreover, several
authors have noted that the phenomenon appears more common in patients with secondary
hypertension (Hany et al, 1987; Imai et al, 1990; Middeke & Schrader, 1994).
These initial clinical observations made no attempt to standardise the monitoring
procedure, and methods for calculating the nocturnal dip in blood pressure and classifying
patients as dippers or non-dippers varied widely, with several different definitions of day
and night used to define the diurnal profile. In Chapter 3, I have examined the
ambulatory blood pressure profile of 249 subjects and shown the profound effect which a
change in the start of night-time can have, with the proportion of subjects classified as
non-dippers varying from 47% (night-time = 8 pm to 7 am) to 36% (night-time =
midnight to 7 am). I have then explored the potential for wrist worn activity meters to
improve the definition of the diurnal profile by allowing the accurate quantification of
sleep time, rather than relying on an arbitrary definition of night. Prospective study of
319 patients who underwent simultaneous activity and blood pressure monitoring
confirmed that the nocturnal fall was greater when defined on the basis of sleep. As
inclusion of wake readings in the night-time value will erroneously increase this value in
most patients, this observation suggests that the activity-derived sleep time is more
physiologically sound. Night-time blood pressure defined as midnight to 7 am was most
similar to sleep blood pressure. On the basis of this study, I have recommended that wake
and sleep blood pressure be used in clinical studies whenever possible, and 12 midnight to
7 am used for the arbitrary definition of night-time where sleep times are not known
(Stewart et al, 1993).
Activity is a major determinant of blood pressure and differences in the pattern of activity
on different monitoring days can reduce the reproducibility of the ambulatory blood
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pressure profile (Pickering, 1990c). Activity monitoring has the potential to assess
change in activity pattern and so correct for this. A subset of the patients studied in
Chapter 3 were therefore asked to undergo repeat monitoring and the strength of the
relationship between activity and blood pressure was studied to determine the optimal
actigraphic measurement for activity-blood pressure regression analysis and determine
whether such adjustment could improve reproducibility. While there was wide variation
between patients in the activity measure most closely related to blood pressure, mean
weighted activity over the 30 minutes prior to each blood pressure monitoring proved to
be the most useful value for modelling the wake blood pressure value. On average,
actigraph measurements accounted for 20% of systolic and 26% of diastolic blood
pressure variability, but with marked intra- and inter-individual variation, limiting the
applicability of this technique to routine clinical practice. The impact on reproducibility,
while marked in some individuals, was limited and not clinically significant when applied
to the group as a whole. At the present time, while worthy of further study and
refinement, this technique has not been applied to continued clinical work.
Blood pressure is Normally distributed in the population and the distinction between
normotension and hypertension is now known to be a medical artefact dependant upon the
definition chosen for hypertension. In Chapter 4, I have demonstrated that the same
tendency to divide the population in two has been erroneously applied to the nocturnal
dip. Analysis of the diurnal blood pressure pattern of over 1000 individual subjects
referred for ambulatory monitoring over a 4 year period found no evidence of significant
deviation from Normality and, more particularly, no evidence of bimodality. This
important observation means that the nocturnal dip should be treated as a continuous
variable, using parametric statistics. The absolute change in blood pressure variation is
more important than classification as a dipper or non-dipper.
Analysis of this same data set allowed study of other extraneous variables with the
potential to influence the nocturnal dip. Age was shown to be an important determinant
of the dip, with a progressive decline in diurnal blood pressure variability as the age
range increased. Severity of hypertension did not, however, appear to have any important
impact. When studying different population groups it is therefore important to allow for
age as a possible confounding variable.
The effect of anti-hypertensive drug therapy on any blood pressure variable ideally
requires double blind, controlled study, but the numbers required for study of each
different class of anti-hypertensive drug prevented such analysis here. However
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retrospective analysis of this database has enabled some conclusions to be drawn. Treated
patients tended to have a smaller nocturnal dip than untreated and, after correcting for
age, this appeared to reflect lower day-time pressure in the treated group. This may be
because decisions about drug treatment continue to be based solely on blood pressure
measurements made during the day, with sub-optimal wake blood pressure prompting a
change in therapy, while an inadequate effect on nocturnal pressure is either not noticed
or ignored. Analysis by drug class revealed blunted diurnal variability in those treated
with calcium channel antagonists, but as such patients were older with more severe
hypertension it is difficult to determine whether this is a specific effect of these agents.
Diurnal variability in the other major classes of drug were, allowing for age, similar.
Study of those patients who had undergone repeat monitoring after a change in treatment
found similar lowering of day and night pressure with no overall impact on diurnal
variability. Thus, it appears unlikely that anti-hypertensive drug treatment, as used in
normal clinical practice, has a major independent effect on the nocturnal dip.
Several authors have suggested that knowledge of the nocturnal dip could aid the
differential diagnosis of secondary hypertension (Hany et al, 1987; Imai et al, 1990;
Middeke & Schrader, 1994). The data in Chapter 4, while confirming that diurnal
variability is attenuated in certain forms of secondary hypertension, suggests that this
effect is non-specific, and, as the number of patients with essential hypertension far
outweighs those with secondary, blunting of the diurnal profile will be more commonly
found in primary than secondary hypertension. As such, knowledge of the ambulatory
blood pressure profile does little to aid the diagnosis of secondary hypertension.
However study of such patients does provide some insight into possible mechanisms
underlying the nocturnal dip. Catecholamine excess appears to have the most profound
impact on diurnal variability, suggesting an important role for the autonomic nervous
system. Attenuation of the nocturnal dip in patients with acromegaly, whose hypertension
is thought to be volume mediated, and in those with both mildly and severely impaired
renal function leads me to speculate that hypervolaemia resulting in posture related
changes in blood pressure also plays a role in diurnal blood pressure variability.
Blunting of the nocturnal fall in blood pressure in patients suffering from glucocorticoid
excess, whether due to Cushing's syndrome (Imai et al, 1988b) or exogenous
glucocorticoid excess (Imai et al, 1989), has been a consistent finding in published work
and I have confirmed this in a small group of patients with Cushing's syndrome. The
study of patients with hypopituitarism who require glucocorticoid replacement therapy
permits study of change to glucocorticoid exposure within the physiological range. Study
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of such patients has previously shown that the diurnal blood pressure profile is not altered
by reversing the pattern of therapy (Jyothinagaram et al, 1989). In Chapter 5, I examined
the effect of a doubling of the dose of hydrocortisone given and, although achieving a
significant increase in exposure to glucocorticoid, found no evidence of any effect on the
diurnal blood pressure profile. Thus, it appears that pathological, but not physiological,
quantities of corticosteroid are capable of modifying the diurnal rhythm, making a
physiological role for Cortisol in the control of the nocturnal dip unlikely.
Data on the ambulatory blood pressure profile of patients with accelerated phase
hypertension is surprisingly limited, with the study most frequently quoted as
demonstrating loss of diurnal variability in such patients actually referring to a group
studied with a stationary monitor which tied patients to their beds (Shaw et al, 1963). In
Chapter 6 I have studied patients with accelerated hypertension before and after treatment,
and confirmed blunting of the diurnal profile, as compared to essential hypertensives,
which returns towards normal after successful treatment of the accelerated phase. Seven
of the 11 patients studied had impaired renal function which, as described in Chapter 4,
has the potential to influence the nocturnal dip, and it is not possible to determine the
extent to which this contributes to the observed effect. Nonetheless, the normalisation of
the diurnal profile, which was pronounced, does imply that the accelerated phase per se
may influence the nocturnal dip.
However, 9 of the 11 patients were hospital in-patients when first studied. To determine
the potential importance of this I have also studied two control groups requiring
emergency hospitalisation: patients with acute stroke who were hypertensive, and a mixed
group of emergency hospital admissions who were normotensive. Although blunting of
the diurnal profile was more pronounced in the patients with accelerated hypertension,
there was no statistically significant difference between the three groups. The blood
pressure changes which occur following acute stroke are complex, and it is possible that
loss of the nocturnal dip is part of this pathophysiological process. However, taken
together, these data suggest that emergency hospitalisation itself may result in an initial
loss of the diurnal rhythm.
Both cardiac and renal damage are correlated with blood pressure and the severity of
hypertension but, while it is clear that ambulatory blood pressure is a better predictor than
clinic pressure, debate as to which blood pressure measure is most important has not been
resolved. Previous work has tended to concentrate on one blood pressure measure and
has frequently studied selected patient subgroups. In an attempt to overcome some of
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these limitations, I have studied a randomly selected group of healthy, working
volunteers, with no previous history of hypertension or cardiovascular disease. By
undertaking a screening study prior to randomisation it was possible to weight this cohort
such that most subjects with an elevated clinic pressure were included. Comprehensive
blood pressure assessment included nurse-measured clinic pressure, blood pressure
response to isometric exercise, and 24 hour ambulatory blood pressure monitoring with
activity derived sleep/wake indices. Target organ damage was assessed by
echocardiographic measurement of cardiac structure, Doppler assessment of left
ventricular haemodynamics and by measurement of urinary albumin excretion. In
multiple linear regression analysis I have found wake blood pressure to be the most
consistent predictor of both left ventricular mass and diastolic function, while sleep
pressure was the better predictor of urinary albumin excretion. While 57% of the
predictive information was attributable to the ambulatory blood pressure, knowledge of
diurnal blood pressure rhythm accounted for a further 19%. Peak exercise blood pressure
accounted for 10% and the increase in blood pressure with exercise and clinic blood
pressure a further 4% each. This work, described in Chapter 7, suggests that the mean
blood pressure from ambulatory monitoring is the best single predictor of target organ
damage, but with additional information imparted by knowledge of diurnal variability.
Exercise and clinic blood pressure appear relatively less useful measurements.
Hypertension and sleep apnoea commonly co-exist but the pathophysiological relationship
remains unclear. In Chapter 8, I have investigated the possibility that occult sleep apnoea
accounts for nocturnal hypertension and loss of diurnal blood pressure variability in
patients with essential hypertension. Patients with proven, symptomatic sleep apnoea and
with chronic obstructive pulmonary disease, who experience profound nocturnal hypoxia
but not apnoea, were also studied. There was no evidence of any association between
sleep apnoea and nocturnal hypertension or diurnal blood pressure variation in essential
hypertension, and normal diurnal variation in BP in those with symptomatic sleep apnoea,
making any pathophysiological link between the two conditions unlikely. Minor blunting
of the diurnal blood pressure rhythm in COPD patients with significant hypoxia makes it
impossible to exclude an effect of hypoxia on nocturnal BP but there was no clear linear
relationship, and reduced day-time activity, with consequent failure of blood pressure to
rise during wake hours, appears a more likely explanation for this observation. The
increased prevalence of sleep apnoea in essential hypertension is probably caused by the
confounding variables of age and obesity. There was, however, a greater prevalence of
sleep apnoea in treated subjects, and a potential adverse effect of anti-hypertensive drugs
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on ventilatory control remains a plausible mechanism for the previously observed excess
of sleep apnoea in a hypertensive population, with possible therapeutic implications.
The heart has a central, active role in haemodynamic regulation and is no longer thought
of as a simple pump. An independent role for the heart in the control of the diurnal blood
pressure rhythm has heen suggested by studies of orthotopic cardiac transplant recipients
(Sehested et al, 1990b), patients with left ventricular hypertrophy (Verdecchia et al,
1990) and those with systolic dysfunction (Caruana et al, 1988). In Chapter 9, 1 have
studied patients with mild to moderate congestive cardiac failure before and after the
introduction of ACE inhibitor therapy, known to improve haemodynamics, ejection
fraction and prognosis. The diurnal rhythm was preserved but blunted in such patients,
with no evidence of any relationship between severity of left ventricular dysfunction and
the nocturnal dip. Diurnal blood pressure variation was reduced further by active
treatment, largely due to a greater decrease in day-time than night-time blood pressure,
arguing against a significant role for the left ventricle in the maintenance of the normal
diurnal blood pressure profile. Concern that excessive reduction in blood pressure may
have an adverse effect on renal function proved unfounded, with no significant change in
glomerular filtration apparent.
Arterial blood pressure is a complex physiological variable, controlled by an interplay
between anatomical factors which vary with age (i.e. length and structure of the resistance
vessels), autonomic nervous system function, baroreceptor reflexes, and both tissue and
plasma hormone levels. As such, it should come as no surprise that one measure of hlood
pressure variability, the day-night rhythm, should prove so difficult to define accurately,
with multiple confounding factors and causality. Whilst intrinsically related to sleep, the
nocturnal dip varies widely in the population, with multiple additional factors determining
the extent of the fall. This work has clearly demonstrated that classification of an
individual as dipper or non-dipper is no more physiologically sound than the classification
into normotensive and hypertensive. Indeed, study of the relationship of the dip to age,
and of diurnal blood pressure variation in patients with chronic lung disease or heart
failure, suggests that the day-time rise is as important as the night-time fall in many
subjects - blippers and non-blippers ? Nonetheless, knowledge of diurnal variability does
appear to provide additional prognostic information over and above the ambulatory mean,
and as such could aid the characterisation of the risk profile in the individual patient.
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ERRATUM
Attention is drawn to the following typographical errors in the text of this work :
p29 Paragraph 1 and Wilcoxon misspelled as Wilcoxan
p 83 Paragraph 1
p46 Title of Table 3.2 Dependent misspelled as dependant
p54 Paragraph 3 The first sentence should read "Short term blood pressure
variability has also been shown to be higher in
hypertensives than in normotensives ..."
p56 Paragraph 7
p69 Paragraph 3
Compared misspelled as compered
The final sentence should read "Patients with
hypothyroidism, now recognised as a treatable, secondary
cause of hypertension ..."
p76 Paragraph 3 The first sentence should read "....benign hypertension is
likely to be ischaemic in origin."
pi03 Paragraph 3 The first sentence should read "As sex and body size
significantly influence LV size,..."
pi 19 Paragraph 3 This sentence should read "Where peak BP after exercise
was less than that at baseline, the BP difference was
scored as zero."
pi26 Paragraph 3 In the second sentence, qualitative should be replaced with
quantitative.
pl28 Paragraph 3 In this paragraph, variation should be replaced with
variance.
pl33 Paragraph 1 and Apnoeic misspelled as apnoic.
pi33 Paragraph 2
